var title_f24_42_25248="Disseminated candidiasis nodule";
var content_f24_42_25248=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nodules in disseminated candidiasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 247px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large erythematous, nodular lesions with central necrosis in a patient with acute leukemia and disseminated candidiasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paula Jones, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25248=[""].join("\n");
var outline_f24_42_25248=null;
var title_f24_42_25249="Enlarged nuchal translucency2";
var content_f24_42_25249=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F54043&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F54043&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronal view demonstrating the abnormal fluid accumulation and the nonfused amnion separate from the fetal skin in the nuchal region",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 318px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE+AbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5ZkkfzG+dup70nmP/AH2/Okk/1jfU0lADvMf++3512nwl0Vdc8WIb6IT6dZRPd3KyyiOMqo+VWY8KGYqM+9cTXTeCY0ne/gmMhheNd6KxAfDAjcAeR9aAPdvEmiWVxYX+i6b4Q01Lye1vPsUtvHukYRCIxOjdCWEnJ9vrXlmkaXeWVotnfW7w3tvI8csUi/MrBjkH3rbt4zDFbMlxdKIEMcJS5kHlqeqr83yg+grUs4LcQO0u6UuS5ZnLMWPJJJ5JoA5670+J49zDypR1yKxSR8yuivt7qa2NQubmHzFUbo+27muQvXnR3kUYB7qaAEu5jljEpI9B2qgJ3VWw/wCBqOO4ZpceYcn1rXm0US2fm+ayvjOMUAYbahcAEZFVXmkZsl2/OlnheGQq/bvUdADvMf8Avt+dHmP/AH2/Om0UAO8x/wC+350eY/8Afb86bRQA7zH/AL7fnR5j/wB9vzptFADvMf8Avt+dHmP/AH2/Om0UAO8x8ffb8zR5j/32/Om0UAO8x/77fnR5j/32/Om0UAO8x/77fnR5j/32/Om0UAO8x/77fnR5j/32/Om0UAO8x/77fnR5j/32/OmnI6jFFADvMf8Avt+dHmP/AH2/Om0UAO8x/wC+350eY/8Afb86bRQA7zH/AL7fnR5j/wB9vzptFADjJIf42/OjzH/vt+dNooAd5j/32/OjzH/vt+dNooAXzH/vt+dL5j/32/Om0UAO8x/77fnR5j/32/Om0UAO8yTj52/OjzH/AL7fnTaKAF8x/wC+350okkBzvb86bU1naz3t1HbWkMk88p2pHGpZmPoAKAIzI+c72596PMf++350pRgrfKRt6+1R0AP8x/77fnR5j/32/Om0UAO8x/77fnSxyPvX526jvTKWP/WL9RQB3nw/8N2niHR/FCyWzz6nHHEmn7MkiZmY4wDzkKRz610mq/DG01C6tLbRJvsU8WmCSZJYpJPOnVpFkYkZEa5TqTiuI8HalrthJfjw/bibyzHfTny93lrAxcMfRQTz69K6yDVviFpeiWtyunKthcrFDbyNAjlyzOyFec7z5jjp0PtQBzWt+CJdN8OpqcepWty4toLue1RWDwRTcKSTwfm4wOeQeldT8O7XSLrwZf3FtZhNVtAomm+0kyOTJ18voIwCBnru9qzPHWq67PLp3hFtPnspUt7W1e2kiVZpXVQAu4feQt8ygnqa2fC0PiyHwo0V5phh0aBSqXSwoHYLIcozDllDbvoaAFeKWTdGzce3BFUXlvLUlUl3p2rSfQNd1CdEsbG4klMQmXZ3Q/dOc45wcetYumRavqepnTraymmvhu/dhcN8vXOemMd6AMjWtUmQ4KFD3I6Gueu71pFwpAJ9K6nWp7jyninth5iEqwYYZT6VxlwgD7gCh9KAHxwySYbOR61uwC8W3/cN5i45U1gRXEgIHGPpW7pV55BJIDjvg8igDI1J3ZiJIWjbvkdazhW3r139pfCDj361i4PpQAUUUAe+KACijHpRQAUUUUAFFFFABRRRQAUUUUAFFFFAFvT7UXUm1sgeorptD0WzNyBLl+e9ctZ3TWz5ABrVtNYbzBhSG+tAHoL+FLCYLhVGax9a8KWsCnYuCBVfT9bmDDe5/Ouhj1SO7h2uUJx60AeV6jZ/ZZNoORmqldvrdhE5ZiwB6jNcbcx+VMy5B+lAEVFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFnTJ7e21C3nvLVby3Rw0luzlBIP7u4cj6iu6+GXirQ9C8evql7Yy2dpKQsHkSlvsgLAnkglxtBU98E155RQBdu3jl1G4NqHW2eVzGrnLBCTjJ9cYqpIjRuVYYINWtM2G5XzOnvV7xHbxq0M8H3WXa31H/1qAMWiiigApY/9Yv1FJSx/wCsX6igD0H4XTM0uu2s2r2On2c9lNEyXdwIVlkdGRPqATk+nWrvhrWtO8PXPgu2e+jEKTTXt/NEd4SRt0cecc/Koz9GyOtUPhl4YsvEKa3LeabqGpy2hhEdtZTCJyHdgzEkHgAUus/DW9hGs3ulXMFzpNlOY45WbDSqGVWYYBB2swU88nOM0AdzomqaHZ6no9lc6zot1qGlx20M99dZkgaHzpHkWJzyXG6LBGDwecA1p+HdS02bTYpFutHkMdrdwtIs2bxGeeXaFUHGwhlPTua8s1H4d3umQ6jc3Oo6ZJb2E62shilY+ZKcFo1+X7wzznHPTNegeB/h6NP8T3TXktvBZXMzwW8HnGSUKkhBO7aAeVI7H2xQB0GrpDqdtLpdjqVtZNbTw+XLJJtjeOOPblSOwbLAe/rXGW1qdU8W6n9p17ZZOrmaeeb7M1+oIwhPbcQMnsOa6e60/TVhur26aZ7W1ZIhFbSBDI7EgfMRwMKTVW48JaddWc9wb4xxT/ZPsolcBkEzYJfA+bGGA9cZoA8y8X317ceINQlvJrSSeSYsz2jboT/uHuMYrnpmWVSM/OK3fHlra6R4l1OzsJC1tBcNFHubecDjk4GTmuciZWcNlc/WgCxZW4bO5CT6gVcOlSEhgCV+mKvaPeW8UimVQpHrzmuyt7u1vSix+WOlAHI2HhlrwZaKTH97Ga6Sw8CRyQExqWfsK+gvhP4X0DVrBzcgGYDnY+K2LnRtE0G7mK/MoPy7uaAPjbxB4au7KZg9o4x/FjFYS2LqTvUge4r6P8etDqsxMIREXI4HWvMLyCC1kKvyPdc0ActomlQTTAyMB9a6i98MWklnvRYycdVPNYt4yROHtjgey0251qRbcIAGPtkUAc3qdi1nMVHK1SrVkEt4/wDq2OffNWItAmfBMb8+xoAwaWunt/DMryBfLYk10Nv8Nr2eMMsDgHvQB5vRXaat4CvbNsAYPoawrnw/ewLkpmgDIoqZ7WdPvRMPwqHkdRigAooooAKdExDDk49qbTo1LDigC/umIHlHC1qaI6pKN7uzeg4rDjhuD91DViGZrNgXb5vQUAdxezQtDgw/jXFaxFEHLRqQanl1sumMtWVczmd8nOPc0AQ0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFLHy4zQBb0y0lubpFjA5PU16ZP4Oe78NTYkDTBN6Y6bgM4/pXBWErRToIly3HHpXrHh++dLEPcyHpwBQB4awKnB4I6ivrn4OfBbwL4m+G2gatrGnXEt/eRM0rrdSICRIy9AcDgCvmHxnZfY9euCiMsM5MqZ9zz+ua+0v2f7nZ8I/Cq56Qt/wCjnoA+INegitdb1C3gXbFDcSRoCc4UMQB+VUY/9Yv1FaHiU58RaqfW7l/9DNZ8f+sX6igDf0S61QaTrmnaXZy3Edysc1xJEjM0KRMW3cdBzyTW7pmseJdP8BtaPo1xPohfzIbt0mVIssCcFSEYEr/EDWn8IoNZY6jdabdRraW00UrWX2mOA3kyk+WjFiP3YyS3YjjqeOisWu4bbwxq91eW8Ph230qaLUIBeIFdmebMQh3ZYtuUAYx05oA47TfFWuaoviODSNDW5udYma5uXt0lkZE3BioUHaBkdSMjPWuh8NfETU7u9uEFha27reHUJsGQ75Cx4IZiFHzY4AJxWD4Ojv8AUvA8uneGr2O01dNR+0XCm7W2aSHywFOSw3BW3ZHbcODXqnhi30HVm8Sak0NjOkl+IJ74thmUW6eY6HPOZMsD15zigDCsb+4jeWMWEV5BekH7FKjFZOSV2454PQj6VmTa1rN5IUtNLM32meEwRQwsQPsxJEaAdQM89+/eu2F0/wDb/haeODTl09UtEecMA8ZBcFcE5A454qtZ6ik+h2Y0WxsYfNN3GdOe9ZDcZMZ+WYkGJuN2c4O0igDx3WbHVNe1bU5k026lufNknuIYYWYwncS2RjIAJ71jw+HdbNj9vh0fUJLDyzL9oFu5j2Dq27GMe9ex6s97qF0tp4T16O2vrPUVmvJprtImVBDGqsx4EwjIdSRnPvnNcTqWs3T+ANcj/tdp9+uIqtE5jWSMxy5Kx8YQk5xjHNAHFWsqtgliB6eldBYSBmUJ19QcVy9siK3LYb2rqNKszPGGjchh3oA9I8OzatYwiXTLqdXPPyGrGoeJdaQk3U7Fx/z0BFYXh7VrjTHCSqHQd84NaXifxJZ6habM4kxjlaAOYv8AxBLNOc5Vu+08VQluoJR+8kIaqTNGkpcNlqjuwJULqpzQAl1MkeTFhx/smoIkM67ymPrVS3dUm/eLx71sxzeYAqxgA980AS6X5UTDeAPwruNOv7F4wrOuR6Cuc0u1gZgJkHPfNd/o2h2jopjjj/EUAYt1cW4YGBSzDpxxTx4ovoEEYgKj1zXrWneEtPfTQ8xhjcf3Rmud1jwvbSq7QXKqF6grQB5rqPiVXYG7xWPfa1ZTxnYy/jUviLS4/tTIrk7Segrn5NFmXJGSvbNAFe8kikUkEE+1c7c25UljnB9K6SPRpt5Yj8qe0P2Zv38RIHtQByHlt2VsfSm11N3qNsBsEWPwxWBeohYvGevagCrWlpcbO2FQE+9ZlXLa+a3HyqM0AdTpts5OJolAPpUOv6TFt8xGANZ1n4gkh+8oNMv9de5QrtAHtQBjzII3Izmm0MdzEmigAooooAKKKKACiiigAooooAKKKKACiiigAooooAtaZLaw38EmoW7XNqrgywrJ5Zde4Dc4quAXkOwYyeKb3q3ZKFfecEUAbPhq1L3kaydM8k16/Z29skEaQDzpe5PQVwHhiBbhwSm1fWvZfDWm2KWu+dwox/F3oA8r+LtpEuk2c5KtcJNs+UcAFSSP0FfQPwLn2fC3wyPSJv8A0a9eF/Gw2/8AZUItzn/SRz2+61ev/Befb8NPDoJ6RN/6MagD5N8Q86/qf/X1L/6Gaox/6xfqKu68c65qP/XzJ/6EapR/6xfqKAO7+HHg+08VLrMl0upytZeUUg05I2kfexBPzkDAx61ia14bnstLGsxbV0ma5kgthNKguG2kg7owc8Y5I4zTNK1Oe20XXNKtrV5jfmFmkQnMQiYtnAHOc4qHUtZN9oGjaX5IT+zvPxJuyZPMYN07Yxj3oA9Buvhfaf8ACIxajbPq32uSwgu0mlSIWsksm39yrZ3bvm4yOxq94L8K65pem6xZ6jPAbO3ijvreK3njlWZ3by9yMp5wAV474HeuRXx6+Qk+mQT2ws7S28iV9yeZbkFJSMdwCCvcMRmu00H4hTeINbvJl0xbdY7JIYlEjSeXtn8xWJwOAeMYxjAoA1x4Vlk1CC21Z7W2jmK4fzUJO7IwBnk5UqfQ4zWN4r8JSWEjHTEleAvFDJDd4SWJ5GKorDoQSMhgeldPqustqV7BfyaQ1xLGu0GWRnTYc7wBjAB3cHseaztT8Ttp0UcMuhedp0XlfZbaeaTcjxuXXLkZfkn5eO34gHnl/wCCdbW2kuHitDEv2glDcIXxASJGC9cAqRnuelcn4g0+60fVbjT75US5hIEiowYAkA8EexFdtcePrq18UaLqqacsc2l3FxN5bsT5ollZ2U5HGNxH61wesXk2o6pd31zjzrmVpnx0yxJP86AK8D7ZByMe9dboV3HGuAvPsa45QWOB1rf0m1nj2ybAw+lAHS3LzshfDAetcxc3ri62zSceua6SfV447Ly5Iihx2ri7wxzTEpkAnrQBoSywEjbM3506O68r5cMV9Qao2tud4KLvB9q6fTdHS8Kq6tGx7igCDTYVvJAfLYj6V0UGlIzhV2j6jFTW+k3GjEPG3mIexq7LLLdqCIWQ+oFABFpiWy/OF3diKmR7q1y6TsE7AHpVdo7uOPcW3D/aFRJKzkCbbt9KANmLxJfYwt66j0Jq1N4iung8tnLZGMiqa6faG3E0RCkde9WbZY0hMmFYDtigDNdAuZrjawPPFZ93fxM22JSw9K3xLa3AYsoTHGD0rM1HTIZTm32lv9mgCG3kjMZ8yAKfWrun2FrdoxnQD0zU2m6BvTLyuxH8NXJtOdE2wKwYetAHL3/hCC8DmIpkc1w+q+H5bKRlIyO2K9YQtECOWkHYVzuuyzvIVESZ9xQB5g9rIpwI2zVd0ZDhxiuxuoXEuJEVeeayNctdvzRrkDvQBh0tJT442kOApP0FADKXGTitC30e8uG/dwnFd34M+H95f3CgxFyfUUAecJBK33Y2P4U42k46xN+VfUK/B2a3sEmljjAI6ZrHvPhwoQkyRpjsOtAHzkyOn3lI+opoBJwBzXtOp+BbeBG5Ut24zWOnhOC3lBkXOT/doA80FrORkRPj6U3yJf8Anm35V73b+CllsVl8kAEfxVC3g+ziiZp2QH0FAHg7Iy/eUikwcdDXqeq6HaxkiKAFvc1y15prl8RqoPoKAOW2nGcHFJWpqEU0Q2bBnuQKy2Ug4I5oAKKXaQORSEEdqACigAk4A5oIIOCKACrdh/rRuGVHNVVUseK6rwrpNzqFwttY2k13cEFvLhQu2B1OBQB0HhV5rieNI0wueuK9k0yxhNmGuHxgclj1rjvBOmCG4KSQlJkJVlI+ZSOCCOxzXUeJoGgtQZiUj7KDyaAPK/jBcwyWyRwOGVZx06dDXrXwinCfDzQBnkRt/wCjGrxf4i+UdIhMahf9IHHfoa9W+Fcu3wHogz/yzb/0Y1AHzjrX/IZv/wDr4k/9CNVI/wDWL9RVrWDnVr4+s8n/AKEaqx/6xfqKAPVfg8959m1SKwhuGMlxEJJtNlCXluvPzkEYeDruUkc45qzqvhjRJdIvL1YYJUaR5hqls5SFrj7Rs+ypHnABT5x398V5KZXjkcxsyE5B2kjimeY2zaGO3OcZ4z60Ae3XfhLw1Pf3Y07Q5DNYX93Zw2P2p2OovGqMqE9QfmYgL2UdTzW94P086bLNZeDZkEcF3Ib4b1bYSsZCSE8mNQZFPbI9a+dRPKCCJHyDuB3HOfX611/w0j8+9v1MrRkxDkE8/N3oA9oudTuY/CDra6lIAt6YkET4TaEztX/Z7iqs3xBkdit9p8twEeOWLzWVwjqgG4ZHB3At+Nc/DOlj8l/b+dH1DL296dd3FlcxEQqVwOCaAOB8XOL/AFO/ugpjFxO8wV+cbmJxn8a4xwVYg4/Cuz8RNdBmXy9y+oFcbIj7zlTn6UAMUlSCOorqtA1NolHmwhwO61zCxlh3H1FXLOXyPu7s+1AHWavqNvdQYSM5xyGWuctYYmnAdAFzSNdyl+MlT6itK0hSTDnBz2oA3dMis0Cr8vT0rsdJsoGK42lf5VyOjWMbyrsYiu3t7V7eNWQGT2FAFnVdPa3gD73KdsnNcpJflWKiXYc8Gu1kM9zaeXJEQnuawn0lEckW2/HvQBlQXlzL+7eYSJ6Co762ROVV1J9jXR6ZbwCYFogmPUVuamkUllgBCf8AdoA4jTrRyfnuSE9uK1BdwxDyjlh03VQmtX3EiZVHpTobIyDBYn3oAtLaQsGk+dl9CeKhtFiFxy4VQemadeCW3tiihth71kaeJRcE43gmgDoxew2swZC5HqDUkl3Letut5WXIxg9axZL1oXAWLP4Vq6Nf23mbrpNuPegChf21zbHzQZAO5rGnuN0m9m6eorttY1ayni2R4HHeudhtoHYmU78ntQBnRQw6nIB5IPv0ovvDStHiKCVs9+orr9EsIEl8zKqg/vCunfU7Q25gtwjOBjOMUAeGjwjMzkfZ8HNaEfg2e2jDyxlR7iuo1KYwXZdrgr9KZPrUt0oQzEgcdKAM6zs4LOLB3F63/DWtz6fcBokY4qrZIk0oEuzHqTXpPg+68P6dEz3qwuw9RmgChq3jfWr2BY4z5aAf3a5ybXLzYRNP81afiW6i1O8ZrBSIQTgDgVz66R51ypnLge/egCaB72+f90XkJ74wBWhb6DfxOJ5kEh65PQV2Ph7QoPs6FJGBI7CrviHFjamBXyzDHzdqAOJ1nV7iG1EbTRAjgKtcdczXMxMlxPhewFdzbaNaXDmS7ulb2UZq/P4Q0yeIuxZFxxu4oA8jnuIwSzyH2Gcms/7LcXJaWCFtueCTius8R6ZZ2dwY7LEsnbaM4qosV1BbYI2juW6j8KAOLmtJ2mYPGCfQVSn0pnkwiqh7nFdXNN5YIABJ/DNZc5dTu2jr0FAHLXmmPaAtkue5xxWXgs3zbq9FSzN8oEvyr6Via7pot1xAo/CgDliTGfl4NMLFjyc1JLGyN+860ixs/KjigCzpFxBa6jbzXdqt5Ajgvbu5RZB6EjkfhXq3gjxRottrpeGysdDs5YBFMmya7Eo3hjjncrEDGRxXkKqEI3/lXV+GlMzqUQKPU0AeteH7pluLmWxjMNo8jtGG5YKSSMn1xU2pteanKRgsB/EfuiovD1vcvCicKnqam8RytZwBY7nc2PuJ2oA88+J2nCz0OCRn3SNcAH/vlq774aTbfBWjD0jb/wBDavNvH1xPPoEJmB2i4GCf91q7r4eS7fB+kjPRD/6GaAPDdV51O8PrM/8A6EarR/6xfqKn1M51K7/67P8A+hGoI/8AWL9RQASf6xvqaSlk/wBY31NJQAV1vw6/4/7v5iuIxz/wKuSrpPBH/H5c9j5Y5/GgD1SOVHh2STJnsSKhntZChaIxMRVW0s1uICzruI7qaozyT2blYyzKOxODQBBqKuAQ8RVvUcisi3jQTjzYc5PXbVq+1edRlrdjUml61bvIBLEV9eM0AaLaXaXEXz2ilT/EoxXM6n4dhtrndBuA9M16NbeIbKGAIEUgj0rmdbnFxKXhCgE8A0Ac6LKIRgnJPpir+ladlwyqCPQipre2eX5iuCPQ10vh26treVUu1AHqRQBDYWTGUARbG9RW/m508K0iMy1qvPp8W2e2kjIAzwagvdYt9Qj8pWUN6igCtNr1uqR7439xSNfw3K+ZAGVR2AxWPdabfM/yAyJ7Co4ra6iO0o4z2LYFAGrcX1p5e9XxIOxFUbnxBcNb+WkKsB3Xiq1xaSjnAGevOaZYPHaytvyx7gDigCr/AGq0oKvGFb/aFSRajKpAB/AVqrLBLKDJDGV9xW2mm6bLarJtRH9jQBhSzu9uDcBlB9RT9KiicFoYia2I9PZ1IjkRoxzhuahQIjbYwY3HHy9KAMOcym4IeAIvriraWMLxb3kxnsK1bqNxjcN2e+RT3sw8Yc4BA6UAQJoFtLp7z7PlXqxNcvcwtHIy228AHrmujN1JBG0AJaM9RniozbSzRnYiqD70AY1lLdrnLMR781aVLqUnYCo9aZI0lm5VoyQepq/ZywsoZ2H+6WoAo3GlSGNpWBdgO561RtbGeaTDAIM4GBWvdyREnyuv14pLUyOQqyqhJ65oAgt7Hy59ssldfpmjRvAXZkAxxxXM39k0LBhOZD61dtppRa4nmlWMdQrYoA0JJI7afZ5iAZ5wKralcxtJ/oYaRs9ax7m/ti+yDjnq55rotA8swl9pdu21aAGaRf6lBOq+XKRjjmuh/sqXUriM3MjSE9VPQVnG5kt2Z/Kfnu3aiLWpoQZFLcf3RQB7N4J8N6Vp8Sy3EEW4DrJjArJ+KGt6QLX7Jp7WrTEYZlHT8q8a1fxpq16vkrNIkY7DgVgXV5cbCWlVmPoeaAOgjtWM2YV86UnooxT77RNTdMvGqKecAZNc9pWt3VpKrBSQPSu3sPE13fRhZ0KRgdupoA4iXRNs4WVTuJ9K6G18J2ctmSxAfFaMtxbSXDYiQY5yzVWkuGaT5pVSLptQ9aAOE1/S47CZhE5ds8KtYhiZ1Pmwtn0Nev6fLpCyHzFRn7lh0rn/ABa2mxMzWbI7k9ulAHjeoaRdTzl9gSPsO9ULn/RT5Q69zXfXG94XIA6V59qkUj3jjHfigCGLZJKAwJr0HwjpxwsiwsQOdx6VyWg2DfaVZlJ/lXr+mSomnKgUZx0FAG94ZgGoXSRPuEQPOOldD4nsdMtbcRxRpkdWauMsLy9iYrZoQfUVW1O8u2cm8LM3oTQBynxYuIG0O3ggGSLgEkDA+61bPgOTb4V0seiH/wBDauT+Iju+kwl0CjzxgY5PBrf8FSY8M6cPRD/6EaAPJtR/5CF1/wBdW/magj/1i/UVNf8A/H9cf9dG/mahj/1i/UUAEn+sb6mkpZP9Y31NJQAV0vgZit9cMvUIP51zVdH4IMi3tw8YJCoC2B2zQB6ppNzCygSwlT3xUmpxW0smIsOPQnmrOk39nc2O1tgk9SMGojZO8jOAjqOhXqKAMy7itlt2SSABiOCa4y8079+TGjKPauv1VmUsowceprn7l7ggmCPafrxQBTTTphHuDSD6DNWLYTAYkKug7d6taZqs0B23UXy9yOauTTWs7bowhBoAhiMX/LLcG9K0rGQNIFcZPoRnNTaba2pXcNre2ajmj8u6Btvl56E0AdJa3HlxbVs0Yn/ZqpNazmcSx2yxn2p1nfvCFMrjjtmtuK/t9RQR5O8cZWgCzpWpeXDsmhycelV75GuckfIP92rlvpAjG9Z8H0apmaZUKFlZaAOTmtCpIRtzH2qpFaFZsSooB75xV7V0YS/u5GDfpWZOl4sR86GQp2YGgB2q2saqDGVz/vVlLe3UXyQ44/GnsXcFDup8GmXDAskLOPWgDd0G7nuF8qTajeoNX73SHjfzJJTg85Nc5Z201vPk7oz712GlXSzOEuPMkPSgDEu7SV8GBzgeppgMnl7Crk+orqNasFCBh+5BFcxeadLH8wvGK0AVhCoJaRm+maFlmlcR27lfr0p6xzsQqxo6/wB5hWhbwqihWMSMfagDNudOuEG6a4R89sdKorZRtJl3OfY11o01ZBnzgxPZaR9FjSLeGG/sM0AcjcJEnCeYD9KgtI52n+XOPetvUILpFIaHA9TVO1guyT5ce33oAsm3ubmRI/N6+tei+GPAKahaBru4AUjON1eZLHPDOHk+U+pNdPY69fQW21bsKpGMbsUAS+KfCdhpU7eS3mMp6CszTrqa2fEeFX0FEst1eEtLMGz6NVzT9FUxmT96fU54oAq6vqz7RuYZ9M1VsNTm/wCWsbFPQDAqTVIbe3V2LneOmaxLS5a4nAPK59elAHUT6YuqQ7/MWAY+6vJ/OsDVPDb20fmLckr6Zq5qt/BZWo8ub5wPuqa4+98RXlyDGG2R+tADzdSWsuxRuIq/BqUkpCF2Ud/mxWRpsS3dwFMpXJ5bvXS3OkaXaW2Y2M05HJLUAQ393bxRKI5Bu7/Nmsp7uaUfLKwHuapy6ddXM22MhEJ7Cuy8I+ETM6mVS/ux4oA5MvKoLyO2wc4HenWkj3UmCrBO2eK9S17wlDDb53KAK851CL7HcFYcHnrQBbutPRbYgSKpI5rhdVsY4rj93l37mvRtEht50LXbjpXO+LUiidvsg/ECgCp4Yjto7uJtQHmwKwLxBtu4eme1dpb6hZwxiOPbk9K870a1eWQPJnFeg+GdOt5LlHnUYHrQB3Gg2iSacZnkWMEcADmsW7tbWOV5HJZvzNbOo6jZW8SW0Tbn7qO1YGvXtutkUiXBPVsYxQB5h8TrhJrVAh4EwwB24NaPhByPDunj/ZP/AKEaxPHIQ6KjRIQn2gfMR1+Vq0fC0mNBsh6Kf/QjQB5ze/8AH7cf9dG/nUUf+sX6ipLv/j7n/wCujfzqOP8A1i/UUAEn+sb6mkpZP9Y31NJQAV1nw8mWG9vC+NpjA5/3q5Ouh8GSrHd3G8ZUoO2e9AHpMUcDsHicDPatmwswTviuGVuuD0rk40hZN0UjIf8AZORW3pKXIwYLpW/2W4zQBoajYRzD5lYv6isK60t442ZEbA7iutiguXx5qgGrpsQsBLqMEUAeR3UYMuDJt57iuh0CwheP94iOD3B5o8R6UDI0kBHuKydKSZJwsTsGHYHFAHS/2VDFcZUumemK6LS/Da3vzNLgepWs63nlijH2hG+rCuk0TxNaWkLKzgE8YIyKAMnXPDb25xAqSD+8oxWF9iu7D98Aygema2da1q5nnL2aELnopqkfFH7sQ3CFZO+5aAF0/V5JZQJXfg/xCteS7MsmDnHtxUukvZXdqzTpGzdivBrNvYpFmxZqygHjceKANNXiVuANw/vjNWzqdqYzDcKM47Yrn1fUBxMsR9KvWegS3582aNBn0agDl/EM8dtdbooyQeRt5qXR9UnmG0rIo9OldWfCNwJQPLjZD3NWh4Mu4sNsO088HgUAYMpiYZdST9c1Y0eRFuQ2Sg9xWpLoRh5wSw7DnFLBodxNy0cmwdyKAH61dmZBiRWGKxYRKSSZE2+nWujj0JJzsKhyO3StrRbLStPuUW4t/LXPzFhkUAcRFa3NzKPKwQO2KnOh6jJLxFgete6aXZ+EZXRonRpG7dK1dX0vTYbbzYPLRR/dwc0AeDw6XcWg8yRQ3tWZqupCCTfJb4A/uiu68YeILCC3aGGJ3kB9BXmlzq3nMVeBNp9TQAtxqzahGVhhyw6bqitr2a0IN6igDstZ8ssiOXinK/7KiqpDzy7rjzGHqTQBpak8N8DIDjHbNc0ys0+I8YB9TXRmO2aDYmPpWLd2jQtlW4POBQBuWMiRQgSH8ua1JPFNvb2LwoH3Yxmuc0qVkVgkZOe7Gq2pLLJITlVHsKAKWoTzXsrSFpAmf4jVE6qlnGUj5buatSyPs2kgisa5iDyH5M/QUAMkuJLxssWb0GcU5YJwRtjyfeiISxtiOFgPUitezYRgS3TYA7UASaZpl43zNhVPoK2I4PIUh42J9Wp1hrsQU+UvyDuRWTrHiPzpdkYOKAL/ANtEcw4GK3rLxULRAkbhSO5ri4Nk0e+aTYD706GKy80bC0zE9ulAHpFnqr60fKt0luJSPvN90VR13QGsRvuwvmnkItafhUTWdsHh2BscAdqi8UtdXQWSSUK3ooyaAOYSzlkQ9EX0Fc7r1qUfDOAP510trbXOCSWb3Y1z+txM9ziVlPvQAnhuyaZ8RgsRzgV2Fjpl8z4QBM+hrK8PRQW8G+N8Pjua6zSpp5G8uAvNMw4jiXJ/CgDKvrZdLwZHBkPXuazY/O1e5SJhmMe3AqTVSGumlulbdn7rHp+FOsNWhslLbAAO54FAGZ8abGzsfBtikGDObtd302NXKeG3xotmP9k/+hGr/wAU9VOpaJCVB2C4BBxx91qxtAfGk2oz/Cf5mgDi7r/j6m/3z/OmR/6xfqKfc/8AHxL/AL5/nTI/9Yv1FABJ/rG+ppKWT/WN9TSUAFdJ4HAN5c57Rj+dc3XU+AApvrrdtx5Y6/71AHe6e8EZyUjbPoa2ba60x3InzA2O44Nc1d23yAwxf98tkUlr5jLsZWHbBoA7a0voYc+W+8Dng5q/D4htbj90SNw4wRiuLhs57cb0RsY+lX7CxaaVZWwpBydxzQBq6vHDN80cOD3qHR7CyuJwJI1STPetvdbLa7JJFVuxBrjdau5oZWMLbwOjpQB6rY2KJBsBhZPRwDWNq/h4NIXtxCpP90cV5nb+MNTtWCvKxQdnFdPo/wAQI+Bcwo30agCxNpV3Au6MwkjrhsfpWLqM7JkTxYb1xmutk8W6PdKA9q+fXHFaEVp4c1KH94PLZv4g/T8KAPObG9njfNu6/wC6Riugg1G4u1CzxhD/AHlrutE+FVnqbSS2dwDEvP1FN1PwDaWMhWJ5C49M0Acclskhw1yT+PSrdksttcKIJt/PRnrVl+H+oXaF7OGZsdxXB63baloV00cyOGBxzQB754cRZ7YfaPKib/ezXQz22nx2paRQ+O4Ir5ftPFd5b/NiRmHYsasXfxO1BYjFLGNv5mgD6Gg1Tw5CGV1QSAdGxSPqelSRkGECMjqpFfMX/CbGZtz5XvwtWoPHQjXEYY+7GgD3jyfC8txua68v1APNGraz4asrcRwTmTA/iANfPF34oe8kwHZSf7lH2x5F/eO5z3agD0vUfG1pFNizKjngCmSeO7mS38tncrXBQxQlM7Qx9d1RzXkVgpLYI9OtAHQyX76hcgRy9eu6nalYxwQKzzruIyQK86vPE7rKfsuQfVRWfP4ivpDhmyP9qgDqLzUpLeQ+S0Z571WTUru4b51XH+zXLtLcXTBsqOe1dPooZYvmxmgCdZ/LYFjj61qw31sY/wB9ImfQVgahhnKv8o9c1USK3jGVZi3rjNAHY2txCx3Ejb0qe/MDW5KnJx2rlrK3MxzulPoOlaC2s8ziDe6L04oAzrqdU3bEGfWsG71ExscNlvYV6ZH4Ht3gDzSsxxnGa4rxF4fitJT5SuwHagDM0++ubiQAgEe5rWunXygZQowPrWJbO9lkiBvbNW4J5b1gJVCr0AoAqy3hJIQkIPSo0kLncsbY/vGus0rwwl3Kpcoq9a29Q8LQW8WRJkDoAvFAHFWjW335iW+tXodYt0bZbxEt64ptzYxJLhnZuego/s7zE3Rxyqo9BQB12k+JDFEqMwX1q3qfi6wt7cgbWkI7cmuISyCgqAV9yail0yFRvlfaD7cmgDUj8Qfa5yzu2w9FWor2VbqQbANvvWdZ20JkwNwT1rVhMcbYtIDIw6s3QUAaujxiKSF5LUTRqQWRyVDj04r0TwncWNtc3Di3FukwxtALhRnOPWuS0QzugecfJjoBWjNqflKRGwjHTCck/U0AZ3ioo99KIIsguSq98Z4zWAbMlx56GR+yL0Fasl+iM7MvJ9smqB1KSR9seAxPYc0Ac58TImi8NWwbC/6SuEHb5WrntFfGm2w9j/Ot74mW88ehwSTqQGnGCf8AdauY0t9thDz0H9aAOdn/ANdJ/vH+dNj/ANYv1FLL/rX/AN4/zpI/9Yv1FABJ/rG+ppKWT/WN9TSUAFdn8MY1l1G9ViB+6HX/AHq4yul8DXX2W+uHwcFBn86APULq1jjjBCD/AIDxWb9taNtqjOP7wq5DqENzb/JIAcdDzWRdiUOcDj25FAG1HrbSwmJynpzxVczBDzKwU/jWRE2HH2iHcvritqG10u8iwjMjf71ADftFtnb5h3euafDAWfcqBwfQ4NZ1/ohhG6G4JHo1R2F/e2Z2r8w6YYZoA0tV0qGW3LEOjAdDyK4G+RLaQ7Qx57V2l9e3lzGzAbfXaf6VyOoSHdiU4agCh/aEsS5gmdCO2TVmx8TXkEg8yVmHseazJpNhyHB9iKryTRypggZ9qAPYPDPxZ1PS4vKtr2RRjGGXNbkHxXuJ7jfd3KO3cMuBXglrDE4O2YqfrVuO1Jz+9Vj78UAfUuj/ABqWztyixQlT6PXF+J/FlhrVw81xIMsc49K8MeGeMHJG3/Zaq8EsiTjfLhfc0AelXotrhs2LHJ7E1GNCurpcrGpPvXHw6q0R/dtuxXS6T40+zoEkBB9c0AVNS0W5jB3QqMejVjPZzoeYjx3BruH8RW14Mu0eT602NLe5BII57gUAcZELkN+7i/OrokuMATQjHs1atxZmKX92S/1NOOk3VymQEQH1OaAMw3ohi/dttb61kXFzczk+dK23PStm70Ga2+d2V/pVS4EqpkIq49aAM6ILH8xHHc4qC6mXlo+vuKtXFw7RlTtz9KzokjZv37gDPagBsepTIMKwJ9MVYtdeukfDuFWq15FbKuYDz9aowwtI3IOPWgDp31ZJCOd7HvW5p1zGkO5oxI31rlLaxQrkHH41pW9yLYbRyR6CgDqYdSn3ArAFA7CtS2vLuWQMyqi9gOtcza6rlcKp3fSp7SS+uJ/lfC+1AHV6nfXzwAJOUQDoDXNyXs2472DH1PNaM9pcmJVUFm7kii30O/aInYq+5HNAHPXaLOpeQkn3OKzooboz5ibCiumubAWTbrmRXb0PSo/MV1Owgn0UUAU49QvbEZM4T6cmhdavb5tjSTMvc9BT1h8yUGRMjPfmujsNNt2iBMEjH1xgUAVdONvBh5gGb3rdW9t7qPZErO+OijArA1SFUfaiYGam068kt0IhhA98c0AacVggly4Xeex5xVfV9OiiTzJHLk9h2q5pdynmb5kUN6yVY1meCePbHIrt7DAoA4guZJNsceFBrotHEa7RIMn+6Kz2hVGChk3nsDzXZ+FrOCCMSSIjsR1Y0AQXN0qRfMrBQOnQViT6qobAT8MV2uqwQXKHaYx7CuUubeGGQ4jDEHBJoAqCUXXVAM9zxiur8O6DAqGdym7GelY9rbxykMVwg7VautVith5SyBQO2aAOa+OKr/wj9sVbOLpQP++Wry2wfFpEPb+prvfitfQ3Phy2SNy7/aVY+3ytXnNtJiBBnpQBnyf6xvqaI/8AWL9RQ33j9aI/9Yv1FABJ/rG+ppKWT/WN9TSUAFdH4JTfe3A44Qd/eucrX8NtIl1I8fZRn35oA9VsbO3niwEAl7dqW9sbmCPKwkj1HNY2latFGyHzNr+9dha6o91EFZ4ivTNAHOWj7shgA3cHiq8lmj3ORKUP+ycGtDWVhkYj5Q2eqms+0s2lkAZmHPBoA3LHT7iOMMJfPj9G61S1m2iVSyRmNvatS3trmxjBD7kPTHNUtQuZLjKsQvvtoA5ZLiRH2q7MPTNWhon9oIXZc5HY4qC8spVk3pPGfqMVb03VZ7c7JFB91oA5nWtENqSFZiPRhWMtsyg/uwfxr0+68q8i3bCxPYiuR1m1eLcY7bb70Aco9u3mdGH0q9DCIwCZSv41Ve7eOTDp0pxvo3++pFAE00oK8XH4EVnzSDkcE+tOleE9FzULGMjgEUANV2XoTU6sWGdzD8ar/SpoWQD5s5oAsC8YcB+R7Vag1q4thhZSR6VnNJGe1CRoxzjigDcs9fmdwJGH41t2/iJoAMyKfYA1xMhSMgxjml86Zx12igDs7rXzdDjJP6VlTXzOSNyqPrmucMsg43k/jUkUgB5AJ96ANmImVjmRcVXvbRV+Ytn6UW7E84UVaKCZcO4A+tAGMXKnGFx71chni8sABd1RXlnDFkrKD7VQVTv4yKANqF3DcsoWtSFYHT7wz65rm9ke3O5yfc0nm443t9M0AdVCYYnHO78a27O+8hNysB3wK8+ivFi6gn8a07DUGmYKoVV96AO8tvFDI+DEX+tX5vEs88YWGLZnuea5K1kC8vKBW5Z6lZwxZ3bnoAo38F3eNyHY+pFSW1pLapmVetStr2ZSEU4rQs9QSTDXAz6DFACadPCswaRdo9hXSjVFliCQRHA7kYrBv5gyKYo1jHYmrejQb4WmmuflXtigCxLFb4LzLufsi9TTbOwuJ5CywiNO26tC31GygD/KvT7xrLu9aVnJt5Wd/ReBQAzWbJoB94s3otYLxyjJkYgegNXbn7TccyyFCewOTTYLVoiCAW9S9ADNNt2WUMkBP+03Neg6JZvcQruTCj1OBXJpLIQqrg49OMV0mlXb2sBdiGYjgZzQBZ1u4ttOKF0EyqcvGpKhh6Z7VwqXbTzMzEkZ6Vt6uZdQl3XLkJn7oqWz01Y4tyxhFx1PU0AZw+33ihLZDHH6t1q/qngp9P8AD/hq8e7Se8CyDUQJVbez8qRg87T8vFTyztAMKxAH93jNMk0TQNI0Hwhf22pz3AeOcWiOir5iyEyOWweNv3eO9AHHfFO0ht/CNsyABzdLk/8AAWrypJMIBXqnxc1W1u9Ct7a1IIW4ViQOPutXktAC96WP/WL9RSUsf+sX6igAk/1jfU0lLJ/rG+ppKACtTQAxnl2nHyjP51l11PgG3W4vrpXxgRj+dAGpZ6eHKua7nQLGxliCSvsb61SXw7IYw9pMq/7JqNLS9tXxcxlh6qM0Aa2r6PZQk5fdnowNZtmqwN8js6fnWnYRwTELLIcejiryaPbwP5tvLjucGgDNha5nfbBNtz2YVeNne2ZElxFHLF3xV0R2bR8yYkH4Gsm51UwEwyMzx/WgB9/daXPBta22Pjutc09taO2IyU+lb9itvNKHDkg9VarOq6Xp0sIaMBJO5U4oA5hLaaE/uZy6n1pLy2aaEmdvypZ4mtwRHdFh6NVX7SY/9d0+tAHJaxp0KsSpYn3rAkiSPrk13WqbLiJjGoz6iuNu7VxIdxI+oxQBTwSPlHFMxg81aSXyUK/K1QSPubOAKAG0A46UlL9RQAlOVsdzQFJBIBP0pOe4oAViCeBQGxSVJDHvOT0oAioqV0VWxuphx2OaAHJM68ZOKv28tttzKzZ+tZtFAHSWslpKAqjPuRV2LRYrg5Vua5qxd/MRI0eR3O1VTkk+w71vJrM2k3L293bSwzxNteN1wyn0INAFibwtKVyCQPWsy48PSRN97Oa2n8YeaAoj+X1Jpq68kn39iigDmbrTvIGXbFV45fKYCJj+Vbt7eQ3UhEKbye+Krf2XJIAxGB6CgCazuwFHmuD9a0rWaCRs5X+QrKj0kk4xWlBppUBQOR6CgC6VWZgsLKD6irUUJhGTKWb25qC20m5kbEUbsffit210PURGN8RCewoAyp7iRELFmwO2KZbahfTt5cEUjjsCcD8q6JNEMgxMdo9AKkaKHTBlW5oAzBouqzjzLllijHOAKtwvaWKbMgy/Tmm3niSZ08mMrg8Uuj24ubhXmILE9AKAJ7SC8vJN0UbYP8RrQTSZAC91IQPQV3mnwWlrpys8Z3Y7msHUJYZpSGKKvZQaAOeisxPMI7feee1dhp2iW9ra+ZeSkNjoTTdOkhtocRRxo56cc1k6vbXs7l3nJB6KDQBNemEynymG0elUppruX5LdAqD+I1RWzuosMWwvpmr+lf2ldTNHZ2kty0Y3Mka5IHTNAFeTTrkQtLOzHHOegrkZrSWY2tvEp+z2m9YEBOIw5y2Pqea7DU9RvZ2MV1iBUJUx9wRwRVD7QEGI4sA9z1NAHEeO4xDocEYTBE4yf+AmuBr0r4kndocBPBNwOP8AgJrzWgApY/8AWL9RSUsf+sX6igAk/wBY31NJSyf6xvqaSgArtfhfAk+oXyvIIyIlwT3O4VxVd/8ACAQPqeoJcR71aFcc4x81AHetBd2vK7ZI/UGoLmSQxlo5NrdwTXRRWCqP9HZmX+7msPX4o7dsvGwPU5XFAGXHM87bWkUN7GtW1t5wOJt30Nc2ssDS5V1Bz3rd07ZMVUyY9w1AFiW2umJ4Y/hWPqFrcoCXhZh612sDfY0+aUSA+oqSPyb4lVcKT6UAcLpcrBtqpg+jGtO5JiBaVGH0ORW9f+G+DJHIhP0wa5y7+0WpKyIXUd80AZF1JZzMcS7G9DxWFewOrZhcyL9c1tz+XdvgRKG96ls9GnEgKxoy+1AHP2U/kNmaGTHqBRrU9tJASqsDjutd6ujzCME2xI9lqpfWtpHCyzxlW90oA8UuCpkO0Goq9m8DWugjV9budT0yDUbS00uWdoJUHOHjBKns2C2D2Jq7D4IsNLu/DllcWttdiS21yUXHlgi6jW0aS2l9+Crr6ZoA8Pc7l7VHXqfw28N6br+h6TBqUC5ufEsFrJIuBI8RgdjErdtxAH1IrHsvEa67rNpp11omhQWc17CsccGnxxPAvmLlBIoDuCPlPmFuD680AcMGI6HFIea9e1/wvoNja/E+ayvtPvJrPH2e2jtpUazzqESHaWULwpKfKTwfSrPizwLHZfCuNI9Jjh1fSbe21C6vQVMk6zlvMjYA5Hl77cdOMPQB4xQCR0NdZ8VLK107xzfW1jBHb26RWxWONdqgm3jY8e5JP410XgWLTrf4b32o3cui2t1/a0dutzqWnG7BQwsxRQEYjkA5x2oA8x60V2njC2tf+EM8N6hDBapc3l1qBllt4RGJAsibcKAMKMnAxwDiulTRNM/4XNZacbC3+wNpMEzQeWNhY6WshbHrvy2fXmgDyalXGea9c8OwWOoW3wmtrnStMKX+t+RdutoivcRpPEgV2AywKu2QevfpWPK1p4l0LxebrSdNsrnRolura8soBbg/6RHEYXVcK24SEg43ZTrjNAGLoV7brq1hY6LC0PnSqk1zM372Rc/MvHCqeeBknuar+ILn+3beXVdzvdwylLgyHLuhJ8tz6kD5D9F9areFxsuLy5P/AC72czgf3iV2Yz2+/n8KxQSBgE0AFFITSjnpmgC1aXLxuoGAM10EV+DGA0lcwsMh5CN+VSLBP2DCgD0bR76zRD5pQ5HetSLVLIyAR7CPWvNbLT7ycj5mArftNKkjUF3wB2oA9SsPEOlWkKk7GkxzgUt14xtZQQpVQPQV5fOyRjgk4rKur8qcAHaKAO91jxZCMrFJk+1cjc69PdSELlh9K5+S7aV8JGCa0dPhumI+UBaANOAucM3BPtXYeHZ5gR5Vuxx/ERWNpdqDIvnENjqBXa22oxw23kwQ/N9MUAatxePLa+WxKsRg5NR6VpJkbcqPIx744qPTgsbefPAZW/ukcVvQ+IXjwsdvsHYYxigDH1LTru2Jdty9wBWXC1xLMfMlKgeprtL7U45oCZwrOR0PauZnFvK5J+8ey0ASO9ta7JXKXAQ5aJ2IDexI5qho2r2y+I4rmQC3tlcyCKMlhkAlV9SM4q3/AGXayJ6HuWNUptPsLRgRMAfbkmgCz9lEymZvmlkJZmY5JJ5/rRLpUoi3LtiX1PWp9OYjH2eBv956XVpZzHtaQAn86APNfiVCkWhxfvC7/aBz/wABavNa9I+JMQTRoWL7nNwOp/2TXm1AC0sf+sX6ikpY/wDWL9RQASf6xvqaSlk/1jfU0lABXpvwO0wanqOsKZPLMVsrA+vz15lXpvwLuZLXVtVaNlGbdQQx6jdQB315YXlsxCSbgOhFc9rM+pR5LhpB6Hmu9uNS0+9+SQmCbv6VFd+Hobq2MttduSBkjgg0AeZW1xaSP/pKeW/uK6LT0tCRskiJ7Vla5pj28hIUZHcDFZ1pKythgrHpjFAHeTidIcwKsi+gbNYf2idp/wDUNG2eSpxUeml2bO50Hoc1oXcLbQ9tuJHvmgDRtLu4eIpLK6/7xzVe9hTbmV1eqlq9y/yuwHsRU11auUz5q/TpQBiXcEUZLxR5/GrujXqiQbm2/Wp4LeDP784/GoJWhhl/cBTz6UAeleG9YtCnlypu98VJrlpY3KnYIeexrltFum4Cw9fQVo6rp1xPCXPmRqe9AHL6hYrYG9FoUiF1A1vNtUHdGSCV5HHIHI5rlNT1jVYBogh1ORf7FDiwwq5hDHLDOPmB6YbIxx04rZ1PTFiZiZ52J9zXLapDCwIJYH1NAGP4g8QatffY1Fxb2cNnKbiCGwto7VElOP3mIwvz/KvzHkYAGKj1Lx1rt8zPJ/Z0dw8qzTXFvp1vFLM6sGBd1QFvmAJHQnk5rOu4lSRgJ2I9CKoypjlUP1oAuf8ACRar5usSG5BbVzm+3RIRN+9WbkEYHzop4x0x04p7+KNZfWtT1WS9LX+ppNHdyNGhEqyghwVxtAOeMAYwMYwKyWBJ5f8AOmFfegDotb8aaxrlpJb6n/Zk29URpxpVqlwQmAv75YxJ0UDO7kcHiskapeDRW0kTf8S9rgXRi2rzKFKhs4z0JGM4ql0pyqD/ABAUAdDpnjTWdO0m30yL+zJ7K3Z3hjvdKtboxlyC21pY2Izgd+1SJ4512PS1slnt8rbGyW6NpEblbcjb5Qm27wu0lev3Tt+7xWbpdtE7/vHUj3NdbZWWllBvEbGgDEg8aa+trodtbzWkaaJcJdWDR2FurwyqQQ28JubJAJDEhiATnApdZ8QeIddszZ3bwR2bSCZ4LOzhtI5HGcO6xIoZhk4JBIyfWuqgtNJQ9IhWta/2GhBk8qgDzC00/UlguIYVxFOoWQEZ3AMGH6gVas/Cd7O2Cp/CvXLfUdCi+6sJ/Ctyz8YeH7HH7uLp2WgDyaz+HV9MAVgc/ga1IPh7cwY82JV9zxXpd18VdLig226Ln2FcNrnxHFyzFAB6ZOKAEg8JwQDM8icdgKjutP0u1XJCk+9clqPjKaXO2Xr/AHai0q2vdfhlupXme2jbaYrdd80jcHaq57g9fQHg4oA0tQ1qytwVhKZHpWDc68ZGIUkCqOr6gssYs4LKOzt42yUIzKzdMu5GSfYYHtWWiAjJ4FAF+bUSzdWP41DLcmbhUP1JpkEAdsAZq7HaomD/ADoAbbQgYPJb2rbsIpXZRvCgnpVWJoo1/gz2re0VoZGGWUGgDptJtI4YA8koHHYc1qWktmJARuc5rCmhSQKFmZh6CtPT7NTEERSCe5NAHe2Gq2bRCJQobGOmadqNqXhLQBQTzuNYWmaULZDKj/P/ACpupz3Uq+ULraD2TrQBi6hcC3nKSShm780621BGAWMNI3oP6mopNLgt18yc72PqetQxOQ5MZWJB7UAdFb2jSxl7iXywegWnLa2FuxcsHf1PNYNxeM6hY5mfHp0rC1G7lRiDM5NAHfT6pBEm2MqGPAA61z985kcs8zbj/CtZGjrubc+5mPcmtS4GMFAQfbrQBxvxDgEWkQHfljOOCcn7prz2vSPiJbTR+HoZZIDGhuFAY9SdrV5tQAtLH/rF+opKWP8A1i/UUAEn+sb6mkpZP9Y31NJQAV0ngi6a1u7plk8vMYGfxrm63PCf/HzP+73jYMj8aAO8W78wZeUH8a0LLxBLaLtjlbb6Bq5lzBsIEbI1Y1zJKsmYyRzQB6M+oNqWf3gDejCsu6t2hcs0XzDup4rE0e5mOMHJH41vm7lZNrxq3FAEEWv3VowTycr71vWGqtOA/wAqEjoRXF6mjBt43qPaobO5mDYV/wA+KAO1vbrzGIkZFI6FWxVe3mDHa0zNWLCk9ywDnr3roNN06SLD5JHsKAN7TdLa7jAWJnpJPChjnDSF0GenSrGn61NZELsIA77a1bnVJtSgK+ZHyOh4oAgWzjsUUwzgMO2atxa0zp5UvzL61yV5G0E375Gb3VqUagqphGaM+9AGnrVxCVOyPn2FcBqiedKfNjZffFdNJeyMPnYuPUCqkzLIpCZ3d80AcNfWFmqklnB9xXN3CbZP3cmV+tek3Glm5z5gOPpWDquh29vkeWxzzmgDiZYuegP41G6YHArYurKNf9WxHtVCa3KqSHIoApUlKc565ooADkd6csjr912H0NMzRQBMLmYHIlb86eb64/56Gq9FAE/2u4/56sKa9zO33pXP41FR17UASCeQdGNI7u33jTF4PNO6nj9aAFUjHNbfh8/aYtQ05eZLiHzIQOvmxncAPqu4fkKwie3FEbsjBkYqw6EHBFAG4niCSdFi1mCLUoQMbpflmUf7Mo5798j1qlqQsN0b6W85Rhlop1G6M+m4cMPfA+lZ560+AAvycUATwpN1Q4PpVu3tppGAkOBXRHwve2Xh3TNbmZDa37ssSLkuoGcMw7BsHHrg+ldLpPge/uT4fMfkt/bW7yCd2I9pwd+Bx60AYWl6Is6qBj64rfj0C3to8jeXrW0nTNRj0u5v4YImtra7NnLg8q3Tdj+7njNdDDpTza0dJuJ4UuRIYt2Ts3D8KAOMtYxHIFXP5V0lsEjjDSOQKsWvh+S5vDHE8YClsuW+XaOrZ7DHNLqunS20ltHFNay287bY5423KxyAR7YJoAiuNYIiMNrGxz1Y9KZpsUkjF5CSfatCPQ5LHULuPUBE5tJI45UYkg+Y2FZcVQvb5I7uaOyhLFXK7V6DBx/SgB17bM7clQnqaz7hbWLh5AfYGmXrXMo/fZGe2awbwiFxtUu57UAbUd7bwyoxt1kgBy8ZYrvHpkcj61hoYHnP8Rz1JqaHT57pN0uUT+6KctrFBJgkEelAGlYeT5ihQ0h9FFdNZaf543OFQDnHeuetGdYx5ERPpgVaa61LZjJiTphRzQBifGdgnhq2iBzi6X/0Fq8ar0r4kow0KBnZmJuByTn+Fq81oAKWP/WL9RSUsf8ArF+ooAJP9Y31NJSyf6xvqaSgAr0b4L6Kus6jqqsCfKt1fj/exXnNeh/BjVptK1bUWgIBlgVTn03UAdtf+FEMpRWUHOOayNS8FXcEZkCq6exrs768uLweYsKlvVKzpLzVVjMbRl09xQBwkGneTLtyY3HbNaaQz5+8GI7EVbvYZ5nyyBT7jFMtbe9U4TyyPc0AQXMfyYliP1FZqW65zGBnPQiuwOm3M1uTIyjjtg1zOoIbOU5fOPUUARpNNE2FibI7rVy21G5Rx+8ZfZqTTtVtkYb0DHpXT6fdaTd4E8SD3NAFSyu7iQgkh/pXV6XZzXMYYQ9O9ULiHTYot1s2w9sHIqvZ69dWr7LeRWX0oA3723gMZSaIBx3AxXK3Omh3JRmAzxzWpLq88w3PAHJ64aolv7aYbZYDEx4yWoAwJ4pbZ8EFl+tVhcoHyUP4Vu3doGBeKVCvvzVSFLXfh2i3CgBbW/VR8iZ+tM1K8ikiO+NM+4ratbSykjO8IR/smqWpaRYyZEZK/U0AcJe2aXD5CIO/FY13paqMkZ9q7aTTxan90yv9TWffwXboT5MeP9k0AcFc6em0lYyD9azZLYrnPH1rpryCVGJPFYt6WORtz9BQBl/dPrQTk1Oq8/Mh/KmzIo5FAEVFIKXafQ0AFAJA4o59DS7T2B/KgBKKlitpZWwsbH8K07fR7kj/AFDH3oAx8HsKesLkZxx710cGgXEhHykfQVeXwzJgebnHpQBy9rab3+c1t2mnxKMqhZu3FdHpfhiIsMhQPUmujFpp9hFjAZ8dqANO88Q2OoaPdaJHYpHpkFvCtlP5RErvHjAfnAHzScgd66LQtZ02103T4XizJbRRKG2H5CJWL7ef7h61wAuI3cBAEHqavRlTGAJB+dAHW6dqNtaxtGjl45L6WWeIjiSF1wRnseM+2Klt57BfGT6m80pgNw0w2rlgO3FcxBb26gNNISPrira3cEagQYRe5FAGhFfxW19NHIZvsk0ckDeWvzhW4DAeo44qrdzWkS6ZZ2T3E1va3BuJJ5Y9rOxK5wuTgAKPxqjcajDEpbec/rVNdRluciKFsZ+83AoA7ZtUt9VgvLUkiZrxZIZnIUGASl9rE9xk4+uKxblbW1uZ0SaMuZGJKsCOST1Fcnc/a2kK7jt/2atWtqqqGmcr9TzQBrTzxqv7o+ZJ9KzPKfzDIyDmpZ5jEo8iFnHYkYFUXubiWUBhgegoA2La3nulIAwmKE0pYpgZAMA81pWGopZWW10y56VkahfXF5KUjjcnrsiQs2O/AoA6GXxDpFhb+UqxmQDHA71zt1rP26X9yuE965O5likkKxrg55zWvpaRKgAbdIew5oAwviQp/sWFmkyfPHy+nymvOK9L+JUQTQIGJAY3C/Lnn7rV5pQAUsf+sX6ikpY/9Yv1FABJ/rG+ppKWT/WN9TSUAFdV8P7hIL678wHDRgcf71crWpoEywzyliQSoAx9aAPWLS7CsDDO6j0rr9I1TCgtKGx2YZzXkWn6jtyPvZ9a6HS7yTzF42g+9AHqF1rVnKnlzWkBb12YqhG1iG3GJQPbBpukWtrqMQE0iZ9N1Le6BaQkmOR/wORQBV1W50toyIZAsnoK8/1x4HcqwDe/NdVf6NC+T0x3BrIk02F0ZGlVj2oA5m2gR2/dZH1NdNpuntKm04Brn7/T5bWQmItj2qK21W7t2wu5vbNAHY/2Ndo2UYlfrVW4sZEOSrBu5BpmmeIZWGJCRns1WJroTsGLECgCC3jcSf6x1Pua1fJuHTmaMj3FS6ddW6rtMTSN74rXiPm4CWRX3xQBzptbgZHm5HoDVG4gRTjY5f1rqdS0eV4w4zGfasIWtxExxOGwejLQBTtorqNgyB0Ue9XnuGf5JJOfeo7i5cZjcAe4OKqpbK7bzKR+NAF9rAzLlJVz9Kij0q5kJBcFfpVV5JYmxHMpq5ZXk0YzIpYeuaAILzw1Iw+8uPzrPPhWI/611H4V0a63IW2xoAPdah1CdJId0kiq/oKAOXuvC1sB8rqTVWHwgkxIRF/OttfKL5eUFavQXdvHjykckd8UAc6ngV1kwYfl9cVp2/w+EoGSin0JrpbTxCYvlMSt/vCrMmrtcDIjSM+q0AUdK+EUdyfmaH/gTCtib4RWdtGWea3UAZ6ioorwouTduD6A0ya+80FDczNntgmgCD/hDdKtZNq3COw7IAatnw5DDECsQx6tiqsFs4bzE80+4Q1b3T527pF+ooAqJYWkTZl7Hoq06eKzmUrChT3IouIZQC2+Rz9Ky5XuS21UdvYCgBt9B9mUiCQFvcVg3CXDserE11Vjol/fMD5LqD611Vh4Ue1g82aNWIFAHlEFm5cGRWP0rat4FjAIUJ9a3tRsGFy4AWNaz2sgxwrgnvk0APjuraNMOoc+4qtcTNP/AKqNFHrUsuhKy7pbjA9AabDJZ2A2rlj+dADbTRZZDvdkQepGatjT0jYBZwfesy81B7h8oZNvYDioFeaRtpd1H1xQB1UOmWIUvNPuIH3azr64ijfbawR49TWbMwijyXOPY5pbGeORiXbavuKAGTpd3TYLkL6LULINPUuwGe5Y1qy3MBBWFmz61gapbwynMjvIfTNAEH/CUwJeRCaF7qFW/eRxtsLj0Ddq3vAmtw/8JBqUz3B0m1mjQQCaVsgCVWKmRRnO0Ht83Q4Ga5CWMR4WNFjB9ua2PD+iXF9INuEXuxoAztYtBc6xfXEcxaKW4kkUhdu4FyQcDpwelaOmWxjjK+YUXvjqa72z8I6dBEDcTb3q1H4Zilz9lhLAdwKAPHviMqLoUAjDY+0DJPf5WrzivZ/jTpR07w3bbxhjdKMf8BavF6AFpY/9Yv1FJSx/6xfqKACT/WN9TSUsn+sb6mkoAK0tDx58gbuo/nWbW34Xs5bya4EKliiBiB9aANiLaijC5+lXbSWV3CqzL9eKjggeFsSxMprcsoDIAdoI9QKANDRlvEIYFm/GuhbUZYAPOjdcdSTxWZZR3NuMwqHHp0p+o3N7PEUNuwyKANGXVIbmLaGjBI71g3GnzO2+LYw9QayJbHUVk3RxyDv0zVm21C5t8LPA+fXkUARX1rdbTncPrXN3UVzFJkBc5/vV38GsW0qbZo2B96xtWt/N+eCAMvXpQBzsF1dDG6HOO4NbGn6ncAgGAMPeswkxsVKNGacgk3htxx9aAO5sL0TYV4Np9sVt2939l+cSkjHQjNee2zzIMxSc+5pLnU7xeGY/gaAOz1DXxcHy2k2CqJi8wbo7rOexNcjHM0zEvuJ7Vb+1TIPk4A9RQBq3cF0GBXy2/GmwRXUg2sqj/dqhBqJBxKwA+tb2lamisCoV+elAFG9tbiCMMIy2e+KyVubtXwpCjPQ16s2saf8AYcXFuN230rz/AFOS3kmZoggXPQrQBUW9nVecfWn20qzy4m3sPQDNAaEocqPwpbe7FvINkYx+tAF+aG3aMLHCUPrtpLew/vXLIPSrEd5HIAXGPrWlYXlqPllRGB9aAMr7OIzmJxIf9rmnRWmsXL/6Nb7l9hxXV28Wnsd4RFHfmtmy12C0xHbKh98UAc3p2l6ooHn2HbqRXSWdk8IBntQv/Aa2YtclkjBUfP8ATirIa6kQPOUIPQCgCmt7Bbp80Lkd8CqN1qFpPuMVozN64raOmrdlTMJEQe+BV9IdN06EgOhb0xmgDmNL0aTVJgDH5aHu9WNQ06LS2xugXHGcVdudfwpW0iYAdxxWBqEsVyC944z1+Zs0AaNtf2pQhWZmA42jArC1i91CQMLdiqf71Y91P+82WsvGe1QzRXpiz5+Ae1AFHUL+SOMrOcseprGW9AYsC+atXUc2SGdc+pqnHayl9wO73xQBMJ5ydxEhWjzLiU4SEgd+K0rKG4lZY9yqD3IrrrXSbOGzD3FwXb0FAHFwt5aHfEoPqapXVzEJQVMefrmug1ewt5c7chc+tYn9mxKxMaBR/ePJoAIrqHbmVS49+BVa91Dd8lrCqj2GKut9jt0+fDv781SuA8w/cwEKe54oAfp0PnMPPn5P8K1oXNhbQIWZwPrWRb5tvvOAfRTST365wYi7HuaAK9x5Zm+UBgDxxmt3R7m74WBCi+vSqVg/mEFkRB71v2s8ajCOo9cUAdN4e037TOpupnc9SvavVLFLS1sNq+WOOgrxi1v5I2/dyPj+dab6/JFBtM4i9s5Y0Acn+0iqnQ7Zww5vB8uf9hq+fK9Z+L14LrRoTvd3NyCST/stXk1ABSx/6xfqKSlj/wBYv1FABJ/rG+ppKnkgbe3K9TTfIb1WgCKvU/gDpsmp6zqyRru2WykjH+2K8x8hvVa3PC3iLXfCl1Lc+HtQexnlUI7oqncoOccg96APpLUPB8Kxl54QD3BFZ9t4RsJD+7doH7FTxXkFz8WfH9zH5c/iKV06YMMX/wARWSfHHirfvGsShj3CqP8A2WgD3W40ttMzubzo8/eUZpiXNnINuSG9CMV4g3j7xcww2tSED1jT/wCJqtJ4v8SScvqjn/gC/wDxNAHueESTJLhT3xkVsW1rpd5GFkwW+gr5zHi7xIOmqy/kv+FPXxn4nX7urSD/AIAv+FAH0RP4RspuYwg+vFYOqeGvsiN5bZ9hXjS+O/FqjC61MB/ur/8AE0v/AAnni0DH9tSke6If/ZaAOk1zTpw7FVb8q5me5uLY7ZOAPWoZ/F3iO4z52ps3/AF/+JrNn1LUrjPnXO76gf4UAb1resfmWUH1FatpeiU7ZNuenK1wouLwdJgPwH+FSJqGoofkucfgP8KAPSIEYjKorfSrH2Yzjbsxn3rziPXNZi+5fMPwH+FSDxJroORqDZ/3V/woA9DXw3I/zYIX3NW7a1NgflAJrzdfFviMDA1R8f7q/wCFRSeJNdkOX1Bj/wABX/CgD1NmeY/vY2A9jVhLbTzGSwO/HpXkH9va3/0EH/T/AAp6+I9dUYGoN/3yv+FAHoWoRrG+Ykyv5VBAyFvnCKa4Ftf1puXvif8AgK/4U3+3NX/5/P8Axxf8KAPTRESuIpYz7YqxFbzEfN+i15bH4g1qM5S+IP8AuL/hVhfFviNQANUcf8BX/CgD1KOK7UfJuC96u203lD942WryE+LfEhBB1WTB/wBlf8KrnxDrhOTqDk/Qf4UAe+2N2sjAyyFRn+9iugsdcsNPbfKVZR/tZr5hPiDWieb98/Qf4U8eJNdA2jUGx7ov+FAH0rrHxHgmXybWPGOKyItTur47wwA968A/4SPXO1/j/gC/4VMnivxFGMJqbgf7q/4UAfQIv5EUrIygeuRVO7utNUFrh97ehavCX8VeIX4bU2P/AABf8Krvr+tOfnvi31Vf8KAPZpdUhLkWcagVTuftt30aQD2PFeSpr+sp92+Ix6Kv+FSnxNr5GP7Skx9B/hQB6jBYGE7pmDH0JzWlH5hQeXC231ArxlfEOuKwYag271wD/SrQ8ZeJlG1dWkA9Ai//ABNAHrH2l4m5TaR3NQXOqSjgufpuxXkz+JNdckvqLk/7q/4VA2s6uzZN4SfoP8KAPWBczz5CMoPuc1JHaTsN09yNvoOleTLr2sp92+I/4CP8KkPiTXiMHUXI/wB1f8KAPT55rW1BO5Tism41M3r+WkuyP2rz2bVdVn/1t4W+oH+FMj1HUYxhLnH4D/CgD0iKzLn93Lgepqf7JDGuZLkZ9jk15odX1bGPthx9B/hTl1rVx0vP/HV/woA9Ls5LWO6jZ7drmFWy6O+0OPTI6Vp2UyxjKKgHvXkJ1rWM/wDH6fyH+FSReItbiXCX5H/AFP8ASgD2lryN1CLIAe+BVS5C7CIc7j1c15KvifXlORqBz/uL/hSt4q8QN11Jj/wBf8KANjx+sg06MuzMPOHJ6dDXB1sahquqanAIb2782MMGAKgc/gPeszyG9RQBFSx/6xfqKk8hvVadHA29eV6igD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lynn Simpson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25249=[""].join("\n");
var outline_f24_42_25249=null;
var title_f24_42_25250="Patient information: Insect allergy (The Basics)";
var content_f24_42_25250=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/82903\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/23/27000\">",
"         Stinging insects that can cause allergic reactions",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/41/7824\">",
"          Hives",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/55/32626\">",
"           Angioedema of the lips and tongue",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?32/30/33250\">",
"         Patient information: Anaphylaxis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/51/15155\">",
"         Patient information: Insect bites and stings (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?14/57/15250\">",
"         Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/14/41186\">",
"         Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/22/18786\">",
"         Patient information: Bee and insect stings (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/44/19138\">",
"         Patient information: Fire ants (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/30/28134\">",
"         Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Insect allergy (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/insect-allergy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H23545684\">",
"      <span class=\"h1\">",
"       What is an insect allergy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;An insect allergy is a condition that causes a serious and sometimes deadly reaction to an insect sting.",
"     </p>",
"     <p>",
"      Insects that cause the most serious reactions include (",
"      <a class=\"graphic graphic_picture graphicRef82765 \" href=\"UTD.htm?26/23/27000\">",
"       picture 1",
"      </a>",
"      ):",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Honeybees",
"       </li>",
"       <li>",
"        Yellow jackets",
"       </li>",
"       <li>",
"        Hornets and wasps",
"       </li>",
"       <li>",
"        Fire ants",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These insects have special &ldquo;stingers&rdquo; on the back of their bodies that can shoot venom into your skin. Insect stings can cause the area around the sting to swell, turn red, hurt, and feel hot. But if you have an insect allergy, the sting also can cause symptoms throughout your body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23545699\">",
"      <span class=\"h1\">",
"       What are the symptoms of an allergic reaction to an insect sting?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Flushing -- Flushing is when your skin turns red and feels hot, especially on your face.",
"       </li>",
"       <li>",
"        Hives &ndash; These are red, raised patches of skin that are very itchy (",
"        <a class=\"graphic graphic_picture graphicRef79242 \" href=\"UTD.htm?7/41/7824\">",
"         picture 2",
"        </a>",
"        ). &nbsp;",
"       </li>",
"       <li>",
"        Angioedema &ndash; This is swelling of the face, eyelids, mouth, tongue, hands, and feet (",
"        <a class=\"graphic graphic_picture graphicRef73131 \" href=\"UTD.htm?31/55/32626\">",
"         picture 3",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people have a more serious reaction, called &ldquo;anaphylaxis.&rdquo; Call 9-1-1 for an ambulance if are stung by an insect and you suddenly:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have trouble breathing, become hoarse, or start wheezing (hearing a whistling sound when you breathe)",
"       </li>",
"       <li>",
"        Start to swell, especially in the throat or around the face, eyelids, mouth, hands, or feet",
"       </li>",
"       <li>",
"        Develop belly cramps, nausea, vomiting, or diarrhea",
"       </li>",
"       <li>",
"        Feel dizzy or pass out",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23545714\">",
"      <span class=\"h1\">",
"       Is there a test for an insect allergy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you had a severe reaction after an insect sting, you should see an allergy specialist. You will need a blood or skin test, or sometimes both tests.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23545729\">",
"      <span class=\"h1\">",
"       How is an insect allergy treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Allergy shots &ndash; These shots will make you much less likely to have a serious reaction to an insect sting. You will likely get shots 1 to 3 times a week for a few months. After that, you will get a shot once a month for at least 3 years. Some people get monthly shots up to 5 years or longer. &nbsp;",
"       </li>",
"       <li>",
"        Epinephrine &ndash; This medicine helps stop the symptoms of an allergic reaction. It comes in pre-filled injectors, so you can give yourself an injection (shot) if needed. If you had a serious reaction to an insect sting in the past, you should always carry at least one epinephrine injector at all times.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23545744\">",
"      <span class=\"h1\">",
"       What can I do to reduce the chances of getting stung?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Stay calm and slowly back away if you see a stinging insect. Do not wave your arms.",
"       </li>",
"       <li>",
"        Keep foods and drinks covered when you are outside, and clean up any spills right away.",
"       </li>",
"       <li>",
"        Avoid wearing sandals and open-toed shoes in the summer. &nbsp;",
"       </li>",
"       <li>",
"        Avoid doing things that might disturb an insect nest, such as mowing the lawn or pruning a hedge.",
"       </li>",
"       <li>",
"        If you find an insect nest in or near your house, call a pest-control service to get rid of the nest safely. Do not try to do it yourself.",
"       </li>",
"       <li>",
"        If you live in an area that has fire ants, avoid stepping on ant mounds and wear shoes and socks when outside.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23545761\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/51/15155?source=see_link\">",
"       Patient information: Insect bites and stings (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/30/33250?source=see_link\">",
"       Patient information: Anaphylaxis (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/22/18786?source=see_link\">",
"       Patient information: Bee and insect stings (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/44/19138?source=see_link\">",
"       Patient information: Fire ants (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/57/15250?source=see_link\">",
"       Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/14/41186?source=see_link\">",
"       Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=see_link\">",
"       Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/42/25250?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82903 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-22DD962998-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25250=[""].join("\n");
var outline_f24_42_25250=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23545684\">",
"      What is an insect allergy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23545699\">",
"      What are the symptoms of an allergic reaction to an insect sting?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23545714\">",
"      Is there a test for an insect allergy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23545729\">",
"      How is an insect allergy treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23545744\">",
"      What can I do to reduce the chances of getting stung?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23545761\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/82903\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/23/27000\">",
"      Stinging insects that can cause allergic reactions",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/41/7824\">",
"       Hives",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/55/32626\">",
"        Angioedema of the lips and tongue",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/30/33250?source=related_link\">",
"      Patient information: Anaphylaxis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/57/15250?source=related_link\">",
"      Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/14/41186?source=related_link\">",
"      Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/22/18786?source=related_link\">",
"      Patient information: Bee and insect stings (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/44/19138?source=related_link\">",
"      Patient information: Fire ants (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/51/15155?source=related_link\">",
"      Patient information: Insect bites and stings (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=related_link\">",
"      Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_42_25251="Hindgut formation";
var content_f24_42_25251=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hindgut formation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 309px; height: 625px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A wedge of mesoderm divides the hindgut. Recall that the allantois diverticulum is trapped in the connecting stalk (A). A migrating urorectal septum of mesoderm pinches the base of the diverticulum off of the hindgut (B and C). This results in two portals to the outside world, one of which is still connected to the gut tube (anal) and one of which is a blind pouch (urogenital).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sadler TW. Langman's Medical Embryology, 10th Edition. Baltimore: Lippincott Williams &amp; Wilkins, 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25251=[""].join("\n");
var outline_f24_42_25251=null;
var title_f24_42_25252="Pemphigus herpetiformis";
var content_f24_42_25252=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus herpetiformis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annular and arcuate erythematous plaques with erosions and occasional vesicles were present in this patient with pemphigus herpetiformis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kleker BM, Ramirez-Fort MK, Puchalsky D, et al. A generalized annular eruption with occasional vesicles. Arch Dermatol 2012; 148:531. Copyright &copy; 2012 American Medical Association. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25252=[""].join("\n");
var outline_f24_42_25252=null;
var title_f24_42_25253="Chest tube suction";
var content_f24_42_25253=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F80960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F80960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 478px\">",
"   <div class=\"ttl\">",
"    Chest tube drainage system",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 458px; height: 490px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three functional chambers are generally a part of most chest tube collection devices. From right to left, the first chamber (ie, collection chamber depicted with three sub-sections) accepts air and fluid from the patient via the chest tube; the fluid accumulates in this chamber. The air rises and enters the second chamber (ie, water seal chamber) which contains water at the bottom. Air from the patient enters this chamber below the water level bubbling through the water seal preventing return of air to the patient. The air enters the third chamber (ie, suction chamber) connected to wall suction, and is discharged through the hospital collection system. The height of water in the suction chamber indicates the amount of suction applied. Suction pressures are typically between -10 and -40 mmHg. An atmospheric vent prevents the application of excessive suction; manual venting through a pressure relief valve rapidly equilibrates the collection chamber with atmospheric pressure. Modern devices vary in appearance, method of suction regulation, and volume of the fluid collection chambers; this basic design in common to most.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25253=[""].join("\n");
var outline_f24_42_25253=null;
var title_f24_42_25254="Thoracic endometriosis";
var content_f24_42_25254=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Thoracic endometriosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25254/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25254/contributors\">",
"     Jose Joseph, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25254/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25254/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25254/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25254/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/42/25254/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometriosis is defined as the presence of endometrial glands in stroma outside the confines of the uterine cavity and musculature. Growth and maintenance of endometriotic implants is dependent upon the presence of ovarian steroids, and therefore endometriosis occurs almost exclusively among women of reproductive age or among those on estrogen replacement therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1\">",
"     1",
"    </a>",
"    ]. However, endometriosis has also been described in men receiving estrogen [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endometriosis most commonly involves structures within the pelvis, particularly the ovaries, cul-de-sac, broad ligaments, and uterosacral ligaments. However, endometrial tissue can be found outside of the pelvis in the abdomen, thorax, brain, and skin [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The thoracic endometriosis syndrome (TES) will be reviewed here. Issues related to the general clinical features and treatment of endometriosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link\">",
"     \"Overview of the treatment of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several hypotheses have been proposed to explain the pathogenesis of pelvic and thoracic endometriosis. So-called retrograde menstruation may cause movement of shed endometrial tissue through the fallopian tubes and into the peritoneal cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/4\">",
"     4",
"    </a>",
"    ]. Decreased apoptosis may contribute to the failure of the normal mechanisms that clear ectopic endometrial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/5\">",
"     5",
"    </a>",
"    ]. Alternatively, altered immune responses may contribute to the failure to clear peritoneal endometrial tissue, as suggested by genomewide transcriptional studies of endometriosis tissue that identified a gene signature consistent with an autoimmune profile [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/6\">",
"     6",
"    </a>",
"    ]. Serum B lymphocyte stimulating protein (BLyS), also associated with autoimmune disease, is elevated in patients with endometriosis, but its role remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/6\">",
"     6",
"    </a>",
"    ]. Another theory is that ectopic endometrial tissue develops from a group of multipotential cells in the endometrial basal cell layer and that these cells are capable of transformation into endometrial cells with the appropriate hormonal stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential mechanism for migration of endometrial tissue from the pelvis to the thoracic cavity also remains uncertain. Possible routes include microembolization through the pelvic veins [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1,9,10\">",
"     1,9,10",
"    </a>",
"    ], and trans-diaphragmatic movement through diaphragmatic defects [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. The hypothesis that microembolization might be a pathogenic mechanism has been questioned, as micro-embolization would be expected to affect both hemithoraces approximately equally, but TES has an overwhelming occurrence in the right hemithorax [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, the relatively high prevalence of pelvic endometriosis in women of reproductive age suggests that a comparably high number of TES cases would occur, if micro-embolization were the mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/15\">",
"     15",
"    </a>",
"    ]. Instead, the relatively low prevalence of TES makes micro-embolization a less likely explanation.",
"   </p>",
"   <p>",
"    The relationship between the thoracic endometriosis syndrome (TES) and the presence of pelvic endometriosis is unclear. One study observed that peak incidence of TES occurs about five years after the peak incidence of pelvic disease, suggesting a link between the two processes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1\">",
"     1",
"    </a>",
"    ]. However, a meta-analysis did not observe a statistically significant association between the presence of pelvic and thoracic endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/14\">",
"     14",
"    </a>",
"    ]. Based on this analysis it has been suggested that pelvic endometriosis and thoracic endometriosis can occur concurrently or independently [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of diaphragmatic defects has been suggested by many authors as a mechanism for recurrent pneumothorax in TES [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/11,16-19\">",
"     11,16-19",
"    </a>",
"    ]. However, in a meta-analysis of patients with TES, no increased risk of pneumothorax was noted among those with diaphragmatic defects. Furthermore, diaphragmatic defects were observed in similar proportions in subjects presenting with hemothorax or pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/14\">",
"     14",
"    </a>",
"    ]. Additionally, the recurrence of pneumothorax after diaphragmatic repair and following hysterectomy is strong evidence against diaphragmatic defects being the cause for recurrent pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/11,20,21\">",
"     11,20,21",
"    </a>",
"    ]. Thus, the diaphragmatic defects in some patients with TES may represent areas of involuted endometrial implants.",
"   </p>",
"   <p>",
"    The presence of extensive parietal and pleural endometrial implants is a consistent finding in patients with catamenial hemothorax, suggesting that the increased burden of ectopic pleural endometrial implants contributes to the development of hemothorax in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;While pelvic endometriosis affects approximately 2 to 30 percent of women, thoracic endometriosis syndrome (TES) is an uncommon condition [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among the four main presentations of TES, the relative frequencies are [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1,14\">",
"     1,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Catamenial pneumothorax, 70 to 73 percent",
"     </li>",
"     <li>",
"      Catamenial hemothorax, 12 to 14 percent",
"     </li>",
"     <li>",
"      Catamenial hemoptysis, 7 to 12 percent",
"     </li>",
"     <li>",
"      Pulmonary nodules, 6 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of thoracic endometriosis are typically catamenial, occurring within 24 to 48 hours of the onset of menstruation. Chest pain is the most common symptom, occurring in 90 percent of patients, while dyspnea occurs in approximately one-third [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1\">",
"     1",
"    </a>",
"    ]. Pneumothoraces are typically right sided and small to moderate in size [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/22\">",
"     22",
"    </a>",
"    ]. Hemothoraces are also usually right sided, and vary in size. Endometriosis confined to the diaphragm can be associated with ipsilateral chest, shoulder, arm, and neck pain [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/12,16\">",
"     12,16",
"    </a>",
"    ]. Patients with endobronchial or pulmonary parenchymal endometrial disease usually present with hemoptysis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Combining the results from two large reviews from 1996 and 2010, the mean age at presentation is 35 years, with a range from 19 to 54 years [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1,14\">",
"     1,14",
"    </a>",
"    ]. The mean age of patients presenting with hemoptysis (26 years) is significantly lower than patients with other TES manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/14\">",
"     14",
"    </a>",
"    ]. Associated pelvic endometriosis is present in 65 to 84 percent. Pleural implants are associated with hemothorax more often than with pneumothorax or hemoptysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A high index of suspicion for thoracic endometriosis should exist for women of reproductive age who present with recurrent chest pain, pneumothorax, or hemoptysis around the time of their menses. Early diagnosis should lead to timely specific therapy and decreased morbidity.",
"   </p>",
"   <p>",
"    The diagnosis of thoracic endometriosis is usually established clinically, but is often delayed until several episodes have occurred because the association of chest pain, dyspnea,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hemoptysis with menses is not appreciated. In the older literature, the average duration of symptoms prior to diagnosis was 8 months; however, in subsequent reports, the diagnosis has been established earlier due to increased awareness of the syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chest CT scans may show bullae, small cavities or scarring in patients with catamenial pneumothorax. Scans performed for hemoptysis may show small pulmonary nodules that are well-defined or ill-defined, or ground glass infiltrate suggestive of blood. Scans may be negative unless they are obtained during menses [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Bronchial artery angiography has also been used to establish the diagnosis of parenchymal endometriosis in a patient with catamenial hemoptysis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many patients with hemoptysis undergo CT scanning and bronchoscopy to evaluate the source of bleeding. Although histopathologic documentation of thoracic endometrial tissue is generally not required, there have been reports of the diagnosis being established by pleural fluid cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/27\">",
"     27",
"    </a>",
"    ], needle aspiration of lung masses [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/28\">",
"     28",
"    </a>",
"    ], and cytology from bronchoscopic aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum CA 125 concentrations can be elevated in patients with thoracic endometriosis, but the sensitivity and specificity of the test in this setting are unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, a high level of suspicion during video-assisted thoracoscopy has lead to a greater likelihood of identifying diaphragmatic implants of endometrial tissue and diaphragmatic perforations that may be only a few millimeters in diameter (",
"    <a class=\"graphic graphic_picture graphicRef82975 \" href=\"UTD.htm?36/33/37395\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful treatment of thoracic endometriosis requires suppression or eradication of existing thoracic endometrial tissue and prevention of air leakage across diaphragmatic gaps or perforations.",
"   </p>",
"   <p>",
"    On presentation, patients should be managed acutely as other patients with pneumothorax, hemothorax, or hemoptysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link\">",
"     \"Placement and management of thoracostomy tubes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=see_link\">",
"     \"Secondary spontaneous pneumothorax in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/47/30454?source=see_link\">",
"     \"Massive hemoptysis: Initial management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once the patient has been stabilized, hormonal manipulation is generally recommended as first line therapy, but the recurrence rate is high. When hormonal therapy fails or is not tolerated, surgical therapies are available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hormonal manipulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suppression of the ectopic endometrium by interfering with ovarian estrogen secretion can sometimes be accomplished using oral contraceptives, progestins,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    , or gonadotropin-releasing hormone analogs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1,33-37\">",
"     1,33-37",
"    </a>",
"    ]. However, pneumothorax and hemothorax recur in greater than 50 percent despite hormonal therapy, suggesting that endometrial implant regression is not complete",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    that recurrent embolization from pelvic foci continues [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1\">",
"     1",
"    </a>",
"    ]. Hormonal treatment appears to be more effective for catamenial hemoptysis than catamenial pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/24,29\">",
"     24,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link\">",
"     \"Overview of the treatment of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery may be necessary in patients who fail hormonal manipulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Catamenial pneumothorax and hemothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have recurrent pneumothorax or hemothorax despite hormonal therapy generally undergo direct visualization of the pleura with video assisted thoracoscopic surgery (VATS) or an open procedure. It is important to inspect for visceral or diaphragmatic endometrial implants or diaphragmatic perforations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/22\">",
"     22",
"    </a>",
"    ]. Endometrial implants can be excised and any diaphragmatic perforations ligated [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/18,31\">",
"     18,31",
"    </a>",
"    ]. Use of a polyglactin mesh to prevent further transdiaphragmatic leaks has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/38\">",
"     38",
"    </a>",
"    ]. Chemical pleurodesis can then be accomplished with talc poudrage, pleural abrasion, or partial pleurectomy with or without talc poudrage [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1,18,22\">",
"     1,18,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These methods generally prevent recurrent catamenial pneumothorax and hemothorax, although patients may continue to experience monthly chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1,21,39\">",
"     1,21,39",
"    </a>",
"    ]. Persistent symptoms in this setting presumably are due to cyclical proliferation of pleuropulmonary endometrial implants in response to ovarian estrogens. These residual symptoms may be relieved by hormonal manipulation as described above.",
"   </p>",
"   <p>",
"    There has been some debate about whether closure of diaphragmatic defects aids in the management of catamenial pneumothorax because of recurrences following diaphragmatic defect repair [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/22,31,40,41\">",
"     22,31,40,41",
"    </a>",
"    ]. On the other hand, recurrence following",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/39/28274?source=see_link\">",
"     talc pleurodesis",
"    </a>",
"    has been treated successfully with closure of diaphragmatic defects [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/18,32\">",
"     18,32",
"    </a>",
"    ] and in a small, retrospective comparative study, use of a polyglactin mesh was successful in more patients than pleurodesis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hysterectomy and tubal ligation have also prevented recurrence of catamenial pneumothorax in some cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Catamenial hemoptysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;When distal endobronchial or pulmonary parenchymal nodules of endometrial tissue result in recurrent hemoptysis, wedge or subsegmental resection can be performed, depending upon the exact location of the lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1,23,42\">",
"     1,23,42",
"    </a>",
"    ]. Endoscopic Nd-YAG laser treatment has been used for endometriosis in more proximal bronchi [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14727?source=see_link\">",
"     \"Etiology and evaluation of hemoptysis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Refractory disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasional patients have symptoms refractory to all of the above modalities. These patients sometimes respond to hysterectomy with bilateral salpingo-oophorectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the adverse effects of oophorectomy without estrogen replacement can be substantial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/34/40486?source=see_link\">",
"     \"Continuous postmenopausal hormone therapy\"",
"    </a>",
"    .) In addition, symptoms may recur if estrogen replacement therapy is subsequently initiated and reactivates dormant thoracic endometrial tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25254/abstract/21,44\">",
"     21,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thoracic endometriosis syndrome (TES) may present with catamenial pneumothorax, catamenial hemothorax, catamenial hemoptysis, or pulmonary nodules. Catamenial pneumothorax is the most common presentation of TES. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The peak incidence of TES occurs about five years after the peak incidence of pelvic endometriosis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The onset of symptoms associated with thoracic endometriosis is typically within 24 to 48 hours of the onset of menstruation. Chest pain occurs in approximately 90 percent of patients, while dyspnea occurs in approximately 70 percent and hemoptysis in less than 10 percent. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of thoracic endometriosis is usually established clinically, based on a high index of suspicion when recurrent chest pain, pneumothorax, or hemoptysis occur in temporal association with the onset of menses. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chest computed tomography (CT) scans in patients with catamenial pneumothorax may show bullae, small cavities, or scarring in patients. Pulmonary parenchymal endometrial implants may be small nodules that are well-defined or ill-defined. A ground glass infiltrate seen at the time of catamenial hemoptysis may suggest recent bleeding. Scans may be negative unless they are obtained during menses. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Successful treatment of thoracic endometriosis requires suppression or eradication of existing thoracic endometrial tissue and prevention of air leakage across diaphragmatic gaps or perforations. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to the acute management of pneumothorax or hemothorax, the initial treatment of thoracic endometriosis is usually hormonal manipulation to suppress ovarian estrogen secretion. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Hormonal manipulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who have recurrent catamenial pneumothorax or hemothorax despite hormonal manipulation, the next step is usually thoracoscopy or open thoracotomy. At the time of surgery, endometrial implants can be excised, diaphragmatic perforations ligated, and pleurodesis performed. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Catamenial pneumothorax and hemothorax'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with catamenial hemoptysis and pulmonary endometrial nodules that are refractory to hormonal manipulation, the usual treatment is resection of the pulmonary parenchymal or distal bronchial endometriosis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Catamenial hemoptysis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/1\">",
"      Joseph J, Sahn SA. Thoracic endometriosis syndrome: new observations from an analysis of 110 cases. Am J Med 1996; 100:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/2\">",
"      Schrodt GR, Alcorn MO, Ibanez J. Endometriosis of the male urinary system: a case report. J Urol 1980; 124:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/3\">",
"      Jubanyik KJ, Comite F. Extrapelvic endometriosis. Obstet Gynecol Clin North Am 1997; 24:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/4\">",
"      Vinatier D, Orazi G, Cosson M, Dufour P. Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol 2001; 96:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/5\">",
"      Szymanowski K. Apoptosis pattern in human endometrium in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol 2007; 132:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/6\">",
"      Hever A, Roth RB, Hevezi P, et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci U S A 2007; 104:12451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/7\">",
"      O'Connell JT, Mutter GL, Cviko A, et al. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol Oncol 2001; 80:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/8\">",
"      Mok-Lin EY, Wolfberg A, Hollinquist H, Laufer MR. Endometriosis in a patient with Mayer-Rokitansky-K&uuml;ster-Hauser syndrome and complete uterine agenesis: evidence to support the theory of coelomic metaplasia. J Pediatr Adolesc Gynecol 2010; 23:e35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/9\">",
"      PARK WW. The occurrence of decidual tissue within the lung; report of a case. J Pathol Bacteriol 1954; 67:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/10\">",
"      Duke R, Fawcett P, Booth J. Recurrent subarachnoid hemorrhage due to endometriosis. Neurology 1995; 45:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/11\">",
"      Leong AC, Coonar AS, Lang-Lazdunski L. Catamenial pneumothorax: surgical repair of the diaphragm and hormone treatment. Ann R Coll Surg Engl 2006; 88:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/12\">",
"      Redwine DB. Diaphragmatic endometriosis: diagnosis, surgical management, and long-term results of treatment. Fertil Steril 2002; 77:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/13\">",
"      Funatsu K. Catamenial pneumothorax: an example of porous diaphragm syndromes? Chest 2002; 122:1865; author reply 1865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/14\">",
"      Channabasavaiah AD, Joseph JV. Thoracic endometriosis: revisiting the association between clinical presentation and thoracic pathology based on thoracoscopic findings in 110 patients. Medicine (Baltimore) 2010; 89:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/15\">",
"      Guo SW, Wang Y. The prevalence of endometriosis in women with chronic pelvic pain. Gynecol Obstet Invest 2006; 62:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/16\">",
"      Cooper MJ, Russell P, Gallagher PJ. Diaphragmatic endometriosis. Med J Aust 1999; 171:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/17\">",
"      Cowl CT, Dunn WF, Deschamps C. Visualization of diaphragmatic fenestration associated with catamenial pneumothorax. Ann Thorac Surg 1999; 68:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/18\">",
"      Korom S, Canyurt H, Missbach A, et al. Catamenial pneumothorax revisited: clinical approach and systematic review of the literature. J Thorac Cardiovasc Surg 2004; 128:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/19\">",
"      Yamashita J, Iwasaki A, Kawahara K, Shirakusa T. Thoracoscopic approach to the diagnosis and treatment of diaphragmatic disorders. Surg Laparosc Endosc 1996; 6:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/20\">",
"      Soderberg CH, Dahlquist EH. Catamenial pneumothorax. Surgery 1976; 79:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/21\">",
"      Joseph J, Reed CE, Sahn SA. Thoracic endometriosis. Recurrence following hysterectomy with bilateral salpingo-oophorectomy and successful treatment with talc pleurodesis. Chest 1994; 106:1894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/22\">",
"      Alifano M, Jablonski C, Kadiri H, et al. Catamenial and noncatamenial, endometriosis-related or nonendometriosis-related pneumothorax referred for surgery. Am J Respir Crit Care Med 2007; 176:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/23\">",
"      Kim CJ, Nam HS, Lee CY, et al. Catamenial hemoptysis: a nationwide analysis in Korea. Respiration 2010; 79:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/24\">",
"      Elliot DL, Barker AF, Dixon LM. Catamenial hemoptysis. New methods of diagnosis and therapy. Chest 1985; 87:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/25\">",
"      Kalapura T, Okadigwe C, Fuchs Y, et al. Spiral computerized tomography and video thoracoscopy in catamenial pneumothorax. Am J Med Sci 2000; 319:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/26\">",
"      Hope-Gill B, Prathibha BV. Catamenial haemoptysis and clomiphene citrate therapy. Thorax 2003; 58:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/27\">",
"      Zaatari GS, Gupta PK, Bhagavan BS, Jarboe BR. Cytopathology of pleural endometriosis. Acta Cytol 1982; 26:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/28\">",
"      Granberg I, Willems JS. Endometriosis of lung and pleura diagnosed by aspiration biopsy. Acta Cytol 1977; 21:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/29\">",
"      Wang HC, Kuo PH, Kuo SH, Luh KT. Catamenial hemoptysis from tracheobronchial endometriosis: reappraisal of diagnostic value of bronchoscopy and bronchial brush cytology. Chest 2000; 118:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/30\">",
"      Tsunezuka Y, Sato H, Kodama T, et al. Expression of CA125 in thoracic endometriosis in a patient with catamenial pneumothorax. Respiration 1999; 66:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/31\">",
"      Kirschner PA. Catamenial pneumothorax: an example of porous diaphragm syndromes. Chest 2000; 118:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/32\">",
"      Peikert T, Gillespie DJ, Cassivi SD. Catamenial pneumothorax. Mayo Clin Proc 2005; 80:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/33\">",
"      Marshall MB, Ahmed Z, Kucharczuk JC, et al. Catamenial pneumothorax: optimal hormonal and surgical management. Eur J Cardiothorac Surg 2005; 27:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/34\">",
"      Koizumi T, Inagaki H, Takabayashi Y, Kubo K. Successful use of gonadotropin-releasing hormone agonist in a patient with pulmonary endometriosis. Respiration 1999; 66:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/35\">",
"      Slabbynck H, Laureys M, Impens N, et al. Recurring catamenial pneumothorax treated with a Gn-RH analogue. Chest 1991; 100:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/36\">",
"      Uemura T, Matsuyama A, Minaguchi H, Ikeda H. Danazol (an antigonadotropin) in the treatment of catamenial pneumothorax. Asia Oceania J Obstet Gynaecol 1985; 11:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/37\">",
"      Akal M, Kara M. Nonsurgical treatment of a catamenial pneumothorax with a Gn-RH analogue. Respiration 2002; 69:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/38\">",
"      Bagan P, Le Pimpec Barthes F, Assouad J, et al. Catamenial pneumothorax: retrospective study of surgical treatment. Ann Thorac Surg 2003; 75:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/39\">",
"      Oger P, Alifano M, Regnard JF, Gompel A. Difficult management of recurrent catamenial pneumothorax. Gynecol Endocrinol 2006; 22:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/40\">",
"      Choong CK, Smith MD, Haydock DA. Recurrent spontaneous pneumothorax associated with menstrual cycle: Report of three cases of catamenial pneumothorax. ANZ J Surg 2002; 72:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/41\">",
"      Sakamoto K, Ohmori T, Takei H. Catamenial pneumothorax caused by endometriosis in the visceral pleura. Ann Thorac Surg 2003; 76:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/42\">",
"      Terada Y, Chen F, Shoji T, et al. A case of endobronchial endometriosis treated by subsegmentectomy. Chest 1999; 115:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/43\">",
"      Puma F, Carloni A, Casucci G, et al. Successful endoscopic Nd-YAG laser treatment of endobronchial endometriosis. Chest 2003; 124:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25254/abstract/44\">",
"      Lee CY, Di Loreto PC, Beaudoin J. Catamenial pneumothorax. Obstet Gynecol 1974; 44:407.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6687 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-221.179.173.170-312020EB49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25254=[""].join("\n");
var outline_f24_42_25254=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hormonal manipulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Catamenial pneumothorax and hemothorax",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Catamenial hemoptysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Refractory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6687\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6687|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/33/37395\" title=\"picture 1\">",
"      Endometrial tissue on the thoracic surface of the diaphragm",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/34/40486?source=related_link\">",
"      Continuous postmenopausal hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14727?source=related_link\">",
"      Etiology and evaluation of hemoptysis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/47/30454?source=related_link\">",
"      Massive hemoptysis: Initial management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=related_link\">",
"      Overview of the treatment of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=related_link\">",
"      Placement and management of thoracostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=related_link\">",
"      Secondary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_42_25255="Radiofrequency ablation of lung tumors";
var content_f24_42_25255=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiofrequency ablation of lung tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25255/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25255/contributors\">",
"     Damian E Dupuy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25255/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25255/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25255/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25255/contributors\">",
"     Brian Kavanagh, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25255/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25255/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/42/25255/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation (RFA) is a minimally invasive method of treatment that has shown promise in patients with non-small cell lung cancer (NSCLC) and pulmonary metastases from both lung and extrapulmonary primary tumors. Most commonly, RFA has been applied when surgical resection was not an option due to advanced age",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    coexistent medical morbidities.",
"   </p>",
"   <p>",
"    Other treatment options in this setting include external beam radiation therapy (RT), stereotactic body radiotherapy, or palliative systemic therapy. These approaches may result in clinically useful symptom palliation and improvements in survival. However, not all patients have access to these treatments and many may not be candidates due to medical comorbidities.",
"   </p>",
"   <p>",
"    The mechanism and technique of RFA and its application to patients with inoperable primary NSCLCs or metastases are reviewed here. A general overview of the manifestations and treatment of primary lung cancer is presented separately, as is the role of surgery in patients with lung metastases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=see_link\">",
"     \"Overview of the risk factors, pathology, and clinical manifestations of lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISM OF CYTOTOXICITY AND TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;RFA is a technique that involves placement of an electrode into a specific location to cause focal tissue destruction with thermal energy. Tissue heating is achieved through the generation of heat by an alternating electric current in the frequency of radio waves (460-500 kHz) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An insulated radiofrequency (RF) electrode with an exposed conductive tip is connected to an RF generator and is inserted into the targeted tissue under image-guidance. The tip of the RF electrode conducts the electric current, which causes local ionic agitation and subsequent frictional heat in the tissue in a concentrated fashion, thereby creating a controlled zone of coagulation necrosis. A reference electrode (most commonly a large grounding pad) is placed on the patient's skin in an area of good electrical conductivity (typically the thigh or the opposite chest wall) to complete the electrical circuit.",
"   </p>",
"   <p>",
"    The target tissue temperature using RFA is between 50 and 100&ordm;C. At temperatures greater than 50&ordm;C, tissue coagulation results from denaturing of cellular proteins and damage to cell membranes. At temperatures above 100&ordm;C, however, tissue charring and cavitation occur, which increases tissue impedance and limits current flow, thereby reducing the effectiveness of thermal ablation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The aim of RFA is to destroy the entire tumor, killing the malignant cells with minimal damage to surrounding normal tissue and without damaging adjacent organs. A 0.5 to 1.0 cm rim of apparently healthy lung tissue around the lesion is included in the target because the exact tumor margin is uncertain and because microscopic disease may exist in the tissue surrounding the tumor.",
"   </p>",
"   <p>",
"    Several technical modifications have been introduced to increase the volume of tumor kill and to improve the efficiency of RFA. These include the use of expandable multiple-array needle electrodes, cluster electrodes, and internally-cooled electrodes, along with pulsed algorithms for RF current application that maximize energy deposition but avoid tissue boiling, charring, and cavitation.",
"   </p>",
"   <p>",
"    Percutaneous image-guided RFA has been applied to locally control and palliate tumors in various locations including bone [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/3,4\">",
"     3,4",
"    </a>",
"    ], liver [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/5\">",
"     5",
"    </a>",
"    ], kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/6\">",
"     6",
"    </a>",
"    ], and the adrenal gland [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36138?source=see_link\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Radiofrequency ablation, percutaneous ethanol injection, thermal ablation, and cryoablation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22630?source=see_link\">",
"     \"Role of surgery in patients with metastatic renal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28234?source=see_link\">",
"     \"Nonsurgical local treatment strategies for colorectal cancer liver metastases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tumors in the lung are particularly well suited for RFA because the air in the adjacent parenchyma provides an insulating effect, thereby concentrating the RF energy within the tumor tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/8\">",
"     8",
"    </a>",
"    ]. Early experiments in animal models supported the feasibility of this approach [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATIENT TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are not candidates for surgery on the basis of age, underlying lung disease, or other medical comorbidities and those who refuse surgery are candidates for treatment with RFA. The decision to use RFA rather than another modality should be determined by a multidisciplinary group that includes thoracic surgery, pulmonology, medical oncology, and radiation oncology.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The best results are achieved in nonsurgical candidates with small (&lt;3 cm) lesions. Thus, RFA is suited for patients with stage I NSCLC. RFA is also useful for palliation in some patients with stage IIB NSCLC (T3N0M0) disease (ie, those with chest wall invasion). RFA may also be used to treat patients with pulmonary metastases, when disease is limited to one or a few (usually less than five), small, slow-growing lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Although tumor size is an important limitation in patient selection, RFA may be useful in patients with larger tumors to palliate symptoms of refractory chest pain, dyspnea, cough, or hemoptysis. Even though such tumors may not be completely ablated, reduction in tumor volume may result in symptom improvement and better quality of life. Using RFA for larger lesions often requires multiple overlapping treatments to achieve adequate tumor kill, and recurrence rates tend to be higher [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/11,12\">",
"       11,12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with known nodal involvement are typically managed with external beam radiation therapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      systemic therapy. However, in our opinion, combined treatments with RFA may be beneficial if nodal disease has been controlled and active tumor persists at the primary site since many of these patients with residual primary disease have limited treatment options.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only absolute contraindication to lung RFA is the presence of an uncontrollable coagulopathy. Relative contraindications include poor performance status and large tumor size (&gt;5 cm) where the risks of the procedure would outweigh the benefits of treatment, although such cases should be considered on an individual basis. Other clinical settings that require increased caution before and during RFA include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with severe emphysema or pulmonary fibrosis may have an exacerbation of underlying lung disease that can lead to respiratory failure and possibly death after RFA.",
"     </li>",
"     <li>",
"      The inability to safely access the tumor (eg, bullous disease or central tumor location). However, advances in interventional technique, including instillation of air or saline to displace tumors from important mediastinal structures, have been used to treat previously inaccessible lesions, making this less of an issue.",
"     </li>",
"     <li>",
"      RFA can be used in patients who have undergone a prior pneumonectomy, although emergency placement of a chest tube may be required if a large or symptomatic pneumothorax develops. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Complications'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Coordination with a cardiac electrophysiologist is advised in patients with pacemakers or defibrillators who undergo RFA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients referred to our institution for lung RFA are evaluated by a radiologist experienced in this technique prior to the treatment. A thorough history is taken and physical examination performed. Biopsy proof of malignancy should be obtained prior to treatment. In exceptional cases, cytopathology can be used just prior to RFA to confirm the diagnosis. Such a single day procedure may be advantageous in some frail, elderly patients.",
"   </p>",
"   <p>",
"    Relevant imaging and laboratory tests are reviewed, and the indications, risks, and benefits of the procedure are discussed in detail. Patients taking anticoagulation and antiplatelet medications are advised to stop these between five to seven days prior to the procedure. Interval coverage with low molecular weight",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    may be indicated in some patients.",
"   </p>",
"   <p>",
"    Most RFA procedures are performed in the outpatient setting using local anesthesia and intravenous conscious sedation. Patients are asked to fast the night preceding the procedure. At our institution, all lung RFA treatments are performed using CT fluoroscopy for image-guidance.",
"   </p>",
"   <p>",
"    Patients are positioned on the CT table so that the RF electrode can be introduced from the skin into the target tumor by the safest and shortest route possible. This generally means going above the rib to reduce the risk of damaging an intercostal artery and avoiding large bullae and the interlobar fissures to reduce the incidence of pneumothorax. Large dispersive grounding pads are placed on the thighs or opposite chest and the entry site chosen and sterilely prepped. We do not routinely administer prophylactic antibiotics. Local anesthesia is instilled into the skin, subcutaneous tissues, and superficial pleura. The electrode is then advanced through the chest wall and pleura and directed into the tumor using CT fluoroscopic guidance (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59016 \" href=\"UTD.htm?39/0/39936\">",
"     image 1",
"    </a>",
"    ). Examples of various electrode types used in lung RFA are displayed in the following figure (",
"    <a class=\"graphic graphic_picture graphicRef54069 \" href=\"UTD.htm?7/60/8143\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The ablation parameters (ie, type and size of electrode, number and duration of treatments) are determined based upon the tumor size, location, and goal of treatment. At our institution, we perform RFA using an internally-cooled 17-gauge RF electrode with a 200-Watt RF generator operated under impedance-control. In general, we use a cluster electrode comprised of three closely spaced electrodes with a common hub for almost all tumors. Treatment times are typically between 4 and 12 minutes at a given position. The intratumoral temperature is assessed at the end of a treatment to ensure that adequate heating for coagulation necrosis has been achieved (&gt;60&ordm;C).",
"   </p>",
"   <p>",
"    Upon completion of treatment, the electrode is removed and CT fluoroscopy is used to assess for complications. If either a large pneumothorax or a symptomatic small pneumothorax is identified, evacuation can be performed immediately with a small-diameter drainage catheter. All patients are observed for four hours in the post-procedure recovery room. A chest radiograph is obtained prior to discharge to confirm the absence of pneumothorax or the stability of a previously identified small pneumothorax.",
"   </p>",
"   <p>",
"    If a chest tube was placed, a repeat chest radiograph is performed. If the pneumothorax has decreased in size, patients are discharged with a one-way Heimlich valve attached to the chest tube, and they are scheduled to return to the department in 24 hours for a repeat chest radiograph and clinical evaluation. Chest tubes can usually be removed at this time. Most patients are discharged from the hospital on the day of the procedure. Occasionally, patients are admitted overnight for observation or for wall suction secondary to a persistent air leak.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Posttreatment follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients are evaluated with follow-up CT imaging without and with intravenous contrast at one, three, six, and twelve months following RFA and yearly thereafter.",
"   </p>",
"   <p>",
"    Changes in the CT appearance of the tumor are seen immediately during treatment. Typically, there is a surrounding \"halo\" of reactive ground-glass parenchymal opacity adjacent to the treated tumor (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59659 \" href=\"UTD.htm?36/43/37552\">",
"     image 2",
"    </a>",
"    ) and there may also be cavitation and reactive pleural thickening [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/13\">",
"     13",
"    </a>",
"    ]. At one and three month follow-up, the lesion may appear as an area of consolidation or nodularity, and the mean lesion diameter will generally be larger than the preablation size (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74084 \" href=\"UTD.htm?37/10/38052\">",
"     image 3",
"    </a>",
"    ). This increase in size should not be mistaken for tumor recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/14\">",
"     14",
"    </a>",
"    ]. However, any growth at the tumor site beyond three months is suspicious for tumor recurrence.",
"   </p>",
"   <p>",
"    We use pre- and post-contrast CT densitometry to evaluate for residual or recurrent tumor. Tumors that are successfully treated with RFA show little or no contrast enhancement ((",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67299 \" href=\"UTD.htm?0/43/689\">",
"     image 4",
"    </a>",
"    ), six-month follow-up), while enhancement greater than 15 Hounsfield units is worrisome for recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/15\">",
"     15",
"    </a>",
"    ]. Eventually the treatment site decreases in size and the cavitation resolves as seen at one-year follow-up (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55571 \" href=\"UTD.htm?8/57/9107\">",
"     image 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In our practice, PET is also useful in the follow-up evaluation to assess for tumor recurrence. We routinely assess patients with PET at six month intervals. Successfully treated tumors are metabolically inactive and show complete resolution of increased fluorodeoxyglucose (FDG) uptake on postablation as compared with the pretreatment study [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Residual or recurrent tumors will appear as an area of increased FDG uptake, usually at the periphery of the treated lesion, or within ipsilateral hilar or mediastinal lymph nodes. If uncertainty exists, percutaneous biopsy of the area in question can be performed and the tumor retreated with RFA if necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RESULTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of RFA to treat tumors in the lungs was initially reported in 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/18\">",
"     18",
"    </a>",
"    ]. Subsequently, several retrospective series and one prospective, nonrandomized study have shown RFA to be a safe and effective treatment option for patients who are not surgical candidates or who refuse surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/10-12,19-27\">",
"     10-12,19-27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1222763120\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observational studies indicate that RFA has a role in the management of selected patients with primary NSCLC or pulmonary metastases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1222763429\">",
"    <span class=\"h3\">",
"     Non-small cell lung cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;RFA may be useful in patients with NSCLC who are not candidates for surgery either as a single modality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/11,19,28,29\">",
"     11,19,28,29",
"    </a>",
"    ] or in combination with radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/30\">",
"     30",
"    </a>",
"    ]. Although there are no randomized trials comparing RFA with other approaches, RFA may be a useful alternative in this situation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The largest series of patients treated with RFA for stage I NSCLC consisted of 116 patients at Brown who were not candidates for surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/11\">",
"     11",
"    </a>",
"    ]. The one, three and five-year survival rates were 78, 36, and 27 percent, respectively. The size of the primary lesion was an important factor in determining the outcome from treatment. Better results were observed in patients with small (&lt;3 cm) tumors (median survival 45 versus 12 months with tumors &gt;3 cm, and five-year progression-free rate 47 versus 25 percent). A subsequent analysis from the same institution of 79 patients with a solitary primary NSCLC found that local recurrence was the most common site of relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/31\">",
"     31",
"    </a>",
"    ]. Overall recurrences were identified in 34 cases (43 percent), of which 19 were either local or intrapulmonary. Median disease-free survival was 23 months. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    RFA has also been combined with radiation therapy to treat inoperable primary lung tumors. The rationale is to destroy the central hypoxic area of the tumor with RFA and then use radiation to treat residual tumor. In our retrospective series of 41 patients with inoperable NSCLC (38 with stage I disease and three with stage II, T3N0 disease), the overall survival rates at one, two, and three years were 87, 70, and 57 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/12\">",
"     12",
"    </a>",
"    ]. The synergy between RFA and radiotherapy was confirmed in an animal model [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/30\">",
"     30",
"    </a>",
"    ]. The synergistic effects of RFA and radiation have not been clearly defined in regard to timing and dosages, but in the appropriate clinical scenario their combination may be of patient benefit.",
"   </p>",
"   <p>",
"    RFA may also have a role in palliating symptoms in patients with locally advanced disease, where the tumor is too large to be treated with radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/24,32\">",
"     24,32",
"    </a>",
"    ]. In a series of 30 patients treated for palliation of symptoms, RFA alleviated mild hemoptysis in 80 percent, but was effective in treating chest pain, dyspnea, or cough in only about one third of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/24\">",
"     24",
"    </a>",
"    ]. These results were achieved in patients with poor prognostic features (advanced age, poor performance status, prior treatment failure) and limited or no other treatment options. In another series of 39 patients with 44 symptomatic chest wall masses, 31 patients (70 percent) had significant pain relief [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/32\">",
"     32",
"    </a>",
"    ]. Pain relief may have been more effective when RFA was combined with radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1222763437\">",
"    <span class=\"h3\">",
"     Lung metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple series have analyzed the role of RFA in patients with pulmonary metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/19,28,33-35\">",
"     19,28,33-35",
"    </a>",
"    ]. The most extensive data come from patients with colorectal primary tumors, but metastases from other primary tumors also appear to respond in carefully selected patients.",
"   </p>",
"   <p>",
"    The potential role of RFA is illustrated by a prospective, open label study in 148 patients, in which 140 patients had pulmonary metastases and eight had a primary lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/35\">",
"     35",
"    </a>",
"    ]. In this series, 104 (70 percent) patients had two or fewer lesions. In this series 108 (73 percent) had a colorectal primary; a range of other tumors comprised the remainder. Results in treated lesions included complete response, partial response, and stable disease in 26, 20, and 39 percent, respectively. The median progression-free survival was 11 months; overall survival rates at three and five years were 60 and 45 percent, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;RFA of tumors in the lung is generally well tolerated and treatment complications are usually self-limited [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/11,36,37\">",
"     11,36,37",
"    </a>",
"    ]. Potential complications include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fever, pleurisy, and small reactive pleural effusions.",
"     </li>",
"     <li>",
"      Productive cough with brown sputum lasting one to two weeks after ablation has been observed.",
"     </li>",
"     <li>",
"      Pneumothorax is estimated to occur in 30 to 40 percent of cases. However, only about 35 percent of this subgroup of patients (10 percent of all patients treated with RFA) required treatment with needle aspiration or chest tube placement.",
"     </li>",
"     <li>",
"      Pneumonia, pulmonary abscess, and hemoptysis infrequently occur.",
"     </li>",
"     <li>",
"      Rare serious events that have been reported include bronchopleural fistula, tumor tract seeding, pulmonary embolism, severe skin burns at the grounding pad sites, and death from massive hemothorax or acute respiratory failure. Brachial nerve injury has seen follow RFA of apical lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/38\">",
"       38",
"      </a>",
"      ]. Reported mortality from lung RFA is &lt;1 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25255/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recently, the FDA issued a warning regarding lung RFA due to mortality reporting in the literature. With any invasive procedure in a frail elderly population, the benefits of the procedure should outweigh the risks. Patient selection and operator experience are important factors to reduce potential complications and we recommend patient selection decisions at a tumor board level. Clinicians performing the procedure should be familiar with the technology and have had adequate training in a CME course or equivalent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation (RFA) is a technique that involves placement of an electrode into a specific location to cause focal tissue destruction with thermal energy. This technique has been applied to tumors in a number of body sites including the lung. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Mechanism of cytotoxicity and technique'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgical resection is the standard treatment for patients with stage I and II non-small cell lung cancer (NSCLC) if pulmonary function is adequate and medical comorbidity does not preclude surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/5/1114?source=see_link\">",
"       \"Management of stage I and stage II non-small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients who are surgical candidates and have a single or limited number of lung metastases and no uncontrolled systemic disease, surgical resection is the standard therapeutic approach. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=see_link\">",
"       \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link\">",
"       \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients who have either a small primary NSCLC or a single or limited number of pulmonary metastases and are not candidates for surgery based upon age, underlying lung disease, other medical comorbidities or who refuse surgery, RFA, external beam radiation therapy, stereotactic body radiation therapy, or other radiation therapy techniques may be useful depending upon the local availability of adequate expertise. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Results'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/5/1114?source=see_link&amp;anchor=H10#H10\">",
"       \"Management of stage I and stage II non-small cell lung cancer\", section on 'Nonsurgical approaches'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/21/43350?source=see_link&amp;anchor=H5#H5\">",
"       \"Stereotactic body radiation therapy: Rationale and clinical experience\", section on 'Lung tumors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Author Disclosure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Please note that the author receives honoraria from Covidien, the manufacturer of the Cool-Tip&trade; RF Ablation System.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/1\">",
"      Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/2\">",
"      Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities--part I. J Vasc Interv Radiol 2001; 12:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/3\">",
"      Rosenthal DI, Hornicek FJ, Torriani M, et al. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 2003; 229:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/4\">",
"      Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004; 22:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/5\">",
"      Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/6\">",
"      Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/7\">",
"      Mayo-Smith WW, Dupuy DE. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results. Radiology 2004; 231:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/8\">",
"      Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995; 2:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/9\">",
"      Goldberg SN, Gazelle GS, Compton CC, et al. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 1996; 3:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/10\">",
"      Steinke K, Glenn D, King J, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004; 11:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/11\">",
"      Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/12\">",
"      Grieco CA, Simon CJ, Mayo-Smith WW, et al. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006; 17:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/13\">",
"      Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 2005; 185:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/14\">",
"      Clasen S, Krober SM, Kosan B, et al. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer 2008; 113:3121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/15\">",
"      Suh RD, Wallace AB, Sheehan RE, et al. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results. Radiology 2003; 229:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/16\">",
"      Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004; 15:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/17\">",
"      Okuma T, Okamura T, Matsuoka T, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 2006; 20:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/18\">",
"      Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/19\">",
"      Hiraki T, Sakurai J, Tsuda T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 2006; 107:2873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/20\">",
"      Yan TD, King J, Sjarif A, et al. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006; 13:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/21\">",
"      Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007; 18:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/22\">",
"      Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients. J Vasc Interv Radiol 2007; 18:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/23\">",
"      Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 2007; 109:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/24\">",
"      Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004; 230:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/25\">",
"      Zhu JC, Yan TD, Glenn D, Morris DL. Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg 2009; 87:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/26\">",
"      Pennathur A, Abbas G, Qureshi I, et al. Radiofrequency ablation for the treatment of pulmonary metastases. Ann Thorac Surg 2009; 87:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/27\">",
"      Chua TC, Thornbury K, Saxena A, et al. Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer 2010; 116:2106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/28\">",
"      Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/29\">",
"      Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010; 211:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/30\">",
"      Horkan C, Dalal K, Coderre JA, et al. Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology 2005; 235:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/31\">",
"      Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 2010; 254:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/32\">",
"      Grieco CA, Simon CJ, Mayo-Smith WW, et al. Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. Am J Clin Oncol 2007; 30:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/33\">",
"      Nakamura T, Matsumine A, Yamakado K, et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected]. Cancer 2009; 115:3774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/34\">",
"      Soga N, Yamakado K, Gohara H, et al. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma. BJU Int 2009; 104:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/35\">",
"      Chua TC, Sarkar A, Saxena A, et al. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol 2010; 21:2017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/36\">",
"      Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation--an international study survey. Anticancer Res 2004; 24:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/37\">",
"      Yoshimatsu R, Yamagami T, Terayama K, et al. Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors. Chest 2009; 135:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25255/abstract/38\">",
"      Hiraki T, Gobara H, Mimura H, et al. Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol 2010; 21:1129.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4624 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-197.136.42.3-BBD4CCF919-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25255=[""].join("\n");
var outline_f24_42_25255=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISM OF CYTOTOXICITY AND TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATIENT TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Posttreatment follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RESULTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1222763120\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1222763429\">",
"      - Non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1222763437\">",
"      - Lung metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Author Disclosure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/4624\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4624|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/0/39936\" title=\"diagnostic image 1\">",
"      CT fluoroscopic guidance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/43/37552\" title=\"diagnostic image 2\">",
"      CT image halo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/10/38052\" title=\"diagnostic image 3\">",
"      Three month axial CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/43/689\" title=\"diagnostic image 4\">",
"      Axial CT six months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/57/9107\" title=\"diagnostic image 5\">",
"      Axial CT one year",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4624|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/60/8143\" title=\"picture 1\">",
"      RF electrodes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/5/1114?source=related_link\">",
"      Management of stage I and stage II non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28234?source=related_link\">",
"      Nonsurgical local treatment strategies for colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36138?source=related_link\">",
"      Nonsurgical therapies for localized hepatocellular carcinoma: Radiofrequency ablation, percutaneous ethanol injection, thermal ablation, and cryoablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=related_link\">",
"      Overview of the risk factors, pathology, and clinical manifestations of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22630?source=related_link\">",
"      Role of surgery in patients with metastatic renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/21/43350?source=related_link\">",
"      Stereotactic body radiation therapy: Rationale and clinical experience",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=related_link\">",
"      Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=related_link\">",
"      Surgical resection of pulmonary metastases: Outcomes by histology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=related_link\">",
"      Tumor node metastasis (TNM) staging system for non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_42_25256="Radiology of the trachea";
var content_f24_42_25256=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiology of the trachea",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25256/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25256/contributors\">",
"     Paul Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25256/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25256/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25256/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25256/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/42/25256/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most clinicians quickly recognize a variety of abnormal patterns of diffuse parenchymal lung disease on conventional chest radiographs. However, anomalies of the upper respiratory tract, some of which can cause acute respiratory failure, are often overlooked during the initial assessment. Imaging of the trachea will be reviewed here. The radiologic manifestations of diffuse parenchymal lung disease, and the management of central airway obstruction, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/62/5096?source=see_link\">",
"     \"Evaluation of diffuse lung disease by conventional chest radiography\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The trachea extends from the lower border of the larynx (2 cm below the vocal cords) to the carina, where it bifurcates into the mainstem bronchi. The average tracheal length is 10 to 12 cm, and the normal angle of the tracheal bifurcation is 70 &plusmn; 20 degrees (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61457 graphicRef73228 \" href=\"UTD.htm?22/36/23112\">",
"     image 1A-B",
"    </a>",
"    ). With deep inspiration, the tracheal length increases by as much as 2 cm and the angle of the tracheal bifurcation decreases by up to 10 degrees [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The trachea is supported anteriorly and laterally by 18 to 22 semicircular incomplete rings of cartilage; this corresponds to 2 cartilage elements per centimeter of tracheal length. The posterior (membranous) tracheal wall consists of longitudinally aligned smooth muscle and fibrous connective tissue.",
"   </p>",
"   <p>",
"    The normal transverse internal diameter of the trachea ranges between 15 and 25 mm, with a cross-sectional area of 250 to 350 mm",
"    <sup>",
"     2",
"    </sup>",
"    and a volume of 30 to 40 cm",
"    <sup>",
"     3",
"    </sup>",
"    at total lung capacity (TLC) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. The transverse diameter of the trachea increases by 10 percent with inspiration and can decrease by 30 percent with coughing.",
"   </p>",
"   <p>",
"    The radiographic appearance of the tracheal air column should be assessed routinely when chest radiographs are obtained. If an endotracheal tube is present, proper position must be confirmed (",
"    <a class=\"graphic graphic_figure graphicRef55694 \" href=\"UTD.htm?29/53/30559\">",
"     figure 1",
"    </a>",
"    ). Aspiration of sand or other particulates may create a radiopaque outline of the trachea and large airways (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51489 \" href=\"UTD.htm?21/48/22276\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONGENITAL ANOMALIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some congenital anomalies of the large airways, including tracheal agenesis and tracheoesophageal fistulae, present early in life [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Other anomalies, including congenital tracheal stenosis (with or without complete tracheal rings), generally cause symptoms later in life. They can be associated with significant morbidity and coexisting congenital vascular anomalies, such as pulmonary artery slings and right-sided aortic arch anatomy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82725 graphicRef63747 \" href=\"UTD.htm?35/18/36135\">",
"     image 3A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some asymptomatic anomalies are only detected radiographically. As an example, tracheal diverticula (ie, tracheoceles) are occasionally visible on conventional chest radiographs and are increasingly recognized at the thoracic inlet in the right posterolateral region of the trachea as the quality and availability of computed tomographic (CT) scanning improve (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54260 \" href=\"UTD.htm?5/41/5776\">",
"     image 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68122 \" href=\"UTD.htm?3/57/3988\">",
"     image 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=see_link\">",
"     \"Principles of computed tomography of the chest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Tracheal bronchus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheal bronchus is a general term used to describe an abnormal bronchus that usually originates from the distal trachea and is usually directed towards the right upper lobe (",
"    <a class=\"graphic graphic_figure graphicRef57854 \" href=\"UTD.htm?24/53/25438\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. It is a common airway malformation that is thought to occur in one out of every 400 normal persons. In one series, a frequency of 0.1 to 5 percent was reported [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. In another series of 35 cases, most tracheal bronchi actually originated from a bronchus (69 percent) rather than the trachea (23 percent) or carina (8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/17\">",
"     17",
"    </a>",
"    ]. Aberrant bronchi arising from either bronchi or the region of the tracheal bifurcation should not be called tracheal bronchi. The defect in embryogenesis that results in this anomaly includes abnormalities in migration, selection, or reduction of airways during development. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link&amp;anchor=H21#H21\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Tracheal bronchus'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A specific malformation in which a single right upper lobe bronchus arises from the right side of the trachea above the carina and caudad to the azygos vein arch is known as bronchus suis (or \"pig bronchus\"), since this is the normal anatomic configuration seen in pigs and other mammals including ruminant animals and dolphins (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51135 \" href=\"UTD.htm?34/39/35443\">",
"     image 6",
"    </a>",
"    ). This bronchus can be either rudimentary, meaning that it forms a blind-ending pouch, or supernumerary, meaning that its presence is in addition to the normal complement of right upper lobe bronchi. It may also be displaced, replacing either the anatomical right upper lobe bronchus or individual segmental bronchi to the right upper lobe. In patients with displaced bronchus suis, a correctly positioned endotracheal tube can lead to segmental or lobar collapse of the right upper lobe. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/5/7255?source=see_link\">",
"     \"Radiologic patterns of lobar atelectasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TRACHEAL DILATATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dilatation of the trachea can be either diffuse or focal. Tracheobronchomegaly (ie, Mounier-Kuhn syndrome) and traction tracheomegaly can cause diffuse tracheal dilatation. This pattern can also be seen in rare patients with cutis laxa or Ehlers-Danlos syndrome, which suggests the possibility of an underlying defect in collagen synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/3,18\">",
"     3,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Tracheobronchomegaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheobronchomegaly (also called Mounier-Kuhn syndrome) results from a connective tissue weakness that leads to a tracheal width exceeding 3 cm, a right mainstem bronchial diameter of more than 2.5 cm, and a left mainstem bronchial diameter exceeding 2 cm in cross-section [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. The membranous tissue in between the tracheal cartilages can bulge, forming tracheal diverticulosis. Occasionally, this condition is accompanied by central bronchiectasis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59253 \" href=\"UTD.htm?39/29/40402\">",
"     image 7",
"    </a>",
"    ). The airways are very compliant, leading to tracheomalacia and expiratory collapse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Traction tracheomegaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traction tracheomegaly is a result of severe unilateral or bilateral upper lobe loss of volume due to severe cicatrization atelectasis from post primary tuberculosis, fungal diseases, end-stage sarcoidosis, pneumonectomy, or radiation therapy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80220 graphicRef55049 \" href=\"UTD.htm?5/5/5207\">",
"     image 8A-B",
"    </a>",
"    ). Severe diffuse idiopathic pulmonary fibrosis can also lead to traction tracheomegaly [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Focal dilatation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Focal, circumferential dilatation of the trachea is seen most frequently as a consequence of prior intubation. Endotracheal or tracheostomy tube cuff overdistention can lead to airway wall ischemia and subsequent tracheomalacia with focal bulging of the tracheal wall (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65009 graphicRef74889 \" href=\"UTD.htm?0/57/919\">",
"     image 9A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Localized cicatricial retraction due to adjacent lung scarring can similarly result in traction and focal tracheal wall bulging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=see_link\">",
"     \"Endotracheal tube management and complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11945?source=see_link\">",
"     \"Overview of tracheostomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TRACHEAL NARROWING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheal narrowing can be divided radiographically into long and short segment narrowing (",
"    <a class=\"graphic graphic_figure graphicRef52840 \" href=\"UTD.htm?4/49/4880\">",
"     figure 3",
"    </a>",
"    ). Patients may be asymptomatic until the trachea is critically narrowed (&lt;10 mm), regardless of the length of the stenotic lesion. Acute obstruction of the upper airway is a medical emergency, and imaging should not take precedence over rapid therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Long segment narrowing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway narrowing involving long segments of the trachea is seen with saber sheath trachea, relapsing polychondritis, and tracheobronchopathia osteochondroplastica (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77003 \" href=\"UTD.htm?26/51/27444\">",
"     image 10",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57104 \" href=\"UTD.htm?0/0/9\">",
"     image 11",
"    </a>",
"    ). Less commonly, amyloidosis, granulomatosis with polyangiitis (formerly called Wegener's granulomatosis), tumors, and airway burns cause long segment narrowing. Inflammatory bowel disease, including Crohn&rsquo;s disease and ulcerative colitis, can be associated with ulcerative tracheobronchitis. Ulcerative tracheobronchitis can lead to circumferential tracheal wall thickening and eventual stenosis of the trachea, accompanied by bilateral bronchiectases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Saber sheath deformity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Saber sheath deformity results in coronal narrowing and sagittal widening of the intrathoracic tracheal diameter (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82632 graphicRef68278 \" href=\"UTD.htm?14/20/14663\">",
"     image 12A-B",
"    </a>",
"    ). Ossification of tracheal cartilage is frequently noted and the tracheal index (coronal diameter divided by sagittal diameter) in classic saber-sheath trachea is &lt;0.6 (",
"    <a class=\"graphic graphic_figure graphicRef73897 \" href=\"UTD.htm?19/17/19728\">",
"     figure 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef61119 \" href=\"UTD.htm?34/33/35359\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/27\">",
"     27",
"    </a>",
"    ]. This deformity spares the cervical trachea and is strongly associated with chronic obstructive pulmonary disease (COPD), which is diagnosed on the basis of clinical findings or pulmonary function testing even if radiological evidence of emphysema is absent. It is present in 5 percent of elderly men and only rarely seen in women, even those with COPD. Saber sheath trachea is presumably the result of overinflated upper lobes and repetitive bouts of cough. It should not be mistaken for narrowing due to a mediastinal mass. It is a rigid, fixed abnormality that should not be confused with tracheomalacia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Tracheomalacia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheomalacia is a condition characterized by excessive tracheobronchial compliance and collapsibility. It is usually caused by a flaccid posterior tracheal membranous wall that bulges into the tracheal lumen with forced expiration or coughing, although weakness of the supporting cartilages can also be a contributing factor [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Imaging typically shows a hyperexpanded trachea. Computed tomography (CT) may reveal a semilunate, discoid, or crescentic trachea when viewed in cross section (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58373 \" href=\"UTD.htm?8/63/9215\">",
"     image 13",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef82309 \" href=\"UTD.htm?2/11/2225\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51237 \" href=\"UTD.htm?10/55/11135\">",
"     image 14",
"    </a>",
"    ). A frown sign has also been described, which exists when marked anterior bowing of the posterior membranous wall of the trachea occurs.",
"   </p>",
"   <p>",
"    CT may be helpful in the diagnosis of tracheomalacia because it facilitates the measurement of changes in the diameter of the lumen at end-expiration. Dynamic expiratory multislice CT tends to reveal a greater degree of airway collapse than static end-expiratory CT and, therefore, is the preferred test [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/29\">",
"     29",
"    </a>",
"    ]. Expiratory air trapping in the lung of patients with tracheomalacia has been observed with higher frequency and greater severity in patients with tracheomalacia than in a control group of patients without tracheal abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/30\">",
"     30",
"    </a>",
"    ]. The diagnostic evaluation of tracheomalacia, including the role of imaging, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18088?source=see_link\">",
"     \"Tracheomalacia and tracheobronchomalacia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Relapsing polychondritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Manifestations of relapsing polychondritis include auricular and nasal polychondritis, polyarthritis, laryngotracheitis, and aortitis. The latter two complications can be fatal, either due to severe tracheal stenosis or formation of aortic aneurysms with the potential for rupture. On chest radiographs, long segment tracheal stenosis with thickening of the tracheal wall is characteristic (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58373 \" href=\"UTD.htm?8/63/9215\">",
"     image 13",
"    </a>",
"    ). On CT, the tracheal wall is thickened but the posterior tracheal membrane is not involved; dynamic collapse may be present during expiration (",
"    <a class=\"graphic graphic_picture graphicRef82309 \" href=\"UTD.htm?2/11/2225\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/47/4856?source=see_link\">",
"     \"Diagnostic evaluation of relapsing polychondritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Tracheobronchopathia osteochondroplastica",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheobronchopathia osteochondroplastica (TPO) is a rare entity seen with a frequency of 0.4 percent at bronchoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/31,33-38\">",
"     31,33-38",
"    </a>",
"    ]. It consists of osseous and cartilaginous submucosal nodules connected to tracheal cartilage (",
"    <a class=\"graphic graphic_picture graphicRef62408 \" href=\"UTD.htm?3/48/3843\">",
"     picture 3",
"    </a>",
"    ). The abnormality spares the posterior tracheal membranous wall. In spite of marked radiographic changes, patients are only rarely symptomatic since severe airway obstruction is unusual (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50623 \" href=\"UTD.htm?25/48/26373\">",
"     image 15",
"    </a>",
"    ). Linear tracheoplasty may be required in patients with symptomatic airway obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Short segment narrowing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective disease causes short, segmental tracheal narrowing that preferentially involves the upper trachea. Specific examples include granulomatosis with polyangiitis (formerly called Wegener's granulomatosis), squamous papillomatosis, rhinoscleroma, and cicatricial pemphigoid.",
"   </p>",
"   <p>",
"    Short segment tracheal narrowing of the lower trachea is seen in tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/40\">",
"     40",
"    </a>",
"    ], histoplasmosis, sarcoidosis, and inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/26,31\">",
"     26,31",
"    </a>",
"    ]. Granulomatous short-segment tracheal stenoses can be treated with temporary insertion of silicone stents and CT scanning can optimize the time of silicone stent removal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/40\">",
"     40",
"    </a>",
"    ]. Primary tracheal tumors can cause short segment narrowing in the upper and lower trachea.",
"   </p>",
"   <p>",
"    Short segment tracheal narrowing can be caused by extrinsic compression from mass lesions at any level (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74132 \" href=\"UTD.htm?41/58/42916\">",
"     image 16",
"    </a>",
"    ). Thyroid masses are most likely to influence the position and dimensions of the trachea due to the proximity of the gland to the tracheal wall and owing to the thyroid capsule being intertwined with the connective tissue of the trachea (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70903 \" href=\"UTD.htm?39/60/40910\">",
"     image 17",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50840 \" href=\"UTD.htm?28/16/28932\">",
"     image 18",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Enlarged lymph nodes from lymphoma, metastatic lung tumors or, particularly in children, granulomatous disease, can lead to tracheal narrowing. Primary lung tumors and esophageal tumors, aortic aneurysms, or vascular rings can lead to extrinsic tracheal compression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Malignant tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant tumors account for 90 percent of tracheal neoplasms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/42\">",
"     42",
"    </a>",
"    ]. Most occur in adults. They are responsible for 0.1 percent of all cancer deaths and are 180 times less common than bronchogenic carcinoma and 75 times less frequent than laryngeal carcinoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10821?source=see_link\">",
"     \"Tracheal tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Malignant tracheal tumors include squamous cell carcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, and carcinoid tumors, all of which arise from the surface epithelium or salivary glands [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/43\">",
"     43",
"    </a>",
"    ]. Chondrosarcoma originating from the tracheal cartilages occurs in the trachea as well. Hematogenous tracheal metastases have been described in patients with carcinoma of the breast, colon, and kidney, as well as those with melanoma. Direct invasion of the trachea is a potential consequence of carcinoma of the lung, esophagus, larynx, or thyroid [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/44-47\">",
"     44-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Squamous cell carcinoma is the most common histopathologic type of tracheal malignancy, seen primarily in smokers. The peak incidence is in the sixth to seventh decade of life, with a five-year survival rate of only 10 percent. Tumors progress from an intraluminal nodule or mass to stenosis, mediastinal extension, lymph node metastases, tracheoesophageal fistula,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    distant metastases (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77031 \" href=\"UTD.htm?31/31/32245\">",
"     image 19",
"    </a>",
"    ). Computed tomography may reveal polypoid lesions, focal stenosis, eccentric narrowing, or circumferential wall thickening. Positron emission tomography using (18)F-2-deoxy-2-fluoro-D-glucose (FDG-PET) typically demonstrates high uptake of radioactively labeled glucose tracer [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tracheal adenoid cystic carcinoma, previously called cylindroma, is the second-most common malignant tracheal tumor and has the histologic features of salivary gland tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. It has a better prognosis than squamous cell carcinoma and 75 percent of patients are alive at five years. The peak incidence occurs in the fourth and fifth decade of life. Late tumor recurrence after 10 to 15 years is possible since perineural infiltration occurs.",
"   </p>",
"   <p>",
"    Characteristic features of this lesion include an intraluminal and an even larger extraluminal component, so called iceberg lesions. They have a predilection for the posterolateral wall of the trachea where an agglomeration of salivary-gland-like structures is present (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81685 graphicRef68760 \" href=\"UTD.htm?29/63/30710\">",
"     image 20A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/50\">",
"     50",
"    </a>",
"    ]. Mucoepidermoid carcinomas can involve the trachea, and are also of salivary gland origin (",
"    <a class=\"graphic graphic_picture graphicRef56018 \" href=\"UTD.htm?5/22/5479\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/51\">",
"     51",
"    </a>",
"    ]. Adenoid cystic carcinoma and mucoepidermoid carcinoma show variable glucose avidity on the FDG-PET scan [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/43\">",
"     43",
"    </a>",
"    ]. The magnitude of uptake depends on the degree of differentiation (ie, high-grade malignancies show high and homogeneous uptake of radiotracer).",
"   </p>",
"   <p>",
"    Tracheal carcinoid tumors are relatively unusual and occur preferentially in the bronchi [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/52\">",
"     52",
"    </a>",
"    ]. Carcinoids show intense enhancement with intravenous contrast material on CT scanning, but usually have lower radiotracer uptake on the FDG-PET scan than would be expected from a high-grade malignant tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Benign tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign tumors of the trachea occur predominantly in children and account for only 10 percent of tracheal tumors. They include squamous papilloma, hemangioma, chondroma, hamartoma (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60989 \" href=\"UTD.htm?7/59/8118\">",
"     image 21",
"    </a>",
"    ), lipoma, neurogenic tumors, and fibroma.",
"   </p>",
"   <p>",
"    Laryngotracheal papillomatosis results from perinatal infection with human papilloma virus (HPV). It is the most common pediatric laryngeal tumor (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68678 \" href=\"UTD.htm?14/40/14981\">",
"     image 22",
"    </a>",
"    ). Distal spread of papillomas into the trachea can occur after five years in 2 percent of cases with laryngeal involvement. Bronchoalveolar dissemination can occur after 10 years, and is seen in 0.1 percent of patients with laryngeal papillomatosis. Malignant degeneration of squamous papillomas occurs in at least 10 percent of surviving adults [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/31,53\">",
"     31,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hemangiomas, chondromas, hamartomas, lipomas, neurogenic tumors, and fibromas arise from mesenchymal tissue. They usually display little or no radiotracer uptake on the FDG-PET scan, which allows differentiation from malignant tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Pseudotumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudotumors produce intraluminal space-occupying lesions and mimic a neoplastic process. They include mucus plugs (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75874 \" href=\"UTD.htm?1/58/1958\">",
"     image 23",
"    </a>",
"    ), foreign bodies (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66270 \" href=\"UTD.htm?1/14/1251\">",
"     image 24",
"    </a>",
"    ), amyloidomas, tuberculosis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77978 graphicRef70279 \" href=\"UTD.htm?28/46/29412\">",
"     image 25A-B",
"    </a>",
"    ), coccidioidomycosis, rhinoscleroma, granulomatosis with polyangiitis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80970 graphicRef77000 \" href=\"UTD.htm?25/12/25796\">",
"     image 26A-B",
"    </a>",
"    ), and plasmacytomas. If an unexpected tracheal mass represents a mucus plug, a repeat study after coughing may demonstrate the transient nature of the intraluminal lesion. Occasionally, extraneous artifacts can mimic intratracheal foreign bodies on chest radiographs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35399?source=see_link\">",
"     \"Airway foreign bodies in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Tracheal trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of tracheal trauma are intubation and tracheostomy with cuff overdistention, which can result in focal stenosis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62310 graphicRef70207 \" href=\"UTD.htm?18/27/18870\">",
"     image 27A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef70696 \" href=\"UTD.htm?27/11/27839\">",
"     picture 5",
"    </a>",
"    ), granuloma formation (",
"    <a class=\"graphic graphic_picture graphicRef79856 \" href=\"UTD.htm?17/21/17744\">",
"     picture 6",
"    </a>",
"    ),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tracheomalacia with cuff overdistention (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51237 \" href=\"UTD.htm?10/55/11135\">",
"     image 14",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/54\">",
"     54",
"    </a>",
"    ]. Blunt or penetrating trauma (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63750 \" href=\"UTD.htm?20/31/20976\">",
"     image 28",
"    </a>",
"    ), burns (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69632 \" href=\"UTD.htm?42/52/43846\">",
"     image 29",
"    </a>",
"    ), and foreign bodies can also contribute to tracheal stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22790?source=see_link\">",
"     \"Smoke inhalation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both intubation and tracheostomy can be complicated by posterior tracheal wall perforation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50973 \" href=\"UTD.htm?40/52/41795\">",
"     image 30",
"    </a>",
"    ), pneumomediastinum, mediastinitis, and the development of tracheoesophageal fistulae [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25256/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. Posttraumatic tracheoesophageal fistulae usually occur after penetrating trauma or as a result of compression by a tracheal cuff and a concurrent enteric tube (",
"    <a class=\"graphic graphic_picture graphicRef65016 \" href=\"UTD.htm?43/44/44751\">",
"     picture 7",
"    </a>",
"    ). These fistulae have to be differentiated from congenital, postinfectious, or neoplastic lesions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50963 graphicRef56998 \" href=\"UTD.htm?18/0/18438\">",
"     image 31A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=see_link\">",
"     \"Endotracheal tube management and complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11945?source=see_link\">",
"     \"Overview of tracheostomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The trachea should be visualized and scrutinized on every chest radiograph. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some congenital anomalies of the large airways present early in life. Other anomalies generally cause symptoms later in life and can be associated with significant morbidity and coexisting congenital vascular anomalies. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Congenital anomalies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dilatation of the trachea can be either diffuse or focal. Causes of diffuse tracheal dilatation include tracheobronchomegaly (ie, Mounier-Kuhn syndrome) and traction tracheomegaly. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Tracheal dilatation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tracheal narrowing can be divided radiographically into long and short segment narrowing. Patients may be asymptomatic until the trachea is critically narrowed (&lt;10 mm), regardless of the length of the stenotic lesion. Acute obstruction of the upper airway is a medical emergency. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Tracheal narrowing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Airway narrowing involving long segments of the trachea is seen with saber sheath trachea, relapsing polychondritis, and tracheobronchopathia osteochondroplastica. Less commonly, amyloidosis, granulomatosis with polyangiitis (formerly called Wegener's granulomatosis), tumors, inflammatory bowel disease, and airway burns cause long segment narrowing. A saber sheath trachea should not be mistaken for extrinsic compression. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Long segment narrowing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Airway narrowing involving short segments of the trachea is seen with malignant tumors, benign tumors, pseudotumors, extrinsic compression, granulomatous processes, and other select diseases. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Short segment narrowing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/1\">",
"      Breatnach E, Abbott GC, Fraser RG. Dimensions of the normal human trachea. AJR Am J Roentgenol 1984; 142:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/2\">",
"      Holbert JM, Strollo DC. Imaging of the normal trachea. J Thorac Imaging 1995; 10:171.",
"     </a>",
"    </li>",
"    <li>",
"     Muller NL. Disease of the airways. In: Radiologic diagnosis of diseases of the chest, Muller, Fraser, Coleman, Pare (Eds), WP Saunders, Philadelphia 2001. p.452.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/4\">",
"      Altman RP, Randolph JG, Shearin RB. Tracheal agenesis: recognition and management. J Pediatr Surg 1972; 7:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/5\">",
"      Saleeby MG, Vustar M, Algren J. Tracheal agenesis: a rare disease with unique airway considerations. Anesth Analg 2003; 97:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/6\">",
"      Greiner A, Perkmann R, Rieger M, et al. Vascular ring causing tracheal compression in an adult patient. Ann Thorac Surg 2003; 75:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/7\">",
"      Zylak CJ, Eyler WR, Spizarny DL, Stone CH. Developmental lung anomalies in the adult: radiologic-pathologic correlation. Radiographics 2002; 22 Spec No:S25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/8\">",
"      Berdon WE, Baker DH, Wung JT, et al. Complete cartilage-ring tracheal stenosis associated with anomalous left pulmonary artery: the ring-sling complex. Radiology 1984; 152:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/9\">",
"      Boiselle PM, Ernst A. State-of-the-art imaging of the central airways. Respiration 2003; 70:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/10\">",
"      Goo JM, Im JG, Ahn JM, et al. Right paratracheal air cysts in the thoracic inlet: clinical and radiologic significance. AJR Am J Roentgenol 1999; 173:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/11\">",
"      Caversaccio MD, Becker M, Zb&auml;ren P. Tracheal diverticulum presenting with recurrent laryngeal nerve paralysis. Ann Otol Rhinol Laryngol 1998; 107:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/12\">",
"      Doolittle AM, Mair EA. Tracheal bronchus: classification, endoscopic analysis, and airway management. Otolaryngol Head Neck Surg 2002; 126:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/13\">",
"      Siegel MJ, Shackelford GD, Francis RS, McAlister WH. Tracheal bronchus. Radiology 1979; 130:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/14\">",
"      HARRIS JH Jr. The clinical significance of the tracheal bronchus. Am J Roentgenol Radium Ther Nucl Med 1958; 79:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/15\">",
"      Barat M, Konrad HR. Tracheal bronchus. Am J Otolaryngol 1987; 8:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/16\">",
"      Setty SP, Michaels AJ. Tracheal bronchus: case presentation, literature review, and discussion. J Trauma 2000; 49:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/17\">",
"      Ghaye B, Szapiro D, Fanchamps JM, Dondelinger RF. Congenital bronchial abnormalities revisited. Radiographics 2001; 21:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/18\">",
"      Wanderer AA, Ellis EF, Goltz RW, Cotton EK. Tracheobronchiomegaly and acquired cutis laxa in a child. Physiologic and immunologic studies. Pediatrics 1969; 44:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/19\">",
"      Mounier-Kuhn, P. Dilatation de la Trachee: Constatations Radiographiques et Bronchoscopiques. Lyon Med 1932; 150:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/20\">",
"      Shin MS, Jackson RM, Ho KJ. Tracheobronchomegaly (Mounier-Kuhn syndrome): CT diagnosis. AJR Am J Roentgenol 1988; 150:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/21\">",
"      Hubbard M, Masters IB, Chang AB. Rapidly progressing case of Mounier-Kuhn Syndrome in early childhood. Pediatr Pulmonol 2003; 36:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/22\">",
"      Rapti A, Drossos C, Tzavelas D, et al. Mounier-Kuhn syndrome (tracheobronchomegaly). Monaldi Arch Chest Dis 1995; 50:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/23\">",
"      Woodring JH, Barrett PA, Rehm SR, Nurenberg P. Acquired tracheomegaly in adults as a complication of diffuse pulmonary fibrosis. AJR Am J Roentgenol 1989; 152:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/24\">",
"      Grillo HC. Surgical treatment of postintubation tracheal injuries. J Thorac Cardiovasc Surg 1979; 78:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/25\">",
"      Ravin CE, Handel DB, Kariman K. Persistent endotracheal tube cuff overdistension: a sign of tracheomalacia. AJR Am J Roentgenol 1981; 137:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/26\">",
"      Yamamoto AK, Babar JL. Case 184: ulcerative tracheobronchitis. Radiology 2012; 264:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/27\">",
"      Greene R. \"Saber-sheath\" trachea: relation to chronic obstructive pulmonary disease. AJR Am J Roentgenol 1978; 130:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/28\">",
"      MDCT evaluation of Nonneoplastic Tracheobronchial Stenoses. Contemporary Diagnostic Radiology 2008; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/29\">",
"      Baroni RH, Feller-Kopman D, Nishino M, et al. Tracheobronchomalacia: comparison between end-expiratory and dynamic expiratory CT for evaluation of central airway collapse. Radiology 2005; 235:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/30\">",
"      Zhang J, Hasegawa I, Hatabu H, et al. Frequency and severity of air trapping at dynamic expiratory CT in patients with tracheobronchomalacia. AJR Am J Roentgenol 2004; 182:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/31\">",
"      Prince JS, Duhamel DR, Levin DL, et al. Nonneoplastic lesions of the tracheobronchial wall: radiologic findings with bronchoscopic correlation. Radiographics 2002; 22 Spec No:S215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/32\">",
"      Choplin RH, Wehunt WD, Theros EG. Diffuse lesions of the trachea. Semin Roentgenol 1983; 18:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/33\">",
"      Restrepo S, Pandit M, Villamil MA, et al. Tracheobronchopathia osteochondroplastica: helical CT findings in 4 cases. J Thorac Imaging 2004; 19:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/34\">",
"      Hantous-Zannad S, Seba&iuml; L, Zidi A, et al. Tracheobronchopathia osteochondroplastica presenting as a respiratory insufficiency: diagnosis by bronchoscopy and MRI. Eur J Radiol 2003; 45:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/35\">",
"      Zack JR, Rozenshtein A. Tracheobronchopathia osteochondroplastica: report of three cases. J Comput Assist Tomogr 2002; 26:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/36\">",
"      Karlikaya C, Y&uuml;ksel M, Kili&ccedil;li S, Candan L. Tracheobronchopathia osteochondroplastica. Respirology 2000; 5:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/37\">",
"      Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1999. A 44-year-old man with tracheal narrowing and respiratory stridor. N Engl J Med 1999; 341:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/38\">",
"      Nienhuis DM, Prakash UB, Edell ES. Tracheobronchopathia osteochondroplastica. Ann Otol Rhinol Laryngol 1990; 99:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/39\">",
"      Grillo HC, Wright CD. Airway obstruction owing to tracheopathia osteoplastica: treatment by linear tracheoplasty. Ann Thorac Surg 2005; 79:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/40\">",
"      Verma A, Park HY, Lim SY, et al. Posttuberculosis tracheobronchial stenosis: use of CT to optimize the time of silicone stent removal. Radiology 2012; 263:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/41\">",
"      Buckley JA, Stark P. Intrathoracic mediastinal thyroid goiter: imaging manifestations. AJR Am J Roentgenol 1999; 173:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/42\">",
"      Grillo HC, Mathisen DJ. Primary tracheal tumors: treatment and results. Ann Thorac Surg 1990; 49:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/43\">",
"      Park CM, Goo JM, Lee HJ, et al. Tumors in the tracheobronchial tree: CT and FDG PET features. Radiographics 2009; 29:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/44\">",
"      Weber AL, Grillo HC. Tracheal tumors. A radiological, clinical, and pathological evaluation of 84 cases. Radiol Clin North Am 1978; 16:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/45\">",
"      Hazama K, Miyoshi S, Akashi A, et al. Clinicopathological investigation of 20 cases of primary tracheal cancer. Eur J Cardiothorac Surg 2003; 23:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/46\">",
"      Gaissert HA. Primary tracheal tumors. Chest Surg Clin N Am 2003; 13:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/47\">",
"      Schneider P, Schirren J, Muley T, Vogt-Moykopf I. Primary tracheal tumors: experience with 14 resected patients. Eur J Cardiothorac Surg 2001; 20:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/48\">",
"      Regnard JF, Fourquier P, Levasseur P. Results and prognostic factors in resections of primary tracheal tumors: a multicenter retrospective study. The French Society of Cardiovascular Surgery. J Thorac Cardiovasc Surg 1996; 111:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/49\">",
"      Dean CW, Speckman JM, Russo JJ. AIRP best cases in radiologic-pathologic correlation: adenoid cystic carcinoma of the trachea. Radiographics 2011; 31:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/50\">",
"      Kwak SH, Lee KS, Chung MJ, et al. Adenoid cystic carcinoma of the airways: helical CT and histopathologic correlation. AJR Am J Roentgenol 2004; 183:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/51\">",
"      Kim TS, Lee KS, Han J, et al. Sialadenoid tumors of the respiratory tract: radiologic-pathologic correlation. AJR Am J Roentgenol 2001; 177:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/52\">",
"      Briselli M, Mark GJ, Grillo HC. Tracheal carcinoids. Cancer 1978; 42:2870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/53\">",
"      McCarthy MJ, Rosado-de-Christenson ML. Tumors of the trachea. J Thorac Imaging 1995; 10:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/54\">",
"      Stark P. Imaging of tracheobronchial injuries. J Thorac Imaging 1995; 10:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/55\">",
"      Weber AL, Grillo HC. Tracheal stenosis: an analysis of 151 cases. Radiol Clin North Am 1978; 16:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/56\">",
"      Stauffer JL, Olson DE, Petty TL. Complications and consequences of endotracheal intubation and tracheotomy. A prospective study of 150 critically ill adult patients. Am J Med 1981; 70:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25256/abstract/57\">",
"      Carbognani P, Bobbio A, Cattelani L, et al. Management of postintubation membranous tracheal rupture. Ann Thorac Surg 2004; 77:406.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6984 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-197.136.42.3-C3CD4DCF74-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25256=[""].join("\n");
var outline_f24_42_25256=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONGENITAL ANOMALIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Tracheal bronchus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TRACHEAL DILATATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Tracheobronchomegaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Traction tracheomegaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Focal dilatation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TRACHEAL NARROWING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Long segment narrowing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Saber sheath deformity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Tracheomalacia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Relapsing polychondritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Tracheobronchopathia osteochondroplastica",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Short segment narrowing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Malignant tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Benign tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Pseudotumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Tracheal trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6984\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6984|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/29/27092\" title=\"diagnostic image 1A\">",
"      Normal trachea CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/11/11442\" title=\"diagnostic image 1B\">",
"      Normal trachea MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/48/22276\" title=\"diagnostic image 2\">",
"      Sand bronchogram CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/22/38242\" title=\"diagnostic image 3A\">",
"      Right arch compression CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/63/15346\" title=\"diagnostic image 3B\">",
"      Congenital tracheal stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/41/5776\" title=\"diagnostic image 4\">",
"      Tracheal diverticulum CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/57/3988\" title=\"diagnostic image 5\">",
"      Tracheal diverticul CXR CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/39/35443\" title=\"diagnostic image 6\">",
"      Tracheal bronchus CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/29/40402\" title=\"diagnostic image 7\">",
"      Mounier Kuhn CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/47/16112\" title=\"diagnostic image 8A\">",
"      Traction tracheomegaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/6/14435\" title=\"diagnostic image 8B\">",
"      Traction tracheomegaly CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/9/20639\" title=\"diagnostic image 9A\">",
"      Tracheomalacia CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/60/12228\" title=\"diagnostic image 9B\">",
"      ETT overinflation CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/51/27444\" title=\"diagnostic image 10\">",
"      Tracheobronchopathia osteochondroplastica 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/0/9\" title=\"diagnostic image 11\">",
"      Tracheobronchopathia osteochondroplastica 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/20/14658\" title=\"diagnostic image 12A\">",
"      Saber sheath CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/6/32865\" title=\"diagnostic image 12B\">",
"      Saber sheath CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/63/9215\" title=\"diagnostic image 13\">",
"      RP Tracheal stenosis CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/55/11135\" title=\"diagnostic image 14\">",
"      Discoid malacia CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/48/26373\" title=\"diagnostic image 15\">",
"      TPO CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/58/42916\" title=\"diagnostic image 16\">",
"      Extrinsic compression CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/60/40910\" title=\"diagnostic image 17\">",
"      Goiter CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/16/28932\" title=\"diagnostic image 18\">",
"      Goiter MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/31/32245\" title=\"diagnostic image 19\">",
"      Malignant stenosis MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/43/20158\" title=\"diagnostic image 20A\">",
"      Adenoid cystic carcinoma CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/39/1653\" title=\"diagnostic image 20B\">",
"      Adenoid cystic carcinoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/59/8118\" title=\"diagnostic image 21\">",
"      Tracheal hamartoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/40/14981\" title=\"diagnostic image 22\">",
"      Tracheal papillomatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/58/1958\" title=\"diagnostic image 23\">",
"      Intraluminal lesion CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/14/1251\" title=\"diagnostic image 24\">",
"      Tracheal foreign body",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/52/28495\" title=\"diagnostic image 25A\">",
"      TB tracheal stenosis CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/31/29168\" title=\"diagnostic image 25B\">",
"      TB tracheal stenosis CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/31/35327\" title=\"diagnostic image 26A\">",
"      Tracheal stenosis in GPA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/55/18288\" title=\"diagnostic image 26B\">",
"      Tracheal wall involvement in GPA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/48/35598\" title=\"diagnostic image 27A\">",
"      Airway stenosis tomogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/37/5716\" title=\"diagnostic image 27B\">",
"      Focal tracheal stenosis CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/31/20976\" title=\"diagnostic image 28\">",
"      Traumatic stenosis CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/52/43846\" title=\"diagnostic image 29\">",
"      Tracheal burn",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/52/41795\" title=\"diagnostic image 30\">",
"      Traumatic intubation CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/26/24994\" title=\"diagnostic image 31A\">",
"      Congenital TEF fluoro",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/60/42959\" title=\"diagnostic image 31B\">",
"      Malignant TEF CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6984|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/53/30559\" title=\"figure 1\">",
"      Endotracheal tube positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/53/25438\" title=\"figure 2\">",
"      Tracheal bronchus types",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/49/4880\" title=\"figure 3\">",
"      Types of stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/17/19728\" title=\"figure 4\">",
"      Saber sheath ratio",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6984|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/33/35359\" title=\"picture 1\">",
"      Saber sheath gross",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/11/2225\" title=\"picture 2\">",
"      RP dynamic collapse CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/48/3843\" title=\"picture 3\">",
"      TPO Gross",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/22/5479\" title=\"picture 4\">",
"      Mucoepidermoid CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/11/27839\" title=\"picture 5\">",
"      Tracheal stenosis gross",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/21/17744\" title=\"picture 6\">",
"      Tracheal granuloma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/44/44751\" title=\"picture 7\">",
"      TE fistula Endosc",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35399?source=related_link\">",
"      Airway foreign bodies in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=related_link\">",
"      Diagnosis and management of central airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/47/4856?source=related_link\">",
"      Diagnostic evaluation of relapsing polychondritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=related_link\">",
"      Endotracheal tube management and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/62/5096?source=related_link\">",
"      Evaluation of diffuse lung disease by conventional chest radiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11945?source=related_link\">",
"      Overview of tracheostomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=related_link\">",
"      Principles of computed tomography of the chest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/5/7255?source=related_link\">",
"      Radiologic patterns of lobar atelectasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22790?source=related_link\">",
"      Smoke inhalation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10821?source=related_link\">",
"      Tracheal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18088?source=related_link\">",
"      Tracheomalacia and tracheobronchomalacia in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_42_25257="Facial nerve palsy in children";
var content_f24_42_25257=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Facial nerve palsy in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25257/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25257/contributors\">",
"     Gary D Clark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25257/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25257/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25257/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25257/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/42/25257/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Facial nerve palsy is a common malady in children that may be congenital or acquired. The underlying etiology often remains unclear despite extensive investigation.",
"   </p>",
"   <p>",
"    In 1830, Sir Charles Bell first described unilateral facial weakness secondary to facial nerve dysfunction. His description of acquired, idiopathic facial paralysis is often termed Bell's palsy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/1\">",
"     1",
"    </a>",
"    ]. This topic will review clinical aspects of facial nerve palsy in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FACIAL NERVE ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The facial nerve has a complex anatomy and function that render it susceptible to multiple neurologic disorders based upon the location of the lesion (",
"    <a class=\"graphic graphic_figure graphicRef55677 \" href=\"UTD.htm?23/41/24218\">",
"     figure 1",
"    </a>",
"    ). Cranial nerve VII originates from multiple brainstem nuclei that are functionally specialized [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The motor component of VII, which accounts for movement of the facial musculature, arises from the motor nucleus of VII in the pontine tegmentum. Fibers innervating the forehead receive bilateral input via the corticobulbar tract, whereas the contralateral corticobulbar tract innervates the remaining facial muscles.",
"     </li>",
"     <li>",
"      The superior salivatory nucleus is the origin of preganglionic parasympathetic fibers that innervate the lacrimal, sublingual, and submandibular glands. Innervating fibers of the submandibular and sublingual gland travel via the chorda tympani nerve, whereas the lacrimal gland fibers travel through the greater petrosal nerve.",
"     </li>",
"     <li>",
"      Taste for the anterior two-thirds of the tongue and sensory fibers from the external acoustic canal travel to the solitary tract nucleus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The fibers of the facial nerve emerge from the ventrolateral aspect of the brainstem at the caudal border of the pons and enter the petrous portion of the temporal bone via the internal auditory canal. The sensory fibers travel as the nervus intermedius portion of CN VII and run between cranial nerve VIII and the motor component of CN VII. In the temporal bone, the greater petrosal nerve arises from the labyrinthine segment of the facial nerve and carries preganglionic parasympathetic fibers to the pterygopalatine ganglion. The nerve then synapses and sends fibers to the lacrimal gland; lesions affecting the facial nerve prior to the greater petrosal nerve may cause decreased lacrimation. The facial nerve then courses along the medial wall of the anterior epitympanic recess; it is here that the facial nerve may be affected by cholesteatomas.",
"   </p>",
"   <p>",
"    The mastoid segment of the facial nerve courses inferiorly, lateral to the jugular fossa, allowing lesions there to affect the facial nerve. The stapedius nerve arises from this segment and innervates the stapedius muscle. Lesions of the facial nerve prior to the stapedius nerve result in hyperacusis.",
"   </p>",
"   <p>",
"    The chorda tympani arises distally in the mastoid segment and enters the middle ear via the canaliculus chordae tympani. It exits via the petrotympanic fissure and supplies afferent fibers for taste to the anterior two-thirds of the tongue. It also provides efferent parasympathetic fibers to the submandibular and sublingual glands that synapse in the submandibular ganglion. The facial nerve exits the skull via the stylomastoid foramen and courses through the parotid gland to divide and supply the muscles of facial expression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possible causes of facial nerve palsy are many and may be congenital, infectious, neoplastic, traumatic, or idiopathic (",
"    <a class=\"graphic graphic_table graphicRef76593 \" href=\"UTD.htm?26/20/26958\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Approximately one-half of all cases qualify for the label \"Bell's palsy,\" defined as an acute facial nerve palsy of unknown cause. An estimated 20 per 100,000 people per year are affected by Bell's palsy, rendering it one of the more common referrals for neurologists [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No racial, geographic, or gender-based predilection exists for Bell's palsy, but there is a threefold greater risk during pregnancy (especially in the third trimester or in the first postpartum week) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/7\">",
"     7",
"    </a>",
"    ], and a fourfold greater incidence in diabetics [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common cause of acute onset facial nerve palsy in children has in the past been acute otitis media. However, Lyme disease may be a more common cause in endemic areas than otitis media, as illustrated by a study of 50 children with facial nerve palsy in Delaware [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/8\">",
"     8",
"    </a>",
"    ]. The most common etiology was Lyme disease (50 percent), followed by acute otitis media (12 percent), varicella (6 percent), herpes zoster (4 percent), and coxsackievirus (2 percent). Idiopathic disease (Bell's palsy) was the diagnosis in 26 percent. At least one European study also found Lyme disease to be the most frequently identified cause of acute facial palsy in children, accounting for 16 of 27 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/9\">",
"     9",
"    </a>",
"    ]. Bilateral facial palsy occurred only in children with Lyme disease in this study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Congenital facial nerve palsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital facial nerve palsy may be the result of developmental defects or of traumatic etiology (",
"    <a class=\"graphic graphic_table graphicRef76593 \" href=\"UTD.htm?26/20/26958\">",
"     table 1",
"    </a>",
"    ). Birth weight greater than 3500 grams, forceps-assisted delivery, and prematurity are all risk factors associated with traumatic facial palsy. The presence of multisystem dysmorphia and multiple cranial nerve abnormalities tend to favor developmental abnormalities, although isolated facial palsy can be of developmental origin.",
"   </p>",
"   <p>",
"    A well recognized form of congenital facial palsy is Moebius syndrome, which is typically accompanied by impairment of ocular abduction. In addition, two loci for isolated facial palsy of developmental origin have been identified, designated hereditary congenital facial paresis 1 and 2 on chromosomes 3q21-22 and 10q21.3-22.1 respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Other syndromes are also associated with facial palsies (",
"    <a class=\"graphic graphic_table graphicRef76593 \" href=\"UTD.htm?26/20/26958\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In distinguishing developmental from traumatic facial palsies in the perinatal period, some or complete recovery of function favors traumatic lesions. Early motor nerve conduction study also helps distinguish these etiologies. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Electrodiagnostic studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24001440\">",
"    <span class=\"h3\">",
"     Moebius syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moebius (Mobius) syndrome, sometimes called Moebius sequence, is a congenital facial palsy (unilateral or bilateral) with abnormalities of abducens (cranial nerve VI) function, though other cranial nerves (III, IV, V, VIII) may be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Postmortem analysis has shown hypoplasia of the motor nucleus of the facial nerve with small or absent facial nerve rootlets exiting the brainstem [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/15\">",
"     15",
"    </a>",
"    ]. A genetic cause has not yet been identified and there is some overlap with the hereditary congenital facial paresis syndromes exist, but linkage points to a distinct locus at 13q12.2-13 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, otitis media is a relatively common cause of acute facial nerve palsy. One group found that the incidence of facial nerve palsy was 0.16 percent, which was decreased from about 2 percent in the preantibiotic era [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H111860927#H111860927\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Other intratemporal complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bacterial infection of the middle ear usually is easily diagnosed by simple inspection of the external meatus and tympanic membrane. CT scan may allow for better visualization of the course of the facial nerve through the petrous portion of the temporal bone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H19#H19\">",
"     \"Acute otitis media in children: Diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of acute otitis media is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=see_link\">",
"     \"Acute otitis media in children: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Herpes simplex virus infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;For years, a herpes simplex-mediated viral inflammatory immune mechanism for Bell's palsy was a subject of controversy, but was suspected based upon serological evidence.",
"   </p>",
"   <p>",
"    Polymerase chain reaction (PCR) DNA testing now supports the notion of axonal spread and multiplication of a reactivated neurotropic virus leading to inflammation, demyelination, and palsy. Herpes simplex virus (HSV) activation has become widely accepted as the likely cause of Bell's palsy in most adult cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. In one study, for example, HSV-1 genomes were identified in facial nerve endoneurial fluid and auricular muscle in 11 of 14 patients undergoing decompression surgery for Bell's palsy; the HSV-1 genomes were not found in controls [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Lyme disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, Lyme disease has become the most common cause of acute facial nerve palsy among children in areas endemic for this infection [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Facial nerve palsy is the most common cranial neuropathy associated with Lyme meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Involvement of the facial nerve can be unilateral or bilateral and usually lasts less than two months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=see_link&amp;anchor=H11#H11\">",
"     \"Lyme disease: Clinical manifestations in children\", section on 'Cranial nerve palsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanism by which Lyme disease causes facial nerve palsy may be related to direct invasion of the nerve by Borrelia burgdorferi. This possibility is suggested by studies that have found that virtually all children who have had a tick bite or erythema migrans in the head and neck region develop ipsilateral facial nerve palsy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/9,24\">",
"     9,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with Lyme disease and facial nerve palsy may have other clinical features of Lyme disease, but many have no other symptoms, nor a history of tick bite or erythema migrans [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/25\">",
"     25",
"    </a>",
"    ]. Painless, non-tender swelling and erythema of the face preceding the facial palsy are distinctive features that may be present and help confirm the clinical diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/26\">",
"     26",
"    </a>",
"    ]. The likelihood that Lyme disease is the cause of a seventh nerve palsy diminishes in either nonendemic areas or at a time of year when Lyme disease is not prevalent.",
"   </p>",
"   <p>",
"    In contrast to adults, most children with isolated Lyme disease facial palsy have abnormal cerebrospinal fluid findings, including an elevated white blood cell count, protein, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/9,27\">",
"     9,27",
"    </a>",
"    ]. However, the clinical significance of these abnormalities is not clear [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Lumbar puncture'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The evaluation of suspected Lyme-induced facial palsy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=see_link&amp;anchor=H12#H12\">",
"     \"Lyme disease: Clinical manifestations in children\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ramsay Hunt syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Ramsay Hunt syndrome is caused by reactivation of varicella zoster virus (herpes zoster oticus); the virus lies dormant in the sensory ganglion after primary infection. Ramsay Hunt is characterized by facial paralysis associated with a painful vesicular eruption within the external auditory canal and vestibulocochlear dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'Ramsay Hunt syndrome (Herpes zoster oticus)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV infection rarely causes facial palsy. If it does, onset is at the time of seroconversion, when a CSF lymphocytosis usually is present [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/29\">",
"     29",
"    </a>",
"    ]. In the later stages when cellular immunity wanes, the facial palsy is typically caused by another infection such as zoster, chronic demyelinating polyradiculopathy, or meningeal lymphomatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other probable infectious causes of Bell's palsy include cytomegalovirus, Epstein-Barr virus, adenovirus, rubella virus, mumps, influenza B, and coxsackievirus [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/1,30\">",
"     1,30",
"    </a>",
"    ], although they have been implicated less conclusively. In addition, there are case reports of children with facial nerve palsy and serologic evidence of Rickettsia conorii infection (Mediterranean spotted fever) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other disorders should be considered in the differential diagnosis of facial nerve palsy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cholesteatoma should be suspected if the onset of facial palsy is gradual [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"       \"Cholesteatoma in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The Melkersson-Rosenthal syndrome is characterized by facial paralysis, episodic facial swelling, and a fissured tongue, typically beginning in adolescence but with recurrent episodes of facial palsy [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/32\">",
"       32",
"      </a>",
"      ]. Abortive forms outnumber the classic triad. Perivascular tuberculoid granulomas are seen in the edematous tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/33\">",
"       33",
"      </a>",
"      ], but the cause is unknown and treatment is unproven.",
"     </li>",
"     <li>",
"      Sarcoidosis should be considered, especially in patients with bilateral facial palsy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/8/20616?source=see_link\">",
"       \"Neurologic sarcoidosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bilateral palsies may also be caused by numerous other disorders that are not strictly the subject of this review [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with idiopathic facial nerve palsy (Bell&rsquo;s palsy) typically present with the sudden onset (usually over hours) of unilateral facial paralysis. Common findings include decreased forehead movement, sagging of the eyebrow, inability to close the eye, disappearance of the nasolabial fold, and drawing of the mouth to the unaffected side [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/6\">",
"     6",
"    </a>",
"    ]. Decreased tearing, hyperacusis,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    loss of taste sensation on the anterior two-thirds of the tongue may help to site the lesion in the facial canal but are more useful as an indicator of severity than of anatomic diagnosis. The presence of an ipsilateral abducens (ie, cranial nerve VI) palsy suggests the possibility of a brainstem lesion as the cause of the facial palsy, since the abducens nucleus is in close proximity to the fibers in the brainstem that exit as the facial nerve.",
"   </p>",
"   <p>",
"    Facial movement is assessed by observing the response to commands for closing the eyes, elevating the brow, frowning, showing the teeth, puckering the lips, and tensing the soft tissues of the neck. The examination also includes a general physical examination and neurologic examination; particular attention should be directed at the external ear for vesicles or scabbing (which indicates Zoster) and for mass lesions within the parotid gland. Testing of taste is also helpful in localizing lesions of the facial nerve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Peripheral versus central lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sparing of the forehead muscles is suggestive of a central (upper motor neuron) lesion because of bilateral innervation to this area. However, this finding does not exclude a peripheral site of pathology in all cases.",
"   </p>",
"   <p>",
"    Central activation of the facial nerve is both volitional and automatic or emotional in origin, and the facial nerve is the final common pathway. Thus, dissociation of movement of the face to command from spontaneous movement, as in smiling, indicates an upper motor neuron lesion. Lack of dissociation indicates a lower motor neuron (peripheral) lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of Bell's palsy is based upon the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A diffuse involvement of all of the distal branches of the facial nerve is present.",
"     </li>",
"     <li>",
"      Onset is acute, over a day or two; the course is progressive, reaching maximal clinical",
"      <span class=\"nowrap\">",
"       weakness/paralysis",
"      </span>",
"      within three weeks or less from the first day of visible weakness; recovery of some degree of function usually occurs within six months.",
"     </li>",
"     <li>",
"      Associated prodrome, ear pain, or dysacusis may be reported.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Accurate diagnosis begins with a thorough history and physical examination. The history should address the time of onset, rapidity of progression, associated symptoms (eg, hyperacusis, lack of taste), and any systemic diseases such as diabetes mellitus or chronic otitis media. A careful history should also include exposure to tick bites and HIV risk factors.",
"   </p>",
"   <p>",
"    As mentioned, the primary etiologies of congenital facial nerve palsy include trauma and developmental abnormalities. In traumatic cases, a history of prolonged labor, forceps delivery, periauricular ecchymoses, or hemotympanum may help with diagnosis, but it is not diagnostic. It is important to look for associated dysmorphic features or multisystemic syndromal pathology. As an example, Goldenhar syndrome (craniofacial microsomia) has associated malar and maxillary hypoplasia and hemifacial microsomia, in addition to congenital facial paralysis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The physical examination should include a careful assessment of facial musculature paralysis as well as careful examination of the ear, mastoid region, parotid gland, and neck. Examination of other cranial nerves, hearing, taste, salivation, and lacrimation may help localize the lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing for Lyme disease is recommended for all children with acute onset facial palsy when there is the possibility of exposure. Other adjunctive investigations, such as electrodiagnostic studies, neuroimaging, or lumbar puncture, may help identify an underlying etiology for facial nerve dysfunction and determine prognosis. However, these tests are not necessary in all patients. Patients who have a typical incomplete facial palsy and who recover do not need further study.",
"   </p>",
"   <p>",
"    In contrast, electrodiagnostic studies may be warranted in patients with clinically complete lesions for prognostic purposes. Imaging is necessary if the physical signs are atypical (ie, involve neighboring cranial nerves), if chronic otitis media, acute mastoiditis, temporal bone trauma, or a neoplasm is suspected as the etiology, if progression is slow and extends beyond three weeks, or if no improvement has occurred at six months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H192230175\">",
"    <span class=\"h3\">",
"     Lyme serologies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing for Lyme disease is recommended for all children with acute onset facial palsy when there is the possibility of exposure in Lyme-endemic areas during the spring through autumn seasons. With the exception of the first four to six weeks of infection, serologic testing is highly sensitive and specific for the diagnosis of Lyme disease. Occasionally the cranial neuropathy occurs before the patient has become seropositive; in such patients, follow-up serologic testing in several weeks is typically diagnostic.",
"   </p>",
"   <p>",
"    When serologic testing for Lyme disease is indicated, two-tier testing is recommended, using an enzyme-linked immunosorbent assay (ELISA) followed by a Western blot as the tests of choice (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/21/14681?source=see_link&amp;anchor=H4821958#H4821958\">",
"     \"Nervous system Lyme disease\", section on 'Serologic testing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28425?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis of Lyme disease\", section on 'Serologic tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Electrodiagnostic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the first days after symptoms onset, the blink reflex (stimulation of the supraorbital nerve) can confirm the peripheral origin of weakness and assess the degree of axonal conduction block [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The simplest electrodiagnostic test is electromyography (EMG). In patients who have a clinically complete lesion, needle EMG may show some potentials on active volition, which allows one to conclude that the nerve is still in continuity with a potential for regrowth.",
"   </p>",
"   <p>",
"    Motor nerve conduction study (motor NCS, also called electroneurography or evoked electromyography) is another electrodiagnostic test used for the evaluation of facial nerve palsy. It is usually obtained in patients with complete lesions for prognostic purposes. Motor NCS involves stimulating the main branch of the facial nerve near the stylomastoid foramen and recording the compound muscle action potential (CMAP) in millivolts.",
"   </p>",
"   <p>",
"    CMAP amplitudes reach their minimum level between 7 to 14 days after the onset of weakness in most patients. At approximately 10 days after the onset of symptoms, the amplitude of the CMAP on the paralyzed side compared with that on the normal side yields an estimate of the degree of axonal loss [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/35\">",
"     35",
"    </a>",
"    ]. The amplitude of the paralyzed side is compared to that of the normal side and is expressed as a percentage. This percentage is presumed to correspond to the number of surviving motor neurons [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/36\">",
"     36",
"    </a>",
"    ]. Thus, a CMAP value of 10 percent of normal corresponds with a degeneration or loss of 90 percent of the motor axons on that side [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/37\">",
"     37",
"    </a>",
"    ]. In normal individuals, a 5 to 20 percent difference between the two sides can exist [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At approximately 20 to 30 days after onset, needle EMG may provide confirmation of muscle denervation and the degree of axonal damage [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/35\">",
"     35",
"    </a>",
"    ]. In patients with axonal loss, needle EMG at about three months after onset may be used to assess for evidence of subclinical reinnervation from the facial nerve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, imaging is necessary if the physical signs are atypical, if chronic otitis media, acute mastoiditis, temporal bone trauma, or a neoplasm is suspected as the etiology, if progression is slow and beyond three weeks, or if no improvement has occurred at six months. The initial imaging technique of choice for facial nerve palsies is debatable.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One group recommends high-resolution computed tomography (CT) in the axial and coronal planes for patients with an otoscopically demonstrable mass, history of chronic otitis media, or previous mastoid surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/2\">",
"       2",
"      </a>",
"      ]. Fractures of the temporal bone also are best viewed with CT scanning. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23178?source=see_link\">",
"       \"Approach to neuroimaging in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients should otherwise undergo pre- and post-contrast enhanced MRI including the brainstem, temporal bone, and parotid gland. MRI is the best study to evaluate the intraparotid facial nerve for inflammation, edema, or neoplasm. Contrast enhancement of the geniculate ganglion within the labyrinthine segment of the facial nerve is common in Bell's palsy [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/4\">",
"       4",
"      </a>",
"      ]. However, contrast enhancement of the first genu and proximal tympanic segment is normal [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/2\">",
"       2",
"      </a>",
"      ]. Enhancement of the inner ear structures occurs only in herpes zoster facial palsy and can be taken to suggest this diagnosis even without a vesicular eruption [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lumbar puncture is recommended for children with cranial nerve palsy when there is clinical suspicion of meningitis (eg, severe or prolonged headache, fever, papilledema, or nuchal rigidity). A slight increase in monocytes and lymphocytes is compatible with Bell's palsy, but does not definitively diagnose the condition nor exclude an inflammatory process. The cerebrospinal fluid concentration of antibody to B. burgdorferi is highly specific for the diagnosis of central nervous system Lyme disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25625?source=see_link\">",
"     \"Lumbar puncture: Indications, contraindications, technique, and complications in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=see_link&amp;anchor=H11#H11\">",
"     \"Lyme disease: Clinical manifestations in children\", section on 'Cranial nerve palsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cerebrospinal fluid analysis is of limited utility for the diagnosis of Lyme disease when involvement is restricted to the peripheral nervous system, (eg, isolated facial nerve palsy and no signs of meningitis). Therefore, we suggest that children who have facial nerve palsy and Lyme disease undergo lumbar puncture only if they have clinical evidence of central nervous system infection. This suggestion is in agreement with the recommendations of the Infectious Diseases Society of America and the American Academy of Neurology [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/21/14681?source=see_link&amp;anchor=H10939504#H10939504\">",
"     \"Nervous system Lyme disease\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=see_link&amp;anchor=H12#H12\">",
"     \"Lyme disease: Clinical manifestations in children\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PROGNOSIS AND NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis of individual cases of facial paralysis can be difficult to assess and is based upon the underlying cause.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital facial palsies have a poor prognosis for recovery of function because of insufficient development of the facial nerve, or canal.",
"     </li>",
"     <li>",
"      Traumatic facial paralysis in the perinatal period has an excellent prognosis, with 100 percent of patients showing some degree of improvement of function on the affected side.",
"     </li>",
"     <li>",
"      Most studies have focused on the prognosis of Bell's palsy and found that the majority of cases recover with minimal, if any, dysfunction. The Copenhagen Facial Nerve study evaluated the natural history of 2570 cases of peripheral nerve palsy over a 25-year period, including 463 children younger than 15 years old [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/42\">",
"       42",
"      </a>",
"      ]. A full recovery was achieved by 90 percent of these children. In another case series of 32 episodes of Bell's palsy in 29 children, complete recovery occurred in 31 episodes and was unrelated to treatment with glucocorticoids [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prognosis of Bell's palsy is related primarily to the severity of the lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/44\">",
"     44",
"    </a>",
"    ]. A simple rule is that clinically incomplete lesions tend to recover. The House-Brackmann grading system was devised both as a clinical indicator of severity, as well as an objective record of progress (",
"    <a class=\"graphic graphic_table graphicRef70562 \" href=\"UTD.htm?40/31/41468\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/45\">",
"     45",
"    </a>",
"    ]. On this scale, grades I and II have good outcomes, grades III and IV characterize moderate dysfunction, and grades V and VI portend a poor result.",
"   </p>",
"   <p>",
"    Electroneurography (ENOG; also known as motor nerve conduction study) has proved useful for determining prognosis. One group noted that 84 percent of patients with ENOG responses greater than 30 percent had complete recovery of facial function [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/46\">",
"     46",
"    </a>",
"    ]. An ENOG response less than 10 percent suggests a poor prognosis and is generally used for surgical consideration [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/47\">",
"     47",
"    </a>",
"    ], although one-third of patients may have complete recovery even when ENOG shows 90 to 98 percent degeneration. In one study of patients with 90 percent reduction in CMAP who underwent middle cranial fossa decompression, 50 percent had a better final recovery than did control patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognosis is favorable if some recovery is seen within the first 21 days of onset [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/49\">",
"     49",
"    </a>",
"    ]. A diagnosis of Bell's palsy is doubtful if some facial function - however small - has not returned within three to four months, and additional evaluation to determine the etiology is warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In severe lesions that recover, the outgrowth of new axons from the injury site is not discretely directed but is disorganized and misdirected; on volitional activation of the facial nerve, a mass action of facial musculature or synkinesis ensues. Thus, on blinking there is twitching of the angle of the mouth, and on smiling the eye may close or wink. Similarly, with misdirected autonomic fibers, a salivary stimulus may result in excess lacrimation, the syndrome of \"crocodile tears.\"",
"   </p>",
"   <p>",
"    The recurrence rate of Bell's palsy in children is less than 10 percent, similar to that in adults. One series in children found recurrences in 11 of 182 patients (6 percent), two of which were associated with the Melkersson-Rosenthal syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recurrence of facial nerve palsy should prompt a search for associated findings that may suggest a diagnosis other than Bell's palsy. Imaging should be performed to evaluate for any structural abnormalities. In addition, the blood pressure should be evaluated, since hypertension has been linked with recurrent facial nerve palsy in children [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of facial nerve palsy in children is guided by the etiology and the severity of the condition [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/6\">",
"     6",
"    </a>",
"    ]. In the case of idiopathic acquired facial palsy (ie, Bell's palsy), treatment options include glucocorticoids with or without antivirals (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/35/3638?source=see_link\">",
"     valacyclovir",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The treatment of facial nerve palsy due to a specific cause (eg, Lyme disease or acute otitis media) involves treatment of the underlying disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27498?source=see_link\">",
"     \"Treatment of Lyme disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=see_link\">",
"     \"Acute otitis media in children: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment options for congenital or permanently acquired lesions include muscle transfers and nerve grafts. In both acquired and congenital facial palsies, care must be taken to protect the cornea of the affected side.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Eye care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate eye care is required to help avoid corneal abrasions if the patient with facial palsy is unable to close the eye. This care generally entails administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/15/38131?source=see_link\">",
"     artificial tears",
"    </a>",
"    during the day with ophthalmic ointment and patching at night; tape should not be placed directly on the eyelid because the patch could slip and abrade the cornea. Rarely, tarsorrhaphy or temporary implantation of a gold weight into the upper lid is required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Drug therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lack of large high quality randomized controlled drug trials in children with Bell's palsy and the favorable natural history of the disease make formal recommendations challenging. However, the mainstay of pharmacologic therapy for Bell's palsy in adults is early short-term oral glucocorticoid treatment, which is established as effective by randomized controlled trials [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/53-59\">",
"     53-59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The suspicion that Bell's palsy is frequently caused by herpes simplex virus led to adult trials of antiviral therapy with or without glucocorticoids. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Herpes simplex virus infection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    These trials found no benefit for antiviral therapy alone compared with placebo. However, the data are conflicting with regard to the possibility of additional benefit when antiviral agents are administered with glucocorticoids.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis involving 18 trials and 2786 patients, treatment with glucocorticoids alone was associated with a reduced risk of unfavorable recovery (relative risk [RR] 0.69, 95% CI 0.55-0.87), whereas treatment with antiviral agents alone was not (RR 1.14, 95% CI 0.80-1.62) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In pooled data from eight trials, the same meta-analysis found a trend towards a reduced risk of unfavorable recovery for combined antiviral and glucocorticoid treatment compared with glucocorticoid treatment alone, but the outcome just missed statistical significance (RR 0.75, 95% CI 0.56-1.0) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second meta-analysis of six trials and 1145 patients, there was no significant benefit of combined antiviral and glucocorticoid treatment for achieving at least partial facial muscle recovery (odds ratio 1.5, 95% CI 0.83-2.69) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Methodologic differences probably account for the divergent results of these two meta-analyses. Neither excludes the possibility of marginal benefit when antiviral therapy is combined with glucocorticoids. However, the trend towards benefit was driven largely by the smaller, lower quality trials.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the two highest quality randomized controlled trials, glucocorticoid treatment alone was effective for Bell's palsy, while antiviral treatment showed no benefit when given alone or when combined with glucocorticoids [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/57,59\">",
"       57,59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The results of lower quality trials suggested benefit or a trend towards benefit for antiviral therapy combined with glucocorticoids [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/53,56,58\">",
"       53,56,58",
"      </a>",
"      ]. A subgroup analysis in one of these studies suggested that the benefit of combined therapy correlated with increasing severity of baseline facial palsy [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given the available data, we recommend early treatment with oral glucocorticoids for all children with Bell's palsy. This recommendation is consistent with guidelines from the American Academy of Neurology [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/62\">",
"     62",
"    </a>",
"    ]. Treatment should preferably begin within three days of symptom onset. Our suggested regimen is",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily (up to 60 to 80 mg) for five days, followed by a five-day taper.",
"   </p>",
"   <p>",
"    The two largest and most rigorous clinical trials have found no additional benefit for antiviral therapy and its use is no longer routinely recommended. However, it is possible, but not proven, that the addition of antivirals to glucocorticoids is beneficial, particularly for the subgroup of patients with severe facial palsy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/56\">",
"     56",
"    </a>",
"    ]. Until certainty is reached, we suggest early combined therapy with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily (up to 60 to 80 mg per day) plus",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/35/3638?source=see_link\">",
"     valacyclovir",
"    </a>",
"    20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    three times per day (up to 1000 mg three times daily) for one week for children with severe facial palsy. However, there is no consensus among experts regarding the routine use of antivirals along with glucocorticoids to treat Bell's palsy.",
"   </p>",
"   <p>",
"    Patients with Ramsay-Hunt syndrome should be treated with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"     prednisone",
"    </a>",
"    plus",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/35/3638?source=see_link\">",
"     valacyclovir",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The early surgical management of facial nerve palsy in the pediatric population has not been systematically studied. One uncontrolled study evaluating middle cranial fossa decompression of the labyrinthine segment of the facial nerve demonstrated benefit for patients in whom electrodiagnostic studies show a &ge;90 percent reduction of the compound muscle action potential. If surgery is to be performed, for best results it should be within two to three weeks of the onset of paralysis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/48\">",
"     48",
"    </a>",
"    ]. However, the American Academy of Neurology determined that the surgical treatment of facial nerve palsy could not be recommended due to concerns about the inherent bias of these studies and the potential complication of hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/63\">",
"     63",
"    </a>",
"    ]. The use of early surgery in children with facial nerve palsy should be studied further before considering this as a treatment option in the pediatric age group.",
"   </p>",
"   <p>",
"    Surgical reanimation techniques may be considered in children with congenital or permanently acquired facial nerve palsy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. These techniques do not completely restore normal physiologic function, although they may aid the child psychologically. Surgical procedures are divided into static procedures that provide symmetry of the mouth at rest and reanimation techniques that allow facial expression [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/65-69\">",
"     65-69",
"    </a>",
"    ]. They may involve regional muscle transfers, nerve crossovers, cable grafts, and free muscle grafts. These procedures are advocated in early school age, when the child may have some understanding of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25257/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4519763\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The facial nerve has a complex anatomy and function that renders it susceptible to multiple neurologic disorders based upon the location of the lesion (",
"      <a class=\"graphic graphic_figure graphicRef55677 \" href=\"UTD.htm?23/41/24218\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Facial nerve anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The possible causes of facial nerve palsy are many and may be congenital, infectious, neoplastic, traumatic, or idiopathic (",
"      <a class=\"graphic graphic_table graphicRef76593 \" href=\"UTD.htm?26/20/26958\">",
"       table 1",
"      </a>",
"      ). Approximately one-half of all cases qualify for the label \"Bell's palsy,\" defined as an acute facial nerve palsy of unknown cause. Other important causes include otitis media, herpes simplex viral infection, Lyme disease, Ramsay Hunt syndrome, and HIV infection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology and causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with facial nerve palsy typically present with the sudden onset (usually over hours) of unilateral facial paralysis. Common findings include sagging of the eyebrow, inability to close the eye, disappearance of the nasolabial fold, and drawing of the mouth to the unaffected side. Decreased tearing, hyperacusis,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      loss of taste sensation on the anterior two-thirds of the tongue may also occur. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of idiopathic (Bell's) facial nerve palsy is based upon the following criteria (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnosis'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A diffuse involvement of all of the distal branches of the facial nerve is present.",
"     </li>",
"     <li>",
"      Onset is acute, over a day or two; the course is progressive, reaching maximal clinical",
"      <span class=\"nowrap\">",
"       weakness/paralysis",
"      </span>",
"      within three weeks or less from the first day of visible weakness; recovery of some degree of function usually occurs within six months.",
"     </li>",
"     <li>",
"      Associated prodrome, ear pain, or dysacusis may be reported",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serologic testing for Lyme disease is recommended for all children with acute-onset facial palsy when there is the possibility of exposure. Other adjunctive investigations, such as electrodiagnostic studies, neuroimaging, or lumbar puncture, may help identify an underlying etiology for facial nerve dysfunction and determine prognosis. These tests are not necessary in all patients; those with a typical incomplete facial palsy who have a good recovery do not need further study. However, imaging is necessary if the physical signs are atypical (eg, involve neighboring cranial nerves), if chronic otitis media, acute mastoiditis, temporal bone trauma, or a neoplasm is suspected as the etiology, if progression is slow and extends beyond three weeks, or if no improvement has occurred at six months. Electrodiagnostic studies may be warranted in patients with clinically complete lesions for prognostic purposes. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnostic tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prognosis of individual cases of facial paralysis is based upon the underlying cause (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Prognosis and natural history'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Congenital facial palsies, including Moebius syndrome, have a poor prognosis for recovery of function because of insufficient development of the facial nerve, or canal.",
"     </li>",
"     <li>",
"      Traumatic facial paralysis in the perinatal period has an excellent prognosis, with 100 percent of patients showing some degree of improvement of function on the affected side.",
"     </li>",
"     <li>",
"      Most children with Bell's palsy recover with minimal, if any, dysfunction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The treatment of facial nerve palsy in children is guided by the etiology and the severity of the condition (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Treatment'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In both acquired and congenital facial palsies, care must be taken to protect the cornea of the affected side. Appropriate eye care entails administration of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/15/38131?source=see_link\">",
"       artificial tears",
"      </a>",
"      during the day with ophthalmic ointment and patching at night. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Eye care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children with idiopathic acquired facial palsy (ie, Bell's palsy), we recommend early treatment with oral glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Treatment should preferably begin within three days of symptom onset. Our suggested regimen is",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/23/29047?source=see_link\">",
"       prednisone",
"      </a>",
"      2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily (up to 60 to 80 mg) for five days, followed by a five-day taper. For children with severe idiopathic facial palsy, we suggest early combined therapy with prednisone 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily (up to 60 to 80 mg per day) plus",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/35/3638?source=see_link\">",
"       valacyclovir",
"      </a>",
"      20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      three times per day (up to 1000 mg three times daily) for one week rather than prednisone alone (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Drug therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of facial nerve palsy due to a specific cause (eg, Lyme disease or acute otitis media) involves treatment of the underlying disorder.",
"     </li>",
"     <li>",
"      Surgical techniques for congenital or permanently acquired lesions include muscle transfers and nerve grafts. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/1\">",
"      Roob G, Fazekas F, Hartung HP. Peripheral facial palsy: etiology, diagnosis and treatment. Eur Neurol 1999; 41:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/2\">",
"      Swartz JD, Harnsberger HR, Mukherji SK. The temporal bone. Contemporary diagnostic dilemmas. Radiol Clin North Am 1998; 36:819.",
"     </a>",
"    </li>",
"    <li>",
"     Wilson-Pauwels, L, Akesson, E, Stewart, P. Cranial nerves: Anatomy and clinical comments, B.C. Decker, Philadelphia 1988. p.81.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/4\">",
"      Jackson CG, von Doersten PG. The facial nerve. Current trends in diagnosis, treatment, and rehabilitation. Med Clin North Am 1999; 83:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/5\">",
"      Shapiro NL, Cunningham MJ, Parikh SR, et al. Congenital unilateral facial paralysis. Pediatrics 1996; 97:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/6\">",
"      Shargorodsky J, Lin HW, Gopen Q. Facial nerve palsy in the pediatric population. Clin Pediatr (Phila) 2010; 49:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/7\">",
"      Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol 1975; 84:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/8\">",
"      Cook SP, Macartney KK, Rose CD, et al. Lyme disease and seventh nerve paralysis in children. Am J Otolaryngol 1997; 18:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/9\">",
"      Christen HJ, Bartlau N, Hanefeld F, et al. Peripheral facial palsy in childhood--Lyme borreliosis to be suspected unless proven otherwise. Acta Paediatr Scand 1990; 79:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/10\">",
"      Kremer H, Kuyt LP, van den Helm B, et al. Localization of a gene for M&ouml;bius syndrome to chromosome 3q by linkage analysis in a Dutch family. Hum Mol Genet 1996; 5:1367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/11\">",
"      Verzijl HT, van der Zwaag B, Lammens M, et al. The neuropathology of hereditary congenital facial palsy vs M&ouml;bius syndrome. Neurology 2005; 64:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/12\">",
"      Verzijl HT, van den Helm B, Veldman B, et al. A second gene for autosomal dominant M&ouml;bius syndrome is localized to chromosome 10q, in a Dutch family. Am J Hum Genet 1999; 65:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/13\">",
"      Verzijl HT, van der Zwaag B, Cruysberg JR, Padberg GW. M&ouml;bius syndrome redefined: a syndrome of rhombencephalic maldevelopment. Neurology 2003; 61:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/14\">",
"      Cattaneo L, Chierici E, Bianchi B, et al. The localization of facial motor impairment in sporadic M&ouml;bius syndrome. Neurology 2006; 66:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/15\">",
"      Hanissian AS, Fuste F, Hayes WT, Duncan JM. M&ouml;bius syndrome in twins. Am J Dis Child 1970; 120:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/16\">",
"      Slee JJ, Smart RD, Viljoen DL. Deletion of chromosome 13 in Moebius syndrome. J Med Genet 1991; 28:413.",
"     </a>",
"    </li>",
"    <li>",
"     Pollack, R, Brown, L. Facial paralysis in otitis media. In: Disorders of the facial nerve: Anatomy, diagnosis, and management, Graham, M, House, W (Eds), Raven Press, New York 1982. p.221.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/18\">",
"      Baringer JR. Herpes simplex virus and Bell palsy. Ann Intern Med 1996; 124:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/19\">",
"      Schirm J, Mulkens PS. Bell's palsy and herpes simplex virus. APMIS 1997; 105:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/20\">",
"      Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996; 124:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/21\">",
"      Ackermann R, H&ouml;rstrup P, Schmidt R. Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). Yale J Biol Med 1984; 57:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/22\">",
"      Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985; 35:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/23\">",
"      Clark JR, Carlson RD, Sasaki CT, et al. Facial paralysis in Lyme disease. Laryngoscope 1985; 95:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/24\">",
"      Christen HJ. Lyme neuroborreliosis in children. Ann Med 1996; 28:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/25\">",
"      Smouha EE, Coyle PK, Shukri S. Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria. Am J Otol 1997; 18:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/26\">",
"      Markby DP. Lyme disease facial palsy: differentiation from Bell's palsy. BMJ 1989; 299:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/27\">",
"      Belman AL, Reynolds L, Preston T, et al. Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch Pediatr Adolesc Med 1997; 151:1224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/28\">",
"      Shapiro ED, Gerber MA. Lyme disease and facial nerve palsy. Arch Pediatr Adolesc Med 1997; 151:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/29\">",
"      Murr AH, Benecke JE Jr. Association of facial paralysis with HIV positivity. Am J Otol 1991; 12:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/30\">",
"      Morgan M, Nathwani D. Facial palsy and infection: the unfolding story. Clin Infect Dis 1992; 14:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/31\">",
"      Bitsori M, Galanakis E, Papadakis CE, Sbyrakis S. Facial nerve palsy associated with Rickettsia conorii infection. Arch Dis Child 2001; 85:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/32\">",
"      Levenson MJ, Ingerman M, Grimes C, Anand KV. Melkersson-Rosenthal syndrome. Arch Otolaryngol 1984; 110:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/33\">",
"      Hornstein OP, Stosiek N, Sch&ouml;nberger A, Meisel-Stosiek M. [Classification and scope of clinical variations of Melkersson-Rosenthal syndrome]. Z Hautkr 1987; 62:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/34\">",
"      Teller DC, Murphy TP. Bilateral facial paralysis: a case presentation and literature review. J Otolaryngol 1992; 21:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/35\">",
"      Valls-Sol&eacute; J. Electrodiagnostic studies of the facial nerve in peripheral facial palsy and hemifacial spasm. Muscle Nerve 2007; 36:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/36\">",
"      Qiu WW, Yin SS, Stucker FJ, et al. Time course of Bell palsy. Arch Otolaryngol Head Neck Surg 1996; 122:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/37\">",
"      Halvorson DJ, Coker NJ, Wang-Bennett LT. Histologic correlation of the degenerating facial nerve with electroneurography. Laryngoscope 1993; 103:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/38\">",
"      Austin JR, Peskind SP, Austin SG, Rice DH. Idiopathic facial nerve paralysis: a randomized double blind controlled study of placebo versus prednisone. Laryngoscope 1993; 103:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/39\">",
"      Kuo MJ, Drago PC, Proops DW, Chavda SV. Early diagnosis and treatment of Ramsay Hunt syndrome: the role of magnetic resonance imaging. J Laryngol Otol 1995; 109:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/40\">",
"      Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/41\">",
"      Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007; 69:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/42\">",
"      Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002; :4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/43\">",
"      Chen WX, Wong V. Prognosis of Bell's palsy in children--analysis of 29 cases. Brain Dev 2005; 27:504.",
"     </a>",
"    </li>",
"    <li>",
"     Sunderland S. Nerve and Nerve Injuries, 2nd ed, Churchill Livingstone, London 1978.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/45\">",
"      House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985; 93:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/46\">",
"      May M, Klein SR, Taylor FH. Indications for surgery for Bell's palsy. Am J Otol 1984; 5:503.",
"     </a>",
"    </li>",
"    <li>",
"     Esslen, E. Investigations on the localization and pathogenesis of meato-labyrinthine facial palsies. In: The Acute Facial Palsies, Esslen, E (Ed), Springer-Verlag, Berlin 1977. p.41.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/48\">",
"      Hughes GB. Practical management of Bell's palsy. Otolaryngol Head Neck Surg 1990; 102:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/49\">",
"      Jabor MA, Gianoli G. Management of Bell's palsy. J La State Med Soc 1996; 148:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/50\">",
"      Hashisaki GT. Medical management of Bell's palsy. Compr Ther 1997; 23:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/51\">",
"      Eidlitz-Markus T, Gilai A, Mimouni M, Shuper A. Recurrent facial nerve palsy in paediatric patients. Eur J Pediatr 2001; 160:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/52\">",
"      Lloyd AV, Jewitt DE, Still JD. Facial paralysis in children with hypertension. Arch Dis Child 1966; 41:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/53\">",
"      Adour KK, Ruboyianes JM, Von Doersten PG, et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996; 105:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/54\">",
"      Antunes ML, Fukuda Y, Testa JR. [Clinical treatment of Bell's palsy: comparative study among valaciclovir plus deflazacort, deflazacort and placebo]. Acta AWHO 2000; 19:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/55\">",
"      Kawaguchi K, Inamura H, Abe Y, et al. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope 2007; 117:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/56\">",
"      Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007; 28:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/57\">",
"      Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007; 357:1598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/58\">",
"      Yeo SG, Lee YC, Park DC, Cha CI. Acyclovir plus steroid vs steroid alone in the treatment of Bell's palsy. Am J Otolaryngol 2008; 29:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/59\">",
"      Engstr&ouml;m M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008; 7:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/60\">",
"      de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA 2009; 302:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/61\">",
"      Quant EC, Jeste SS, Muni RH, et al. The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ 2009; 339:b3354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/62\">",
"      Gronseth GS, Paduga R, American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012; 79:2209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/63\">",
"      Grogan PM, Gronseth GS. Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/64\">",
"      Alam D. Advances in surgical treatment of facial nerve paralysis in children. JAMA 2011; 305:2106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/65\">",
"      Barr JS, Katz KA, Hazen A. Surgical management of facial nerve paralysis in the pediatric population. J Pediatr Surg 2011; 46:2168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/66\">",
"      Hadlock TA, Malo JS, Cheney ML, Henstrom DK. Free gracilis transfer for smile in children: the Massachusetts Eye and Ear Infirmary Experience in excursion and quality-of-life changes. Arch Facial Plast Surg 2011; 13:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/67\">",
"      Brandt MG, Franklin JH, Moore CC. Direct nasolabial lift, a technique for palliation of oncologic lower-face paralysis. J Otolaryngol Head Neck Surg 2010; 39:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/68\">",
"      Alam D. Rehabilitation of long-standing facial nerve paralysis with percutaneous suture-based slings. Arch Facial Plast Surg 2007; 9:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25257/abstract/69\">",
"      Boahene KD, Farrag TY, Ishii L, Byrne PJ. Minimally invasive temporalis tendon transposition. Arch Facial Plast Surg 2011; 13:8.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6217 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-528937E1C1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25257=[""].join("\n");
var outline_f24_42_25257=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4519763\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FACIAL NERVE ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY AND CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Congenital facial nerve palsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24001440\">",
"      - Moebius syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Otitis media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Herpes simplex virus infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ramsay Hunt syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Peripheral versus central lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H192230175\">",
"      - Lyme serologies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Electrodiagnostic studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PROGNOSIS AND NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Eye care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Drug therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4519763\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6217\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6217|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/41/24218\" title=\"figure 1\">",
"      Facial nerve anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6217|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/20/26958\" title=\"table 1\">",
"      Causes of facial palsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/31/41468\" title=\"table 2\">",
"      House-Brackmann scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=related_link\">",
"      Acute otitis media in children: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21514?source=related_link\">",
"      Acute otitis media in children: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23178?source=related_link\">",
"      Approach to neuroimaging in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=related_link\">",
"      Cholesteatoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28425?source=related_link\">",
"      Diagnosis of Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25625?source=related_link\">",
"      Lumbar puncture: Indications, contraindications, technique, and complications in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=related_link\">",
"      Lyme disease: Clinical manifestations in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/21/14681?source=related_link\">",
"      Nervous system Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/8/20616?source=related_link\">",
"      Neurologic sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27498?source=related_link\">",
"      Treatment of Lyme disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_42_25258="Sexual dysfunction in women: Epidemiology, risk factors, and evaluation";
var content_f24_42_25258=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25258/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25258/contributors\">",
"     Jan L Shifren, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25258/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25258/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/42/25258/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/42/25258/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/42/25258/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual problems are highly prevalent in women. In the United States, approximately 40 percent of women have sexual concerns and 12 percent report distressing sexual problems [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Female sexual dysfunction takes different forms, including lack of sexual desire, impaired arousal, inability to achieve orgasm, or pain with sexual activity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/2\">",
"     2",
"    </a>",
"    ]. Sexual dysfunction may be a lifelong problem or acquired later in life after a period of normal sexual functioning.",
"   </p>",
"   <p>",
"    The epidemiology, risk factors, and evaluation of female sexual dysfunction will be reviewed here. Management of female sexual dysfunction and evaluation and treatment of dyspareunia are discussed separately. The epidemiology, pathogenesis, clinical manifestations, course, assessment, diagnosis, and treatment of female orgasmic disorder are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=see_link\">",
"     \"Sexual dysfunction in women: Management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link\">",
"     \"Approach to the woman with sexual pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23128?source=see_link\">",
"     \"Differential diagnosis of sexual pain in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36600?source=see_link\">",
"     \"Female orgasmic disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/48/2824?source=see_link\">",
"     \"Treatment of female orgasmic disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FEMALE SEXUAL RESPONSE CYCLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;An understanding of normal sexual response is helpful in the evaluation and treatment of sexual dysfunction. The female sexual response cycle is divided into four phases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Desire (libido) &mdash; desire to have sexual activity, including sexual thoughts, images, and wishes",
"     </li>",
"     <li>",
"      Arousal (excitement) &mdash; subjective sense of sexual pleasure accompanied by physiologic changes, including genital vasocongestion and increases in heart rate, blood pressure, and respiratory rate",
"     </li>",
"     <li>",
"      Orgasm &mdash; peaking of sexual pleasure and release of sexual tension, with rhythmic contractions of the perineal muscles and reproductive organs",
"     </li>",
"     <li>",
"      Resolution &mdash; muscular relaxation and a sense of general well-being following sexual activity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This is a general framework for the sexual response cycle; however, for many women, the phases may vary in sequence, overlap, repeat, or be absent during all or some sexual encounters. As an example, desire may not be present initially, but may increase in response to pleasurable activity. While it is helpful to know where in the sexual response cycle a problem occurs, many women have concerns that relate to multiple aspects of sexual response.",
"   </p>",
"   <p>",
"    The sexual response cycle must also be understood within an interpersonal context. While desire may be an initiating factor for sexual activity, women are often motivated by other reasons, including a wish for emotional closeness and to strengthen a relationship with a partner [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/3\">",
"     3",
"    </a>",
"    ]. Also, subjective satisfaction with the sexual experience may not require achieving all response phases, including orgasm.",
"   </p>",
"   <p>",
"    The sexual pain disorders represent a discrete form of sexual dysfunction, often with specific causes and therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/4\">",
"     4",
"    </a>",
"    ]. These include vaginismus and other forms of dyspareunia, and are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link\">",
"     \"Approach to the woman with sexual pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23128?source=see_link\">",
"     \"Differential diagnosis of sexual pain in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hemodynamic changes that occur during the normal sexual response cycle are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42904?source=see_link&amp;anchor=H3#H3\">",
"     \"The sexual history and approach to the patient with sexual dysfunction\", section on 'Normal sexual function'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ENDOCRINOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Role of estrogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Declining levels of estrogens in peri- and postmenopausal women have been associated with changes in sexual function. Hypoestrogenization results in reduction in both vulvovaginal lubrication and vasocongestion during sexual arousal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/5\">",
"     5",
"    </a>",
"    ], as well as vaginal atrophy and an increased likelihood of sexual pain. This was illustrated in a longitudinal cohort study in which over 400 perimenopausal women were monitored with hormone levels and a sexuality questionnaire annually for up to eight years [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/6\">",
"     6",
"    </a>",
"    ]. Declining levels of estradiol were associated with decreases in libido and sexual responsivity, while no aspect of sexual functioning correlated with any of the androgens measured (total testosterone, free testosterone index, and DHEA-S) (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Role of androgens'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Role of androgens",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Androgen production &mdash; The major androgens in women, as in men, are dehydroepiandrosterone sulfate (DHEA-S), dehydroepiandrosterone (DHEA), androstenedione, testosterone, and dihydrotestosterone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nearly all (98 percent) of circulating testosterone is protein-bound (mainly to sex-hormone binding globulin [SHBG] or albumin). The unbound, or free, fraction is biologically active; binding to albumin is weak, so this portion may also be bioavailable [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/7\">",
"     7",
"    </a>",
"    ]. Thus, factors that increase SHBG concentrations (eg, pregnancy, oral contraceptives, or oral estrogen therapy) will decrease free testosterone. Transdermal estrogen therapy (in physiologic doses) does not affect SHBG levels and has minimal effects on free testosterone concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although ovarian and adrenal androgen production decrease throughout a woman's life, ovarian testosterone production remains relatively constant through the transition to natural menopause. After surgical menopause (ie, bilateral oophorectomy), however, testosterone levels decrease by approximately 50 percent.",
"   </p>",
"   <p>",
"    Androgen physiology in women is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/45/20184?source=see_link&amp;anchor=H2#H2\">",
"     \"Androgen production and therapy in women\", section on 'Androgen production'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Effect on sexual function &mdash; It has been proposed that androgens play a role in female sexual function; however, the magnitude of this role is uncertain [",
"      <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/6,9\">",
"       6,9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The assertion that low androgen levels are a primary factor in female sexual problems is based on the role of androgens in male sexuality and on the results of trials in which supraphysiologic doses of exogenous androgens exerted a positive influence on some aspects of female sexuality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, in studies that measured hormone levels and sexual function in women, the correlation between androgen levels and sexual function is either weak or nonexistent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/6,12-17\">",
"     6,12-17",
"    </a>",
"    ]. As an example, in a study of over 2900 women aged 42 to 52 years, no association was found between sexual function and levels of testosterone, DHEA-S, and SHBG [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/13\">",
"     13",
"    </a>",
"    ]. In another population-based study of over 1400 randomly selected women aged 18 to 75 years, no single androgen level was predictive of low sexual function [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, while women have lower ovarian androgen levels after surgical versus natural menopause, results of studies on the effect of bilateral oophorectomy on sexual function have been inconsistent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/18-20\">",
"     18-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further, women with high androgen levels due to polycystic ovarian syndrome (PCOS) do not exhibit beneficial sexual effects. In fact, sexual function in women with PCOS appears to be similar or worse compared with women without PCOS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. A negative influence on sexuality in PCOS may be due to changes in self-image from PCOS-related hirsutism, obesity, and acne [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adrenal insufficiency may be a special case, as some data suggest that young women with this condition may show improvement in sexuality with the addition of DHEA to their replacement regimen, although studies demonstrate inconsistent effects of DHEA on female sexuality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/16/263?source=see_link&amp;anchor=H3#H3\">",
"     \"Dehydroepiandrosterone and its sulfate\", section on 'Use in adrenal insufficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The best data supporting a role for testosterone in female sexual function come from a large series of controlled clinical trials of physiologic transdermal testosterone treatment in over 1500 surgically and naturally menopausal women with hypoactive sexual desire disorder (HSDD) (low sexual desire associated with distress) and no other etiologic factors. Satisfying sexual activity, desire, arousal and response increased significantly in women receiving testosterone compared with those receiving placebo. Although these studies do not prove that low testosterone causes sexual dysfunction, they support a role for testosterone in female sexuality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/28-30\">",
"     28-30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual complaints are reported by approximately 40 percent of women worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1,31-33\">",
"     1,31-33",
"    </a>",
"    ]. This was demonstrated in a study conducted in 29 countries among almost 14,000 women aged 40 to 80 years responding to a questionnaire in person or on the telephone [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/33\">",
"     33",
"    </a>",
"    ]. The most commonly reported types of dysfunction were low sexual desire (26 to 43 percent) and inability to reach orgasm (18 to 41 percent). For all categories of sexual problems, prevalence was highest in Southeast Asia (Indonesia, Malaysia, Philippines, Singapore, and Thailand) and lowest in Northern Europe (Austria, Belgium, Germany, Sweden, and the United Kingdom).",
"   </p>",
"   <p>",
"    Most studies have not assessed whether sexual issues are associated with personal distress, a key requirement for diagnosis of female sexual dysfunction (see",
"    <a class=\"local\" href=\"#H21\">",
"     'Diagnostic criteria'",
"    </a>",
"    below). In addition, some studies still exclude women who are not in sexual relationships, so that women for whom sexual dysfunction is a barrier to forming sexual relationships are not assessed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The largest United States study of female sexual dysfunction, Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking (PRESIDE), did measure personal distress and included women who were not currently in a sexual relationship; over 30,000 women responded to validated questionnaires regarding low desire, low arousal, and orgasm difficulties [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"     1",
"    </a>",
"    ]. The prevalence of any of these three sexual problems (with or without distress) was 43 percent; 22 percent reported sexually related personal distress and 12 percent attributed distress to a specific type of sexual problem (eg, desire).",
"   </p>",
"   <p>",
"    Low desire was the most common sexual problem in women, reported by 39 percent of women and associated with distress in 10 to 14 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"     1",
"    </a>",
"    ]. Low arousal (26 percent) and orgasm difficulties (21 percent) were slightly less prevalent, and were both associated with distress in 5 percent of women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"     1",
"    </a>",
"    ]. Five percent of women reported both low desire and another sexual problem; 2 percent reported all three problems.",
"   </p>",
"   <p>",
"    Data regarding sexual pain disorders are often not reported by studies of female sexual dysfunction, thus, there are fewer data about the prevalence of these conditions. In studies of over 1000 women, reported rates of pain during sex ranged from 14 to 16 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/31,35\">",
"     31,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of sexual dysfunction is often multi-factorial and may include psychological problems such as depression or anxiety, conflict within the relationship, fatigue, stress, lack of privacy, issues relating to prior physical or sexual abuse, medications, or physical problems that make sexual activity uncomfortable, such as endometriosis or atrophic vaginitis.",
"   </p>",
"   <p>",
"    Similarly, the presence of any serious medical condition is likely to impair sexual function due not only to the condition itself, but also to associated impact on psychological well-being. In a study of sexuality in women aged 57 to 85 years, physical health was more strongly associated with sexual problems than age alone [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/36\">",
"     36",
"    </a>",
"    ]. In the PRESIDE study, poor self-assessed health was a significant correlate of distressing sexual problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Age and menopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of age on sexual function in women is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1,15,31\">",
"     1,15,31",
"    </a>",
"    ]. In the PRESIDE study, presence of distressing sexual problems were age related; although all sexual problems increased with advancing age, the prevalence of a sexual problem associated with distress was highest in women aged 45 to 64 years (15 percent), lowest in women 65 years or older (9 percent), and intermediate in women aged 18 to 44 years (11 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"     1",
"    </a>",
"    ]. When specific types of sexual dysfunction were assessed, rates of low desire associated with distress followed an age-related pattern similar to that for any sexual problem.",
"   </p>",
"   <p>",
"    In contrast, in the National Health and Social Life Survey study in which 1749 women were interviewed, prevalence of sexual problems tended to decrease with increasing age, except for reports of trouble lubricating. Of note, only women aged 18 to 59 years with a sexual partner within the past year were included in this study [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/31\">",
"     31",
"    </a>",
"    ]. In a national probability study of over 1500 women aged 57 to 85 years, sexual activity declined with age, although 40 percent of women aged 65 to 74 years and 17 percent of those over 75 years reported activity. About half of women studied reported a sexual problem, although sexually related personal distress was not assessed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Menopausal status correlates closely with age, and the likelihood of the onset of sexual disorders with menopause appears to depend on the specific type of sexual dysfunction. Vaginal dryness and dyspareunia are consistently increased after menopause, related primarily to the lack of estrogen on vaginal tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/37\">",
"     37",
"    </a>",
"    ]. Postmenopausal women are also more likely to report low desire or arousal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1,38,39\">",
"     1,38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, greater impairment of sexual function may be associated with surgical versus natural menopause. In natural menopause, estrogen levels are low, but ovarian androgen output is maintained at premenopausal levels (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Role of androgens'",
"    </a>",
"    above). In the PRESIDE study, surgical, but not natural, menopause was associated with orgasm problems and the decrease in arousal was greater in women after surgical menopause [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"     1",
"    </a>",
"    ]. Similarly, in one retrospective study of women following hysterectomy, women who had bilateral oophorectomy reported significantly decreased sexual satisfaction postoperatively, despite estrogen treatment, compared to women who had their ovaries preserved [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/40\">",
"     40",
"    </a>",
"    ]. On the other hand, this result was not observed in a subsequent prospective study that found sexuality was unaltered postoperatively in women following hysterectomy with bilateral oophorectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/18\">",
"     18",
"    </a>",
"    ]. Further, a cross-sectional study of over 1000 women found no difference in sexual ideation in women age 57 years or older who had undergone oophorectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hormonal changes alone may not account directly for changes in sexual function. Menopausal symptoms may have an independent adverse effect on sexuality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1,42\">",
"     1,42",
"    </a>",
"    ]. As an example, in a study of 341 peri- and postmenopausal women, common menopausal symptoms, including depression, sleep disturbances, and night sweats, were associated with diminished libido [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other life changes that occur at the time of menopause may also supersede the effect of hormonal changes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/6,39\">",
"     6,39",
"    </a>",
"    ]. This was illustrated in a study of 200 women aged 51 to 61 years that found menopause had a smaller impact on sexual functioning than overall health, mental health, or having a new partner [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Psychiatric and neurologic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depression is present in 17 to 26 percent of women who complain of low sexual desire [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Selective serotonin receptor inhibitors (SSRIs) can cause low desire and difficulty with orgasm in women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2039?source=see_link\">",
"     \"Sexual dysfunction associated with selective serotonin reuptake inhibitor (SSRI) antidepressants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both depression and anxiety were significant correlates of distressing sexual problems in the PRESIDE study. Anxiety and psychotic disorders are also risk factors for sexual dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/44\">",
"     44",
"    </a>",
"    ]. Benzodiazepines have been reported to be associated with sexual dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/45-47\">",
"     45-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antipsychotic medications are associated with sexual dysfunction in both men and women. These medications inhibit dopamine, which may serve as a central neuromodulator of sexual function. It is also possible that a resultant increase in prolactin, causing gonadal suppression, affects sexual function [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. Atypical antipsychotic medications (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=see_link\">",
"     aripiprazole",
"    </a>",
"    ) raise prolactin levels to a lesser degree than typical antipsychotics (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    ), and thus may have less of an impact on sexual function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7562?source=see_link\">",
"     \"First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=see_link\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with multiple sclerosis and Parkinson's disease report sexual dysfunction, the degree of which correlates with severity of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/48\">",
"     48",
"    </a>",
"    ]. Sensory dysfunction in the genital region is found in 62 percent of women with advanced multiple sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=see_link&amp;anchor=H13#H13\">",
"     \"Epidemiology and clinical features of multiple sclerosis in adults\", section on 'Sensory symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sexual dysfunction has been reported in women who have epilepsy, particularly in association with the antiepileptic drugs",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/52-58\">",
"     52-58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Gynecologic issues",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Childbirth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within three months postpartum, 80 to 93 percent of women have resumed sexual intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/59\">",
"     59",
"    </a>",
"    ]. Sexual complaints, including low desire or dyspareunia, are common during the postpartum period. As an example, in a study of over 400 primiparous women, 83 percent reported sexual problems at three months postpartum and 64 percent at six months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no evidence of long-term differences in women who have had a vaginal versus cesarean delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/61\">",
"     61",
"    </a>",
"    ]. Data are inconsistent regarding the risk of dyspareunia at six or more months following episiotomy, severe vaginal or perineal laceration, or operative vaginal delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/59,60,62\">",
"     59,60,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the PRESIDE study, parous women were not more likely to have sexual dysfunction than those who were nulliparous [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the extraordinary fatigue and stress associated with the arrival of an infant, and the strain on couples of an enlarging family, the etiology of sexual dysfunction in the postpartum period is multi-factorial and extends beyond anatomic and hormonal changes.",
"   </p>",
"   <p>",
"    Although having children is a risk factor for sexual problems, so, too, is infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/63,64\">",
"     63,64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Pelvic floor or bladder dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual dysfunction is reported by 26 to 47 percent of women with urinary incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/65\">",
"     65",
"    </a>",
"    ]. Among women with urinary incontinence, 11 to 45 percent experience urinary incontinence during sexual intercourse, typically during penetration or orgasm [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. Urinary incontinence was a significant correlate of distressing sexual problems in the PRESIDE study [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pelvic organ prolapse and urinary incontinence are also associated with female sexual issues [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. In women with both prolapse and urinary incontinence, the rate of sexual complaints appears to be higher than with either condition alone [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While some women report improved sexual function after surgical repair of pelvic floor disorders, others report no change or the development of dyspareunia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/70,71\">",
"     70,71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women with interstitial",
"    <span class=\"nowrap\">",
"     cystitis/bladder",
"    </span>",
"    pain syndrome often also have dyspareunia. This condition also may be associated with low libido or difficulty with arousal. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=see_link&amp;anchor=H28423485#H28423485\">",
"     \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Endometriosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep dyspareunia is a cardinal symptom of endometriosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link&amp;anchor=H11#H11\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Uterine fibroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with uterine fibroids may experience deep dyspareunia. Heavy and irregular bleeding caused by fibroids also may impair sexual function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\", section on 'Pelvic pressure and pain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other medical conditions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22320934\">",
"    <span class=\"h3\">",
"     Endocrine disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of diabetes on female sexuality is uncertain. While one study found reduced genital sensation in women with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/72\">",
"     72",
"    </a>",
"    ], studies comparing sexual dysfunction in women with versus without diabetes have yielded inconsistent results [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/73,74\">",
"     73,74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hyperprolactinemia was associated with lower scores for sexual desire, arousal, lubrication, orgasm, and satisfaction in a study in which 25 women with hyperprolactinemia were compared with age-matched controls with normal prolactin levels [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/75\">",
"     75",
"    </a>",
"    ]. Further study is needed to replicate these results and evaluate whether this is an independent effect of elevated prolactin levels or due to associated changes in hypothalamic or other pituitary hormones, principally hypoestrogenism [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19254?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical manifestations and diagnosis of hyperprolactinemia\", section on 'Hypogonadism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22320941\">",
"    <span class=\"h3\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertension may be a risk for sexual dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. It remains unclear whether this is related to the hypertension itself or is an adverse effect of antihypertensive medications. Several studies have reported that hypertensive women have higher rates of sexual dysfunction, including sexual pain, than normotensive women (42 versus 19 percent in one study) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. These studies also found no significant difference in sexual problems in women with treated compared with untreated hypertension. In addition, prospective data from a study of over 2700 postmenopausal women found no association between sexual problems and anti-hypertensives [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/79\">",
"     79",
"    </a>",
"    ]. In the PRESIDE study, having hypertension or taking medication to lower high blood pressure or high cholesterol was not significantly associated with any distressing sexual problems.",
"   </p>",
"   <p>",
"    Some data suggest, however, that beta-blockers have a detrimental effect on female sexual function. Effects of beta blockers on male sexual function are well known. Two small studies have reported that the risk of sexual dysfunction was greater in hypertensive women treated with beta-blockers compared with those treated with other agents (69 versus 43 percent in one study) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/77,80\">",
"     77,80",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42696?source=see_link&amp;anchor=H189242047#H189242047\">",
"     \"Overview of male sexual dysfunction\", section on 'Drugs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22320948\">",
"    <span class=\"h3\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal failure and dialysis have been associated with sexual dysfunction in both men and women. In women, this may be related to associated anovulation, as well as to the burden of having a serious, chronic medical illness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36484?source=see_link\">",
"     \"Reproductive and sexual dysfunction in uremic women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with cancer may experience sexual dysfunction during or after treatment. At particular risk are those who undergo pelvic or breast surgery or radiation or who have chemotherapy-induced premature ovarian failure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/81-83\">",
"     81-83",
"    </a>",
"    ]. In addition, adjuvant endocrine therapy may result in sexual side effects (eg, aromatase inhibitors) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/84\">",
"     84",
"    </a>",
"    ]. Fatigue associated with treatment, reactive depression and anxiety, and changes in body image following surgery on the breasts or pelvic organs also contribute to sexual dysfunction in women with cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Medication and substance effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications and other pharmacologically active substances may affect sexual function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Hormonal contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of estrogen-progestin contraceptives on female sexuality is controversial; while a few studies show decreased libido, many have shown increased libido and frequency of sexual encounters [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/85-90\">",
"     85-90",
"    </a>",
"    ]. Findings of a beneficial effect may support the assertion that hormonal effects of these contraceptives do not interfere with sexual function; in addition, women on estrogen-progestin contraceptives are more likely to be in a sexual relationship and sexual activity may be facilitated by confidence in the ability to be sexually active without becoming pregnant.",
"   </p>",
"   <p>",
"    Study of the effect of oral contraceptives (OCs) on sexual function derives from the interest in the role of androgens on female sexuality. OCs suppress ovarian testosterone levels via suppression of pituitary LH secretion. In addition, the estrogen component of the pill increases SHBG levels. The net result is a decrease in free testosterone concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/85,91\">",
"     85,91",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Role of androgens'",
"    </a>",
"    above.) However, it remains unproven that any effect of OCs on sexual function is caused by the decrease in androgen activity. In fact, in OC users who complain of decreased libido, treatment with exogenous androgens does not improve desire [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/92,93\">",
"     92,93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Variations in OC formulations do not appear to influence sexual effects. This was illustrated in a randomized trial of the effect on sexual function of an OC with drospirenone, with anti-androgenic activity, to an OC with gestodene [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/94\">",
"     94",
"    </a>",
"    ]. No differences between groups were noted.",
"   </p>",
"   <p>",
"    Also, while there is a dose-response relationship between the estrogen dose in OCs (eg, 35 versus 25 mcg) and suppression of androgens, higher doses of estrogen do not appear to increase the likelihood of sexual side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Well-designed studies of non-oral delivery of estrogen-progestin contraceptives (patch, vaginal ring) have shown no negative clinical effects on sexual function [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/96,97\">",
"     96,97",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"local\" href=\"#H5\">",
"     'Role of androgens'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Progestin-only contraceptive methods do not appear to be associated with sexual dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/87,89,98-100\">",
"     87,89,98-100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Substance use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nicotine may inhibit sexual arousal in women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic alcohol abuse leads to a hypogonadotrophic state and impaired sexual function in both women and men [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/58,102\">",
"     58,102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to endocrine changes, substance abuse often is associated with poor mental and physical health, disrupted relationships, lowered social status and financial instability, all of which will negatively impact sexual function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Relationship factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to overall physical and mental health, the relationship with the partner is a principal determinant of sexual satisfaction.",
"   </p>",
"   <p>",
"    In a national probability sample of almost 1000 women aged 20 to 65 years, the best predictors of sexual distress were markers of general emotional well-being and relationship with the partner [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the Women's International Study of Health and Sexuality (WISHeS), a questionnaire study of over 2000 women, low sexual desire with distress was associated with emotional and psychological distress, lower sexual and partner satisfaction, and decrements in general health status, including aspects of mental and physical health [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a longitudinal study of over 400 women studied across the menopausal transition, sexual response was predicted by prior level of sexual function, change in partner status, and feelings for partner, demonstrating that relationship factors were more important than hormonal determinants of sexual function for midlife women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/103\">",
"     103",
"    </a>",
"    ]. Similarly, when examining correlates of sexual function among multi-ethnic middle-aged women in SWAN, variables having the greatest association included relationship factors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A partner's sexual problems, most commonly erectile dysfunction, will also influence a woman's sexual experience. For older women, simply having a spouse or intimate partner may be a limitation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Relationship duration has a major effect on sexual satisfaction. In a study of over 1800 men and women between the ages of 19 to 32 years in stable relationships, sexual activity and satisfaction declined as the duration of partnership increased [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/105\">",
"     105",
"    </a>",
"    ]. Interestingly, sexual desire over time declined only for women, while desire for tenderness declined in men and rose in women. &nbsp;",
"   </p>",
"   <p>",
"    A history of sexual or physical abuse is a major risk factor for sexual problems. In a community-based epidemiologic study of over 3000 women aged 30 to 79 years, the odds of female sexual dysfunction were doubled by childhood and adult abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Female sexual dysfunction is diagnosed by identifying diagnostic criteria through the medical and sexual history. A pelvic examination is required for diagnosis only for the sexual pain disorders, but an examination is important in all patients with sexual complaints to identify possible etiologic factors and associated conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Psychiatric Association (APA) guidelines for sexual disorders require that a sexual problem be recurrent or persistent and cause personal distress or interpersonal difficulty to establish the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sexual dysfunctions are defined in relation to a specific phase of the sexual response cycle, though in clinical practice, it is uncommon to see a disorder that is limited to a single phase. APA criteria for diagnosing the major female sexual disorders are described below and in the table (",
"    <a class=\"graphic graphic_table graphicRef52726 \" href=\"UTD.htm?23/24/23948\">",
"     table 1",
"    </a>",
"    ); as noted in the preceding paragraph, sexually related personal distress also must be present [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypoactive sexual desire disorder &mdash; deficient (or absent) sexual fantasies and desire for sexual activity",
"     </li>",
"     <li>",
"      Female sexual arousal disorder &mdash; inability to attain, or to maintain until completion of the sexual activity, an adequate lubrication-swelling response of sexual excitement",
"     </li>",
"     <li>",
"      Female orgasmic disorder &mdash; delay in, or absence of, orgasm following a normal sexual excitement phase",
"     </li>",
"     <li>",
"      Dyspareunia &mdash; genital pain that is associated with sexual intercourse",
"     </li>",
"     <li>",
"      Vaginismus &mdash; involuntary contraction of the perineal muscles surrounding the outer third of the vagina when vaginal penetration with penis, finger, tampon, or speculum is attempted",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Emerging concepts of normal female sexual function have focused on the differences between female and male sexuality. Specifically, spontaneous desire is unusual in women, except in new relationships, and thus, its absence is not necessarily a disorder. Desire in women typically is responsive, commonly triggered by emotional factors, exposure to erotic images, or physical proximity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/107\">",
"     107",
"    </a>",
"    ]. This further highlights the importance of ascertaining before making a diagnosis that not only is a problem present, but also that it is associated with personal distress or interpersonal difficulty.",
"   </p>",
"   <p>",
"    In addition, self-reports by women often do not distinguish between desire and arousal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/107\">",
"     107",
"    </a>",
"    ]. Arousal may be either subjective (thoughts, feelings) or objective (genital vasocongestion or lubrication). Management of difficulty with arousal must be tailored to whether the issue is subjective, objective, or both.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Medical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete medical and medication history is elicited to identify organic, psychological, medication, and substance-related issues that may affect sexuality (eg, depression, diabetes, use of selective serotonin reuptake inhibitors) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/34\">",
"     34",
"    </a>",
"    ]. Suspicion of an undiagnosed medical or mental illness should be followed by evaluation or referral (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Risk factors'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    An assessment of sexual problems should be a part of every comprehensive woman's health visit. The importance of this was demonstrated in a questionnaire study of over 1000 women seen for a primary care visit; 98 percent reported one or more sexual concerns, but only 18 percent of clinicians asked about sexual health [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/108\">",
"     108",
"    </a>",
"    ]. Women who discussed their sexual concerns with their clinician found the discussion helpful. Of approximately 3000 women identified in the PRESIDE study with a distressing sexual problem, only 6 percent of women who sought medical advice scheduled a visit specifically for a sexual problem, and about 80 percent of the time, the woman, rather than the physician, initiated the conversation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In women who do not present with sexual complaints, a brief sexual history can be taken while reviewing the gynecologic history (see",
"    <a class=\"local\" href=\"#H23\">",
"     'Sexual history'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    A gynecologic history and review of systems should include symptoms and conditions that may affect sexual activity or signal the need for further evaluation, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Menopausal status (natural, surgical, or post-chemotherapy)",
"     </li>",
"     <li>",
"      Pregnancy and childbirth history",
"     </li>",
"     <li>",
"      History of pelvic injury, cancer, or surgery",
"     </li>",
"     <li>",
"      Vulvovaginal or pelvic pain",
"     </li>",
"     <li>",
"      Vulvovaginal pruritus, dryness, or discharge",
"     </li>",
"     <li>",
"      Abnormal genital tract bleeding",
"     </li>",
"     <li>",
"      Urinary or anal incontinence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following questions help to assess whether the patient needs assistance to engage in safe sexual practices:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Are you currently sexually active?",
"     </li>",
"     <li>",
"      Do you need contraception or preconceptional counseling?",
"     </li>",
"     <li>",
"      Are you practicing safe sex?",
"     </li>",
"     <li>",
"      Would you like to be screened for sexually transmitted infections?",
"     </li>",
"     <li>",
"      Are you currently experiencing or have you experienced previous sexual abuse?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=see_link\">",
"     \"Overview of contraception\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/25/16794?source=see_link\">",
"     \"Preconception evaluation and counseling\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35018?source=see_link\">",
"     \"Prevention of sexually transmitted infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5784?source=see_link\">",
"     \"Intimate partner violence: Epidemiology and health consequences\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/15/6393?source=see_link\">",
"     \"Intimate partner violence: Diagnosis and screening\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Sexual history",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Eliciting sexual dysfunction symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to questions regarding basic gynecologic health, contraception and safe sex practices, all women should be asked an open-ended question, such as: Do you have any sexual concerns?",
"   </p>",
"   <p>",
"    Menopausal women should be asked specifically about vaginal dryness and dyspareunia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/54/8039?source=see_link\">",
"     \"Clinical manifestations and diagnosis of vaginal atrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the response is affirmative, there is typically inadequate time in the current encounter to complete a thorough sexual history and discuss treatment options. The approach we use is to inform the patient that sexual problems are important and should be thoroughly evaluated. A follow-up visit is then scheduled to complete the sexual history and address her sexual concerns.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     How to take a sexual history",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the follow-up visit, a comprehensive sexual history is taken. Questions about sexual activity should be specific, since assumptions should not be made about the gender or number of a patient's sexual partners and about how the patient interprets \"sexual activity.\" (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42904?source=see_link\">",
"     \"The sexual history and approach to the patient with sexual dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/33/25113?source=see_link\">",
"     \"Medical care of women who have sex with women\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Sexual dysfunction may be a lifelong problem or acquired later in life after a period of normal sexual functioning. In addition, it may be generalized or situational, for example, occurring only in certain settings or with a specific partner.",
"   </p>",
"   <p>",
"    Discussion of the sexual complaints should include whether the issues are persistent or recurrent and whether they cause the patient personal distress or interpersonal difficulty.",
"   </p>",
"   <p>",
"    As relationship factors are principal determinants of sexual satisfaction for women, women with partners should be asked about the quality of their relationships (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Risk factors'",
"    </a>",
"    above). A patient should also be asked about whether her partner has sexual issues (eg, lack of desire or erectile dysfunction). Interestingly, in studies of sexual function in older women, a common reason for sexual inactivity was not having a partner or a male partner's sexual problem [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/36\">",
"     36",
"    </a>",
"    ]. As erectile dysfunction in men increases with aging, and women typically live longer than men, the \"partner gap\" becomes a major cause of sexual dissatisfaction for older women.",
"   </p>",
"   <p>",
"    Useful questions are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef71711 \" href=\"UTD.htm?14/53/15196\">",
"     table 2",
"    </a>",
"    ). In addition, there are many questionnaires used to assess sexual dysfunction. For office assessment for hypoactive sexual desire disorder, the Decreased Sexual Desire Screener is useful [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;For diagnosis of sexual dysfunction, a pelvic examination is required only for the sexual pain disorders. However, we suggest performing a pelvic examination in all patients to confirm normal pelvic anatomy, evaluate for genital or pelvic tenderness or lesions, assess for pelvic organ prolapse or vaginal atrophy, and follow up concerns raised by the medical history (eg, vaginal discharge or abnormal genital bleeding). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=see_link\">",
"     \"Approach to women with symptoms of vaginitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link&amp;anchor=H28221188#H28221188\">",
"     \"Approach to the woman with sexual pain\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory testing should be performed only if indicated by history",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    examination, and may include a transvaginal pelvic ultrasound, cervical cultures for gonorrhea and chlamydia, complete blood count, or TSH or prolactin levels.",
"   </p>",
"   <p>",
"    Androgen levels should",
"    <strong>",
"     NOT",
"    </strong>",
"    be used to determine the cause of a sexual problem, as serum androgen concentrations do not appear to be an independent predictor of sexual function in women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/6,12,13,108\">",
"     6,12,13,108",
"    </a>",
"    ]. In addition, available laboratory assays for the low serum androgen levels seen in women are unreliable [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/111,112\">",
"     111,112",
"    </a>",
"    ]. This approach is supported by an Endocrine Society Clinical Practice Guideline, which recommended against making a diagnosis of androgen deficiency because of the lack of both a well-defined clinical syndrome and age-based normative data for serum testosterone and free testosterone concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/42/25258/abstract/113\">",
"     113",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/45/20184?source=see_link&amp;anchor=H7#H7\">",
"     \"Androgen production and therapy in women\", section on 'Androgen deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similarly, testing estradiol or other hormones (eg, follicle stimulating hormone) has no utility in evaluating sexual complaints. Menopause is best diagnosed clinically. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/45/44761?source=see_link&amp;anchor=H93667232#H93667232\">",
"     \"Clinical manifestations and diagnosis of menopause\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/17/11538?source=see_link\">",
"       \"Patient information: Sex problems in women (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/20/16706?source=see_link\">",
"       \"Patient information: Sex as you get older (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?12/4/12357?source=see_link\">",
"       \"Patient information: Sexual problems in women (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sexual complaints are reported by approximately 40 percent of women worldwide, and approximately 12 percent (one in every eight women) has a sexual problem associated with distress. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Female sexual dysfunction takes different forms, including lack of sexual desire, impaired arousal, inability to achieve orgasm, or pain with sexual activity. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of female sexual dysfunction is based upon the presence of diagnostic criteria obtained through the medical and sexual history. To meet criteria for sexual dysfunction, a sexual problem must be recurrent or persistent and cause personal distress or interpersonal difficulty. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The endocrinology of female sexuality is uncertain. Estrogens and androgens are involved, but the magnitude of their roles needs further clarification. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Endocrinology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sexual function is strongly affected by relationship and sociocultural factors, in addition to physiological and psychological problems. A history of physical or sexual abuse is strongly associated with female sexual dysfunction.",
"     </li>",
"     <li>",
"      Menopause is consistently associated with dyspareunia. Otherwise, the effects of age and menopause on female sexual dysfunction vary considerably among women. In general, sexual problems increase with aging, but distressing sexual problems peak in midlife women. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Age and menopause'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hormonal contraception, including estrogen-progestin contraceptives, is unlikely to interfere with female sexual function. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Hormonal contraceptives'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Depression and anxiety are strongly associated with female sexual dysfunction. Other associated medical conditions may include cancer, urinary incontinence, vaginal atrophy, end stage renal disease, alcohol or other substance abuse, anemia, thyroid disorders and diabetes.",
"     </li>",
"     <li>",
"      Medications, specifically certain anti-depressants (selective serotonin reuptake inhibitors), are associated with female sexual dysfunction. Other agents, including beta blockers and antipsychotics, may contribute to sexual problems. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A pelvic examination is required for diagnosis only for the sexual pain disorders, but an examination is important in all patients with sexual complaints to identify possible etiologic factors and associated conditions. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum androgens and other reproductive hormone levels are not useful in evaluating female sexual dysfunction. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/1\">",
"      Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112:970.",
"     </a>",
"    </li>",
"    <li>",
"     Sexual and gender identity disorders. In: Diagnostic and statistical manual, 4th ed &mdash; text revision (DSM-IV-TR), First, MB (Ed), American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/3\">",
"      Basson R. Clinical practice. Sexual desire and arousal disorders in women. N Engl J Med 2006; 354:1497.",
"     </a>",
"    </li>",
"    <li>",
"     Shafer L. Sexual dysfunction. In: Primary care of women, Carlson K, Eisenstat S (Eds) (Eds), Mosby, St. Louis 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/5\">",
"      Berman JR, Berman L, Goldstein I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology 1999; 54:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/6\">",
"      Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas 1997; 26:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/7\">",
"      Bammann BL, Coulam CB, Jiang NS. Total and free testosterone during pregnancy. Am J Obstet Gynecol 1980; 137:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/8\">",
"      Shifren JL, Desindes S, McIlwain M, et al. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause 2007; 14:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/9\">",
"      Hutchinson KA. Androgens and sexuality. Am J Med 1995; 98:111S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/10\">",
"      Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987; 49:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/11\">",
"      Davison SL, Davis SR. Androgens in women. J Steroid Biochem Mol Biol 2003; 85:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/12\">",
"      Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005; 294:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/13\">",
"      Santoro N, Torrens J, Crawford S, et al. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab 2005; 90:4836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/14\">",
"      Kirchengast S, Hartmann B, Gruber D, Huber J. Decreased sexual interest and its relationship to body build in postmenopausal women. Maturitas 1996; 23:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/15\">",
"      Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav 2003; 32:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/16\">",
"      Cawood EH, Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med 1996; 26:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/17\">",
"      van der Stege JG, Groen H, van Zadelhoff SJ, et al. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 2008; 15:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/18\">",
"      Aziz A, Br&auml;nnstr&ouml;m M, Bergquist C, Silfverstolpe G. Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertil Steril 2005; 83:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/19\">",
"      Nathorst-B&ouml;&ouml;s J, von Schoultz B. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest 1992; 34:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/20\">",
"      Bellerose SB, Binik YM. Body image and sexuality in oophorectomized women. Arch Sex Behav 1993; 22:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/21\">",
"      Elsenbruch S, Hahn S, Kowalsky D, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88:5801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/22\">",
"      Battaglia C, Nappi RE, Mancini F, et al. PCOS, sexuality, and clitoral vascularisation: a pilot study. J Sex Med 2008; 5:2886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/23\">",
"      Hahn S, Benson S, Elsenbruch S, et al. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum Reprod 2006; 21:1925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/24\">",
"      Jones GL, Hall JM, Balen AH, Ledger WL. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update 2008; 14:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/25\">",
"      L&oslash;v&aring;s K, Gebre-Medhin G, Trovik TS, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 2003; 88:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/26\">",
"      Gurnell EM, Hunt PJ, Curran SE, et al. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab 2008; 93:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/27\">",
"      Hunt PJ, Gurnell EM, Huppert FA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000; 85:4650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/28\">",
"      Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/29\">",
"      Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; 90:5226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/30\">",
"      Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006; 13:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/31\">",
"      Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/32\">",
"      Fugl-Meyer KS, Arrhult H, Pharmanson H, et al. A Swedish telephone help-line for sexual problems: a 5-year survey. J Sex Med 2004; 1:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/33\">",
"      Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/34\">",
"      Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet 2007; 369:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/35\">",
"      Pitts MK, Ferris JA, Smith AM, et al. Prevalence and correlates of three types of pelvic pain in a nationally representative sample of Australian women. Med J Aust 2008; 189:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/36\">",
"      Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/37\">",
"      Dennerstein L, Alexander JL, Kotz K. The menopause and sexual functioning: a review of the population-based studies. Annu Rev Sex Res 2003; 14:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/38\">",
"      Leiblum SR, Koochaki PE, Rodenberg CA, et al. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006; 13:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/39\">",
"      Avis NE, Stellato R, Crawford S, et al. Is there an association between menopause status and sexual functioning? Menopause 2000; 7:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/40\">",
"      Nathorst-B&ouml;&ouml;s J, von Schoultz B, Carlstr&ouml;m K. Elective ovarian removal and estrogen replacement therapy--effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993; 14:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/41\">",
"      Erekson EA, Martin DK, Zhu K, et al. Sexual function in older women after oophorectomy. Obstet Gynecol 2012; 120:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/42\">",
"      Reed SD, Newton KM, LaCroix AZ, et al. Night sweats, sleep disturbance, and depression associated with diminished libido in late menopausal transition and early postmenopause: baseline data from the Herbal Alternatives for Menopause Trial (HALT). Am J Obstet Gynecol 2007; 196:593.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/43\">",
"      van Lankveld JJ, Grotjohann Y. Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the composite international diagnostic interview. Arch Sex Behav 2000; 29:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/44\">",
"      Zemishlany Z, Weizman A. The impact of mental illness on sexual dysfunction. Adv Psychosom Med 2008; 29:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/45\">",
"      Lydiard RB, Howell EF, Laraia MT, Ballenger JC. Sexual side effects of alprazolam. Am J Psychiatry 1987; 144:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/46\">",
"      Khandelwal SK. Complete loss of libido with short-term use of lorazepam. Am J Psychiatry 1988; 145:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/47\">",
"      Balon R, Ramesh C, Pohl R. Sexual dysfunction associated with diazepam but not with clonazepam. Can J Psychiatry 1989; 34:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/48\">",
"      Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet 2007; 369:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/49\">",
"      Rettenbacher MA, Hofer A, Ebenbichler C, et al. Prolactin levels and sexual adverse effects in patients with schizophrenia during antipsychotic treatment. J Clin Psychopharmacol 2010; 30:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/50\">",
"      Macdonald S, Halliday J, MacEWAN T, et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study. Br J Psychiatry 2003; 182:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/51\">",
"      Hulter BM, Lundberg PO. Sexual function in women with advanced multiple sclerosis. J Neurol Neurosurg Psychiatry 1995; 59:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/52\">",
"      Gil-Nagel A, L&oacute;pez-Mu&ntilde;oz F, Serratosa JM, et al. Effect of lamotrigine on sexual function in patients with epilepsy. Seizure 2006; 15:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/53\">",
"      Grant AC, Oh H. Gabapentin-induced anorgasmia in women. Am J Psychiatry 2002; 159:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/54\">",
"      Drabkin R, Calhoun L. Anorgasmia and withdrawal syndrome in a woman taking gabapentin. Can J Psychiatry 2003; 48:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/55\">",
"      Montes JM, Ferrando L. Gabapentin-induced anorgasmia as a cause of noncompliance in a bipolar patient. Bipolar Disord 2001; 3:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/56\">",
"      Brannon GE, Rolland PD. Anorgasmia in a patient with bipolar disorder type 1 treated with gabapentin. J Clin Psychopharmacol 2000; 20:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/57\">",
"      Newman LC, Broner SW, Lay CL. Reversible anorgasmia with topiramate therapy for migraine. Neurology 2005; 65:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/58\">",
"      Carey JC. Pharmacological effects on sexual function. Obstet Gynecol Clin North Am 2006; 33:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/59\">",
"      Handa VL. Sexual function and childbirth. Semin Perinatol 2006; 30:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/60\">",
"      Barrett G, Pendry E, Peacock J, et al. Women's sexual health after childbirth. BJOG 2000; 107:186.",
"     </a>",
"    </li>",
"    <li>",
"     Viswanathan, M, Visco, AG, Hartmann, K, et al. Cesarean Delivery on Maternal Request. Evidence Report/Technology Assessment No. 133. AHRQ Publication No. 06-E009. Rockville, MD: Agency for Healthcare Research and Quality. Available at file://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1b.chapter.44298. Accessed March 11, 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/62\">",
"      Baksu B, Davas I, Agar E, et al. The effect of mode of delivery on postpartum sexual functioning in primiparous women. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/63\">",
"      Srivastava R, Thakar R, Sultan A. Female sexual dysfunction in obstetrics and gynecology. Obstet Gynecol Surv 2008; 63:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/64\">",
"      Millheiser LS, Helmer AE, Quintero RB, et al. Is infertility a risk factor for female sexual dysfunction? A case-control study. Fertil Steril 2010; 94:2022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/65\">",
"      Salonia A, Zanni G, Nappi RE, et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol 2004; 45:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/66\">",
"      Serati M, Salvatore S, Uccella S, et al. Female urinary incontinence during intercourse: a review on an understudied problem for women's sexuality. J Sex Med 2009; 6:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/67\">",
"      Achtari C, Dwyer PL. Sexual function and pelvic floor disorders. Best Pract Res Clin Obstet Gynaecol 2005; 19:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/68\">",
"      Handa VL, Whitcomb E, Weidner AC, et al. Sexual function before and after non-surgical treatment for stress urinary incontinence. Female Pelvic Med Reconstr Surg 2011; 17:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/69\">",
"      Ozel B, White T, Urwitz-Lane R, Minaglia S. The impact of pelvic organ prolapse on sexual function in women with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/70\">",
"      Dalpiaz O, Kerschbaumer A, Mitterberger M, et al. Female sexual dysfunction: a new urogynaecological research field. BJU Int 2008; 101:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/71\">",
"      Tunuguntla HS, Gousse AE. Female sexual dysfunction following vaginal surgery: a review. J Urol 2006; 175:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/72\">",
"      Erol B, Tefekli A, Sanli O, et al. Does sexual dysfunction correlate with deterioration of somatic sensory system in diabetic women? Int J Impot Res 2003; 15:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/73\">",
"      Erol B, Tefekli A, Ozbey I, et al. Sexual dysfunction in type II diabetic females: a comparative study. J Sex Marital Ther 2002; 28 Suppl 1:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/74\">",
"      Enzlin P, Mathieu C, Van den Bruel A, et al. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care 2002; 25:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/75\">",
"      Kadioglu P, Yalin AS, Tiryakioglu O, et al. Sexual dysfunction in women with hyperprolactinemia: a pilot study report. J Urol 2005; 174:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/76\">",
"      Okeahialam BN, Obeka NC. Sexual dysfunction in female hypertensives. J Natl Med Assoc 2006; 98:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/77\">",
"      Doumas M, Tsiodras S, Tsakiris A, et al. Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens 2006; 24:2387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/78\">",
"      Duncan LE, Lewis C, Jenkins P, Pearson TA. Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens 2000; 13:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/79\">",
"      Addis IB, Ireland CC, Vittinghoff E, et al. Sexual activity and function in postmenopausal women with heart disease. Obstet Gynecol 2005; 106:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/80\">",
"      Fogari R, Preti P, Zoppi A, et al. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens 2004; 17:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/81\">",
"      Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008; 26:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/82\">",
"      Gershenson DM, Miller AM, Champion VL, et al. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol 2007; 25:2792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/83\">",
"      Likes WM, Stegbauer C, Tillmanns T, Pruett J. Correlates of sexual function following vulvar excision. Gynecol Oncol 2007; 105:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/84\">",
"      Mok K, Juraskova I, Friedlander M. The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions. Breast 2008; 17:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/85\">",
"      Bancroft J, Sherwin BB, Alexander GM, et al. Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens. Arch Sex Behav 1991; 20:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/86\">",
"      Alexander GM, Sherwin BB, Bancroft J, Davidson DW. Testosterone and sexual behavior in oral contraceptive users and nonusers: a prospective study. Horm Behav 1990; 24:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/87\">",
"      Schaffir J. Hormonal contraception and sexual desire: a critical review. J Sex Marital Ther 2006; 32:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/88\">",
"      Bancroft J, Sartorius N. The effects of oral contraceptives on well-being and sexuality. Oxf Rev Reprod Biol 1990; 12:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/89\">",
"      Graham CA, Ramos R, Bancroft J, et al. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception 1995; 52:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/90\">",
"      Davis AR, Casta&ntilde;o PM. Oral contraceptives and libido in women. Annu Rev Sex Res 2004; 15:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/91\">",
"      Coenen CM, Thomas CM, Borm GF, et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception 1996; 53:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/92\">",
"      Fucs GB, Coutinho EM. [Treatment of diminished sexual response associated with the use of oral contraceptives (author's transl)]. Reproduccion 1975; 2:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/93\">",
"      Bancroft J, Davidson DW, Warner P, Tyrer G. Androgens and sexual behaviour in women using oral contraceptives. Clin Endocrinol (Oxf) 1980; 12:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/94\">",
"      Oranratanaphan S, Taneepanichskul S. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido. J Med Assoc Thai 2006; 89 Suppl 4:S17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/95\">",
"      Greco T, Graham CA, Bancroft J, et al. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol. Contraception 2007; 76:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/96\">",
"      Roumen FJ. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials. Contraception 2007; 75:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/97\">",
"      Gracia CR, Sammel MD, Charlesworth S, et al. Sexual function in first-time contraceptive ring and contraceptive patch users. Fertil Steril 2010; 93:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/98\">",
"      Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004; 291:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/99\">",
"      Skrzypulec V, Drosdzol A. Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system--Mirena. Coll Antropol 2008; 32:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/100\">",
"      Li RH, Lo SS, Teh DK, et al. Impact of common contraceptive methods on quality of life and sexual function in Hong Kong Chinese women. Contraception 2004; 70:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/101\">",
"      Harte CB, Meston CM. The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: results from a randomized, double-blind, placebo-controlled, cross-over trial. J Sex Med 2008; 5:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/102\">",
"      Van Thiel DH, Gavaler JS, Eagon PK, et al. Alcohol and sexual function. Pharmacol Biochem Behav 1980; 13 Suppl 1:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/103\">",
"      Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005; 84:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/104\">",
"      Avis NE, Zhao X, Johannes CB, et al. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause 2005; 12:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/105\">",
"      Klusmann D. Sexual motivation and the duration of partnership. Arch Sex Behav 2002; 31:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/106\">",
"      Lutfey KE, Link CL, Litman HJ, et al. An examination of the association of abuse (physical, sexual, or emotional) and female sexual dysfunction: results from the Boston Area Community Health Survey. Fertil Steril 2008; 90:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/107\">",
"      Basson R. Women's sexual function and dysfunction: current uncertainties, future directions. Int J Impot Res 2008; 20:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/108\">",
"      Nusbaum MR, Helton MR, Ray N. The changing nature of women's sexual health concerns through the midlife years. Maturitas 2004; 49:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/109\">",
"      Shifren JL, Johannes CB, Monz BU, et al. Help-seeking behavior of women with self-reported distressing sexual problems. J Womens Health (Larchmt) 2009; 18:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/110\">",
"      Clayton AH, Goldfischer ER, Goldstein I, et al. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med 2009; 6:730.",
"     </a>",
"    </li>",
"    <li>",
"     Guidance for Industry. Female Sexual Dysfunction: Clinical development of durg products for treatment. Draft guidance. United States Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, Rockville, MD 2000. Available at: file://www.fda.gov/cder/guidance/3312dft.htm (Accessed February 11, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/112\">",
"      Basson R, Althof S, Davis S, et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med 2004; 1:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/42/25258/abstract/113\">",
"      Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2006; 91:3697.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5424 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-B32189B1BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25258=[""].join("\n");
var outline_f24_42_25258=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FEMALE SEXUAL RESPONSE CYCLE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ENDOCRINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Role of estrogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Role of androgens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Age and menopause",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Psychiatric and neurologic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Gynecologic issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Childbirth",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Pelvic floor or bladder dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Endometriosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Uterine fibroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other medical conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22320934\">",
"      - Endocrine disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22320941\">",
"      - Hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22320948\">",
"      - Other conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Medication and substance effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Hormonal contraceptives",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Substance use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Relationship factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Medical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Sexual history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Eliciting sexual dysfunction symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - How to take a sexual history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5424\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5424|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/24/23948\" title=\"table 1\">",
"      Fem sex dysfunc criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/53/15196\" title=\"table 2\">",
"      Female sexual history",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=related_link\">",
"      An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/45/20184?source=related_link\">",
"      Androgen production and therapy in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=related_link\">",
"      Approach to the woman with sexual pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19254?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/45/44761?source=related_link\">",
"      Clinical manifestations and diagnosis of menopause",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/54/8039?source=related_link\">",
"      Clinical manifestations and diagnosis of vaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/16/263?source=related_link\">",
"      Dehydroepiandrosterone and its sulfate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23128?source=related_link\">",
"      Differential diagnosis of sexual pain in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=related_link\">",
"      Epidemiology and clinical features of multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36600?source=related_link\">",
"      Female orgasmic disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7562?source=related_link\">",
"      First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/15/6393?source=related_link\">",
"      Intimate partner violence: Diagnosis and screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5784?source=related_link\">",
"      Intimate partner violence: Epidemiology and health consequences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/33/25113?source=related_link\">",
"      Medical care of women who have sex with women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=related_link\">",
"      Overview of contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42696?source=related_link\">",
"      Overview of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/20/16706?source=related_link\">",
"      Patient information: Sex as you get older (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/17/11538?source=related_link\">",
"      Patient information: Sex problems in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/4/12357?source=related_link\">",
"      Patient information: Sexual problems in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/25/16794?source=related_link\">",
"      Preconception evaluation and counseling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35018?source=related_link\">",
"      Prevention of sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36484?source=related_link\">",
"      Reproductive and sexual dysfunction in uremic women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2039?source=related_link\">",
"      Sexual dysfunction associated with selective serotonin reuptake inhibitor (SSRI) antidepressants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=related_link\">",
"      Sexual dysfunction in women: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42904?source=related_link\">",
"      The sexual history and approach to the patient with sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/48/2824?source=related_link\">",
"      Treatment of female orgasmic disorder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_42_25259="Urine chemistries";
var content_f24_42_25259=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F63690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F63690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical uses of urine chemistries",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Parameter",
"       </td>",
"       <td class=\"subtitle1\">",
"        Uses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Na+ excretion",
"       </td>",
"       <td>",
"        <p>",
"         Assessment of volume status",
"        </p>",
"        <p>",
"         Diagnosis of hyponatremia and acute renal failure",
"        </p>",
"        <p>",
"         Dietary compliance in patients with hypertension",
"        </p>",
"        <p>",
"         Evaluation of calcium and uric acid excretion in stone-formers",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cl- excretion",
"       </td>",
"       <td>",
"        <p>",
"         Similar to that for Na+ excretion",
"        </p>",
"        <p>",
"         Diagnosis of metabolic alkalosis",
"        </p>",
"        <p>",
"         Urine anion gap",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        K+ excretion",
"       </td>",
"       <td>",
"        Diagnosis of hypokalemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osmolality or specific gravity",
"       </td>",
"       <td>",
"        Diagnosis of hyponatremia, hypernatremia, and acute renal failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        pH",
"       </td>",
"       <td>",
"        <p>",
"         Diagnosis of renal tubular acidosis",
"        </p>",
"        <p>",
"         Efficacy of treatment of metabolic alkalosis and uric acid stones",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Settings in which measurement of urine electrolytes, concentration, or pH may be useful clinically.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25259=[""].join("\n");
var outline_f24_42_25259=null;
var title_f24_42_25260="CBT techniques adolescents1";
var content_f24_42_25260=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73776&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73776&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    CBT techniques for primary care encounters",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Teaching skills to counter distorted thinking:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1. \"Depression often makes us see small or medium-size problems as huge problems, and that thinking just makes the depression even stronger. So a good trick to keep problems in perspective (and beat depression) is to use the \"Rule of Five\" technique.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       <strong>",
"        Rule of Five Technique for battling \"depressogenic\" thinking",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       When you experience a situation that feels like a problem, you ask yourself if the situation that is bothering you will",
"       <em>",
"        really",
"       </em>",
"       matter to you...",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent3\">",
"       &bull; In 5 decades",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent3\">",
"       &bull; In 5 years",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent3\">",
"       &bull; In 5 months",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent3\">",
"       &bull; In 5 weeks",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent3\">",
"       &bull; In 5 days",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent3\">",
"       &bull; In 5 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       If something will not really matter in five years or five decades from now, then it really is not a huge deal, but instead is a small to middle-sized problem. Don't let depression trick you into making small problems into big ones!\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2. \"Depression also sometimes gets in the way of people seeing the good, positive possibilities, or even the neutral aspects of situations. Instead, depression often has us seeing things through \"mud-colored glasses\" where situations are either all good or all bad. So, another useful trick to battle depression is to wipe out \"all-or-none\" thinking and remembering to \"look for the good.\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       <strong>",
"        Words to AVOID:",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Always &rarr; Every single time",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Never &rarr; Not even once",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Nobody &rarr; Not even one person",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Everybody &rarr; Every single person",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       <strong>",
"        Use these words INSTEAD:",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Sometimes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Some",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Pretty good",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Ok",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Liza Bonin, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25260=[""].join("\n");
var outline_f24_42_25260=null;
var title_f24_42_25261="SCD and clinical manifestations";
var content_f24_42_25261=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52309&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52309&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Risk of SCD is related to clinical manifestations of CHD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 276px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    During a 38-year follow-up of subjects in the Framingham Heart Study, the annual incidence of sudden cardiac death (SCD) in both men and women was related to the clinical manifestations of coronary heart disease (CHD). It was highest in those with a myocardial infarction, intermediate in those with angina and no prior infarction, and lowest in those without overt CHD.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Kannel WB, Wilson PWF, D'Agostino RB, et al. Am Heart J 1998; 136:205.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25261=[""].join("\n");
var outline_f24_42_25261=null;
var title_f24_42_25262="Digoxin level and survival";
var content_f24_42_25262=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Serum digoxin in HF is correlated with survival",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 336px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among 3782 patients with heart failure (HF) receiving digoxin or placebo in the DIG trial, there was a significant association between serum digoxin concentration (SDC) and all-cause mortality. Compared to placebo, survival was significantly better for patients with SDC 0.5 to 0.8 ng/mL, and significantly worse for patients with SDC &ge;1.2 ng/mL.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Rathore SS, Curtis JP, Wang Y, et al. JAMA 2003; 289:871.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25262=[""].join("\n");
var outline_f24_42_25262=null;
var title_f24_42_25263="Cat allergogram";
var content_f24_42_25263=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F65499&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F65499&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Cat (Felis domesticus) allergogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 316px; background-image: url(data:image/gif;base64,R0lGODlhMAI8AeYAAP///8DAwEBAQAAAAACZZgAz//+ZM4CAgIiIiERERLu7u/8AAN3d3TMzM+7u7gAmGaqqqv+AgJmZmREREXd3dyIiIr9yJj8mDH9MGczMzAAZf2ZmZgAmv1VVVQAMP39/fzAwMJCQkBAQEABMMwByTCAgID8/P2BgYDc3N29vb9DQ0H8AAPDw8ODg4B8TBi8cCf9mZqCgoHBwcP8iIgATXwATDAAJL185E/+Zmf8zM/+7uwAGHw8JA//u7v/d3f8REf+IiI9WHAA5JgAJBgADDx8fHwQEBAAcjw4ODhwcHAAcE//MzP9ERFRUVEhISCoqKgwMDP+qqktLS99gYJ8gIP/AwP9AQA0NDQkJCf93d79AQP/g4J9AQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAwAjwBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP0lQ4JAwMNDgAS+fkK6gkcSDAZgwQOHFRA0K9CwYcQIwZrwNBfPoYSM2rcyApBg0L+MhD6R7KkyZMoU6pcybKly5cwY8qcSbOmzZs4c+rcybNnywPjNuwzNCCgIgEBOCpd2uoAUHAMGmwg1EFCvwn8jiZlyrXrKKfhLOZziCDfBKuLkHpdy3YTWIJq/9vKnRvp7cC4dPPqPWRXIN69gPX2rfc3sOG2g3UxoMDAIwRahQ9L5po4F4IJGcxC3jq5M9PKuCg08Ff2sazInlNHBH0LQYUOAxgMMB0LterbA1nbYjBhQIKQs2zjHi5Pty0IFBxIwHiaM/Hn84zTcmCa+mbo2Is/7QVhAD8Hs4M7z05enXRZQvU1aBC+efn35rfvYk8ywXX4+Mudl6VgX8JawuUnYDb7yYIcBQgyIN6ADHpTICzdkUQbLAE2aCE0D75CwQAIQOBhVrWNd+F7OPywwAI4ANADEyfm0MMzGbriD4j3jYhfFikC8QMAPjDRQw8zAAGjfLtkMEEHCDK2oP+NgOmwQA4L/LAEIT6caOUMiESxIyE5COlMjK1E+M+Er1hh5Zlopqnmmmy26eabcMYp55x01mnnnXjmqeeed1ZRiJM6AMAEDJL4MEMUhACRA4ZE6kKdhx/OwsUUEVRq6aWYZqrppplSscKnoIKqBacRhGrqCpSSquqqrLbq6quwxirrrLTWaiupW/y5gCAwEDpIlWdiWcgSP6Q4CAwuMhqMAgowYJR7qQhAgwbUVquBB42OhMG23G7rgohMBuMkr746AsQMUwriQw7lDvmLA+yNFtuSqAjAQQH45luABtkOMoABAAcM8AXghvvLuAD0CskMZ+KAQ7Du+lJWAvu0F6L/Kvbqmy+/ivwrcMAEGyyyIGCyIhoEDchGpisVfpKxxvv2K4jHHxsQ8sgGl7zKZaJtMC+09d4LM8eJ0PzxzTgzqfMq9A0wFb2nvKwx0YgYLTDSSY+4tCoOIEABWlCbIrW+VB9iNcgFZy3g1uK07MnYG8sMwNkDpx1uACqRx3YpECCwWJJKAh210FPLTbfNdjMZgAcw4zuA3nLPcnJJK7fididw41s2UTXXrbYgizdewOPZ7U2Ks49CSuMrl3OSecwdd4745wCE3jjp2JnOt3cAgFc5K61v8vrmhRyOddK2w4w7dLqPkt567P2+SvCaDG+47MfjnLzGyz/XvChN52Pf/yb35DNUVPmAnQj1mVgfe+fZj7y9vt0T970o/SW0OiYHJbQQAB3oAAC6s79CsA8T7isa9hJno/nlq37Dud8o9FfATFAEABMwTVHSwsC3EY5s14NfBy/kQMdB7l34GJMnPDIzowxAfTIQgAxnKIIRuu6DcXtfzeInshKO7oQSG0AFKtCACTxLE0LJSgZbSAgVBOCJUASBDYWHQ82FcIdTZJAPIYgbCYJCNAkagEg0EZWnCSKAA+SdVjBWRdgpUIS02yIQeyEaCVTAH9KThFiECAD0vZARB7xEAqu2wDgy7nZz5IU/FNCbCShIcGJrI/FGUsjPybF0kasFPzJAgTFCsv8UgzRbJdV2ydxlkhaN+RqAstg+SV7xaKwUUCmZd0pZ8OYfZrxYtFypQ1gaUnRcvI0XP0GBCXTIZ0dkXSwFycs3YvGXiMTkLyTwkd5ZjELLtEQoOQdHSx5SeYks0gSSNIAE6TJojZukv0aZtVl6r5axEJOEzjm4dL7yatmEjzt5oYIZ+vOfAA2oQAdK0IIaFKAyeMQwPZE6SEGggtHKJyW2WTx2Iu+b3AtGAKQIxY569KMgDalIR0rSkkIxBAJQKDzVEUhtNpOQ3SQlRumn0ZQ6IwA2bcRCr9HSSlCUkjFt50wfWNNn4FSlBenpRF8qyqBeFJhFvWlOGbFTTzDLWTX/qufQ7ok2aIITGEeVKlJ9AS99+OOR9IykPXuJT69mFKxTXUZYdbrSV0ysYnmMKBvX6kxfehOqcDVqXBVR1U2cLGXXVOZet8rWrv41mr+Y6yBaMNIW9EKyiyisJngmlZ+lFZRM5eYzH/vVyA72ADvwgGpXq9od1JUVmCXsa13RtFxic7GFa6znSPtW0xriABoQ3SRlg1ZYxDYRmtVE11SZVbUytq9t5S1NA1sI4Ao3W8SdxXERkVxMQPS2u+QrTEcrU8D6trrBFS8hsisIRg7gLAC44CCQJIrt8mW2rIDAkZL5WVL8dJ1O1d5QTUhdQlhXvYNgLwYrghUKCDABU8FM/30Hi1z8rkIBFRgLAr6r1/A+d7x+LS9kfRHbA394vT9jb2z0u5wG6HcU9v2thVmhgA0llmUSncR/Z5aSHJNnn7socXpPnGDPGhMAl+HHBBx5GQFOeKy96FoKjRg20CK4eATIspaz/AAfZwfIuhDydQ8hm38kwL3wBaB9wKO+T8S4ujNORYQSsOHmWpnIWN6ylrvs1ume18BDzi0v3mzgOKNCAQjwpJ39G9o865kAfJYuUQs8iAPQgAOYzjSmaWDoUhC60p0Gh1J13OiRPJrLXsYOmHMR2xgQNAaXpTB3Qz2Kvv0tScVVrIcFXbVTQzrV0Fk1Lj4tDGIDoLuVmNw8P//J6Cub+tSRFnFpSSzrYxgb2ZRAnUMfWuVm4/nZj462UM1LbcFCmRcEtGZe6wVsRwjABqxdrWs75mtxP3XEsTa3I7BNieet58aWa3cjBBAECxj84Ba4geHqLfDhCPsWxqZ0Zmk9ivD5ZtGjEIAFOoeBhUO74bh5uC0i/meqUnwU+fvPIQ6EAP6KYtSS0DjHPR5ukN9G5LWILWVFatlBV1vGyrBjSc4sNpuvb+M16zi9P97nSZecZC64gNSnLnUXnNwSCuDita/+CVsDLnBI9o0EGOCAxmTY5YjoziD2iPZBwDwSMk86zfVsbwGTO9/VxYDslG6IsjjtEHT+RNYRsXX/OrqYcoOgAHMIsYF1CyKFa3eIu42OiLh/jO+9ZrqkCfz0Y+t95ohAwPgMEXirav3ncO6Fth0KIohymBCDF4RYFl95yh/C8gLDvNkY3nTOlzvve++X6GdGHwmIRQIYTh8A6JyAhWRYPfl4TPL/OP3Tn3sXi2mMiw3BLEFkPxKxJwRwBuFEj0oRY0i//Ny3XHf5DfiHEvd88EM/Pg4h2SGlh++LKaYg1zBANgyxAfahfxOwYAAQfoVQeBKDGZrBeOJDHQCnCAjoL0cUQ/9UQ+gHekXDe5sHf513AJ8nd/THRHa0fAxRZv9wEBgxfHMTEKKHgvmQXRM4CApoeKRhMVk3/wHxgkfghztVcRUc9naQgHsBo3tEwYHS1lu/Z2AhqH4j2IINsXwUIAhp9ngrWH8uOIDqc2Rl0UcbRIOoV2i/4BqwoTKD0B1WoV8Z5niDkEJ/5HdVuD62ZwhECDBG6Gh0N4eTgXO0UGJNmHvZ4ndTsUElaBHI93z4d4VMNHzT5xAWwR5eeEQ1yAu39BtiNAhZhxYWwYbto4eEUIcGcIfgloe954FLWGl/WIRc5wmTiG7JsRyFkABTKAilETWe6HbpB4hLV3OlGEzDdlo3gHAIp3B4R1fBkAEQkGuH8Hquc4uCAIqi6C9IOG745nOG4GoDBWvWuG+rCAo+cxEY93K5qP+Ku0iKHeiLEBeGw9CKulAWSIIPinaARvF9RZeBIriBmpeEfnaKcqWOJNONniAaguA7DugbEMiJCOSMAACN67dnCgkYfKhd/hhVxriAHbIhnpSDOxiBLqOQDFmO7PeQexGRskBy/Chb71JbhICGAzQBa2iL9uiE+MiL50iRzMCOjuI1bZaJshd9MBkt42iHDYlqvWiT/Xh92KeTpDeLYYeQguSRQRmKQ/lrRRl/OxdSPRdkE8lv2dYb+WBbhsCMwgOVGph5NKmPTneSB1ADD9CWbtmWNWBopRcKOBkaxgQByNRtGReV0Tgz03hv01aMlTYCvjYC2ZJ1jySAJgh4tMf/ilsJkJ1ATQPJkRhDlvdoluaIlr4nmCRDmKdmmIeAmIKgmIkwl6BQl7dgJORkTuBVL3w5le3XQ++HjiN3Wp75aKDJfT+jmIHndxdHMV95mo/5C/KkQq0ZNa8Jkg5ZlR94m3qWm4WQdfVhgpnxGMOXAPYhmo6JlLnQUKpDCIzRNx3mmmW5e/lIjYG5jQbmnFsGnbC3m/ZBZyWIZPF5gp7FCagpDL4jkOwWk7o4k5mJnkrImcfGnlrmnpgIn9R5iR1Qn16ojJmQn8Gwn9X0k+R5meZ5lgK6jwR6AAaaZQjaXgoaeN9YAQ6qYPg5nMpAoeOJnOV5hOcJmAOqnoNZmBbW/wFgKZzceQursz8s2p9A+aJ4GJLMqZZCQAJImqRIKgSvlUIpYwoSKgvgQQH9oQDdQSY/aqEuiqEwqqEyyqE0KgjYKFDaqJU7qknldKVXaggNgGg5+nKWKZOYSaQ1GX/JEKWxMKVqSpktKjbJCaB0Sko2oGmaRps5N5F2OmtRdhJOCaf+SY6AupyWxANUR3WG2oeI2nkVtqgm0aihIISP8JGRSpSWdAGyc6kSqW8VyQsUpD/h+Kl/OqeSSkqm2jmoWpKZepKbSlbbFo849qhCqZykSqunapTKgKcGYhK2dSCsCUpx+p+yOqztVKs1c6uxYJIEuqvcUQEI0gETAI9niP949RikXDqkszqtxQpWInBQ7Nqu7vqu/gQCKtoLLGRNPCgIG9IhkTKuFyqnGRqgyEOtH2OtsMACJnWwCJuwCvtRKnCmtlAWF/lCFjMj0/OskBqtVFmq6WpK7+KV+pB1nmQkSNKs/mWxwTqqGUusthpOu7BcdUYjxempE2WyUimsKYuuKytNUVYIPrptYtmJwFqzKBubBhMAAiswBAsYXBkJBDmZtCEBBZQBbdeMQduXc/OX2nO0AZO0e7G0kAAe0PNvtHEyhXAZnKh23ld8gESzVjsAWCs/WgswXCsYkKlcjDoIGRAvG0ABG5BhHSCWkHdGApRua0Su/tqlAJu1G0v/S4uqrx6SWB5hFgnglOG3RFBYuP0Krf8aqDhbrSwbGsUFdoSgcpIQfl/4R+T3UednuJqLuJwbsIv7TuNQuRpUgQCFgax7sZt7rrCbsxwrDuGHRoQrh1ULmyKpF0Ybu/ZTt77ghlbhR212e2xrvHEUtwYwt3nhtcsAqu4Wq7srrb3ruTobDEIxtX0KSt7ruryruL7LuMIQPXopjkI6iq/LvuL7u/r5qqAgqhhLtHdjvdhLF9oLCVFhFRQwev21l/MrjTFqvwP7ubjgGoJQnfELqwvslw0cDVcJUtkQAC8gjAcXwHMxwI/An02bwPJbrvS7vtGAWvG2WiKsUUPwlm8Z/8OIwbya4A8UgJf3qWuZq7vqC77SYGIzOg0B8AC+ZsNsQcKPoJIVvL/pa65C3MKBBqZGjMSnpsRrwcSPoJT66zJRvMJTjCFVnJbVcMRJDMG5cFXme77+FcYM7KVDXMabSQ1onMVqbAtlJS8QCjzTa7P+2wxEbMXScMePpsVewcWMcFcnfJx+esFXm8FkfHd2jMWHnMe1cFhmyGwKrMJxnLhUTMlXnMbjywuc5TN9XLHFC8jHqwqDbMYIlBI4vAiGrGeI3BWKzAhOzMkpfLhSfLPT8Mp1zEzOpgq1vGW3TBmznAnLFb0+vKW+LMbAPMei7FLFnArHrGXJ/BnLzD9e/P/EYAzJbivJMELHpthK14wK2Zxl27wUuawItxSc4Pw2cIzBchzK1UjM32bMlmzLmEwLxXRMX4jCFuzJ9gzKk5zP1rzP2NzPyPzPsyCZ6jbPmFPPkXzPCZ2e+sxrrrDOBNDOSvHOiaCaCFJOohtwqzy0rZwKwnzOCFRq/EzK+Itud+vI6CvOb5vRRbzQHN0KHg3SHCHSiOCd+/rMj2zQF43Q5VzNPgXTDS3T7qt6jOEYX0zPOE3OX2LOiLxj6uzQ2gzRsnAZmfFeVV3RV43RS63QTZ3Op/DTYB0LdcQhfAqkP3yy/bvSqNDSW+3UXQ3VsisxrxEbc62lRx3Nn1y/+Kz/0TwNQtfq1ez81rBQieNH0FB81kqd1Uy9VGwNpY790ZANIa/YmL+au3b9vdOc2Du91gzd13hcyoTxxyp9DXqNOXzd1p0N1Bsh1MHAvQNn0eOM1pit1pq92rbt1xHxapeg28DA24Dk2zmd1oqt2j0NW7fNEQNAqJnGacndzZQgnj/rxp1s2AeN2DpNyNLN2MZV3RsxAGNmCcqdeIf33YR900j925ctyFpN25vtaeqtEey93yhpyvqgHuvRxpbAdhyU0nct2/l9QwAOY/2dEf9N3CYXZW5onKAwnwMH2wtuDbPt4BTO38YNERM+3XXB3ZWQcqSb4f8g2gbE4aYdyMzw/+FU9OD1FeESUeLoXQnvbQjImMqeMNkAUH4dtbp1LbQdXg00Xj21zdkj/hA6nkPujeKV8I32ZwoDDQAW6E+4Wy8FB8LEGNse3uA1HuKk4Nbr3d48TuWT4I4HfImh8IMSgBUJHi1KQMNwSb1jntmkZuN0ieMREeVWtN2/YMKDXQlw6MwvjjEk8Jl6ruRkzuR+fpqATuJqTgk9PgiXEbG+itLR0ui4+ejUsOTobOYQ/uQFIehutOYpiUtl7Tqg/pyiHsyRXuomHtOt7d+XPgmZPgjNvEqM7uiszOB8HnNNLuK5LuG7Lgm9vgvMnRax3p6zTs3C3eemfuOoThCqrk4O+/8Oz34U0X6g047a5j3ct/7UyZ7jy37iSeWR4Q6i4w46IsUCw0DqLz3pblbpUL7ukNDsuvDt6/PuBBCi0ky0A/DCqkUEeM3rtY5AR4DdHKDd6Z3tA3HdEC/xrC4M5UvRsC7sYm42ouMBC8/sDS9IL1CpVcfmhIDm/o3yKU/o73vozhrsoT7sVRPyI18XJa9NFl3c6R7o8zflxCDfGefuHp/kRIHz9b7zPtXzTv7zJB70Gf8LPw7sn370MZ42qi7yS1/scOf0yH7J6y31mK7ykmDlLu7HNC/rNg/yjcP1wmDvggT2Z67vqU72vG72kODm4MrLnyrwBH/YLDwzSh/3TD//UXR/6lAP5XjP7HpfwtXUyEYNSoAf73NT+MEg9zwPyT4v9v7d+OxukcgB55TtMpXf9kSB8B6g8PXuAdZiLVud+Ni++L0gALJcNLfPCYdjtavKqrtc+m9z+h9PFCBscC+Q8/1+Ad3SLbHP+U/v+cKwY9t+crsfZ/7+668uPMKP9BUVYL0Agso7984f9v5MDNLP75VQ/TB/F0Zf88Pf/eQFDODfvu0j+39O8f/u1NPfCeoPCACCg4SFhgAHB4eLjI2Oj4UUkpMUDJCXmIwCAZmdmiQEoaIEI4qMA6OjD5yLAwavsK8XrJ61tosHGLGxA7eLAha7rximvsaCAQ+por3H/861AhwF09QFGsWGA9XV18+DrsIGxMaJ3uaGDgPq6wMQ576b748CoMuljajLBKun4Qaz8gISyuWvmTdg4cYJxJRMHwGDCwNG2zatWyuKFbE5AydM4a1yEZ9BGNlBXQJLIS/FS0mInr57pxzya+UPIEtzBMNBdIawo8abhRrq2wn02ESKFg9pw5j0GcddHm2BLGorQ4IBFRBQdbQSqEt7PwnlWzZTaU1aWz/q0nmuJ9SwVIUuI5oWmjSkcAEsxXvuaayotabWvURBHQUHg3+h9SRDgOPHj2V8eplXr8zFYs8mlrpWGF14wXxuBiA31efR8+5ua1poAIfXsF/TqFzLL/8swJ4Eoz6UDmuD3w0U7O4K7Uhs2EcETAaL73K/cDZ3X8rpuW3ot6NLjzot/ZdqbnkHXBhPfrwL2p7Elyd/nhz60b3ZtRuOOdPRbRyU/6qXCmYr5zRBV193h1C3C3fQXPfXeyFpxwyBmNwH3nOimTMACRhmiKEQDDKiG4SCOCDiiIjRB8931OS3XH+VjZVKWdloBmIjBvJiXUIdLuRgKAjOCICE1LCWGY59OeSfVDn6mBhxngA5jYr7UdacPjC2JqOShtQIS4+duLVgdsoMhaUmKGZEIXYWGplklmuOSRWTXZZZAJSHfMXilGQNqNeVbgqi5Stc2qfgbW2+s+NDfRr/4qQ14fmDmzEujnJkYIUmmhKc9slJp6L8SdoigGYJaKmfnR14Y4WJHRoohIsK+Y2jlf4npS8fjjoaphFqql+dnYoyaWugxijqqH8asKpKgw4Tqzeq2ipIq40SmeasHy3r7Du4qqTrip7i+aKetsmip4/FHguJl4SC6ZC50kF75pfTMkertdeak+25Nnig774e2LArp9QqFWxr65HHw4AqQKbwv2kd4ELB47HLVbLi0FtIwgs/psIhzS6CccYMpyVAvvzqu0N4EF/Q3i8gCxBDTAET8nHGA1lcL0/jzhOEBTz3bEEQIQ9iZ7cw53mKhhoqMWAANhwHm8TnHCAE0hlC/60JxY8aE8ALPvv8Qn0dc9y00xxYbe/OXVtwQ3hUbxhe2jyvXfSdHHMNN0S13rzVvfNQbEHQz/Yayq9iDVw4lUt7gFEBZj9zwAjrnoqmOQFcwOcgYRsSgOIYNf4MusrOTXSoqGaj5iKVF1Sz3rfmPHE4f3Pr66eIiy5KlZhzTpHnxzweub1Y24y55cMGFeZcjGy+OO9GBW/74NGWDmzMw6s+SN6sG8NAA+pIMI/rjYBuQOxRyiur0ed/i7ru2zBPK+RiAi8t5cQLEx0hmQfFfjXugza/6dR71f+mZ76g1M9U1xNe9gTRgQ4AAAIDKJEmwFeIlYiPfMjY1dBm15rDof9PEBCJ1O1oMRXlda4lFMQc4LjCCt/F7xueCIAGnZdASlVvWDLE3PFMg79dmXB3KGxSCmv4LBqS5l8ihJ5YhlS6riSRFMXIITIOaCMiLtAbE3CHXoQTviE+ixUX/JcUfyQ4KHbwG8EKIahKuD9qQIRvmlthF/0EP+QtsRNjFF9UsEejKFIRFjYZY+YE2cZpvNGLP0LkVPQYRSSeDoYCbCItnugfQf4RUKu7ojcGwMUBeG+OXQKj38SowTJOSo21gyQI1xjFQjIuiJkYo31aWEce3jGWM/wfHz3kRxkJcofb6WHulgfLWeamGIxUoQfpBkImTi6RaKSWJa3nJwUuMIv/IOSiIBqjMBGAoGUt86ZjRPACiL1ABJABATrHqYQHuPOdD6hBCRQ2AMgMAJ7wHMI3H1NPfuLznfp8TAnm6RgQEKFk++rnOPcJToWps6EgE6cASlCDf7pToY7BKEQLuk4BkBNiLiCoYwa60YWRtKA8SBkP9vnQgg7Bog/AaEsFYFCE6gujEi3pQnUqUJF+tGAhfcxMBXBPi8rTnvZMWVAfk9Oi/vOoHBVqSiGG0RJYM3sNfGAEZRaArnoVBCHwqljHSlawkvWsYg0BCNDK1q4OoK1sfStcyXqCE8y1rGG9q1fVqtexmrWvbgVsV/kq2LoKtquGBSxhFbtWwf4VsI/t/2ti+7pYwMrVsXmlbGMBe4Krsm573fueEPEox1PU5pijxSU0EMkuWU6nTbuMYwxLWydEwpFNpD1tahlCW9xqcm+29aJrLyExdsVWUcLtLXLTM1vUOpe3zQ3lbjFxXGEyd7qQGO4jqvvbtgQ3t9fthHHXdFvrSle80c0EdzMJXfAa87zqTZJ2HyGx8iqzE+vt7jNUwAJP8LcTLNhYDGuByBa0wL/9zUSAa/FfPHpiwZ0wcC0krGABVxjBGI7wgS884AxjAsKZoLB+R0ziEpv4xChOsYpXzOIWu/jFIUlHBTCBgHVUQJuPkEAF1BEcSDCAHRTAhATYsYFL1HgdWoEEAv8mwONPOsKTghiykdVR5EwoQB1JfsQGqpyABqDEET/+MiawEqIJzNgRNXYgALJiZCYPoAMSbMSVeSxmOXNvAA3IwCWuog41Q8IBfJ5AlhsxZPkQl4s6hkQDsrwBP8MYKAhowARw3AgEnDkBjm4EBD+5gUEzIswAUEADMs2IRHfC0qe+sSAoUOUnf1LKRk6ALRLgaUZsGQAdaECcGwFq8c5nyGeu9AQm4D02P2LTANgeqQ9xZUtg2scT4HIFdr2IBBSZAdiEBAUaEGVZY4LWmeBklINd6TM7INuPBkpWbq3kMy/6Eh0Icid6nYGt5pjcRsb3I4idnlevCgHe9gS4IbH/5Q3oGhO9DncCZN2ABOjbEJZesgOM7Yh4D6Le1DZEswGA6kdEehDn1qIjrA2AeutZ216uxcAPPe4/i1sCE0h3Ua7sAAVMIOMQt3Gtq+1khA/gy+LOMZGnvA4fi/vIrcaHoWM9650fYgPqELnR6wyJASwZAll5eCEsfe4NULwRFE84I5rtgAYknREAJ0QFes6IQDudNxtgcgPYPvK3KwXRWjeExVcu85RAfR10P0TH6y11RnTg7FMXBMYhYepMdBwT/BYEu10d5X8HvBN8b4TBYX7yxItXAlBHwOPRPuMj230QFle8veW8joN7nNtlLny1N1B2eXdiyDg/ROafzMWP/0MCAhMQe98XEnJB+B7NZ643pRcBwSR3OvGiRvwiGk/jvC+CApE/fNX9TePLZ+Lrmi/ykqm+COFvPwM3H/0iOr7j01fee8qGxMYRHm1BOHzP1478IzqQZJjn3hC71wgNBwBlJ32LMAEDOHwpAXOD8GOdh3bs4H6DsGQmsXyH8GNIJmRD126eQIF4FnjZwH1KRmWZgIEpR3BVZmkP+Gns4H344GTqJ3hnNmQSyHFuBmfy93OdIGp0hn+CcGUWCHE7hhVBWG01qHh3lgD/FwlQpoBO+IRQKB3aF4VUWIVWeIXegH4DYIBY2IVe+IVgGIZiOIZkWIZmeIZomIZquIZs2P+GbviGcBiHcjiHdFiHdniHTzgzPLWHfNiHfviHgBiIgjiIhFiIhniIiJiIiriIjKgwFnYzAbBZhzWJZCUFIXCJmJiJmoiJTlAEm/iJmugETgCKpBgCWJBZfTUAqKhXl0VZrahXlaVXk9VXIGBXmHVYqoiLhxWLd3UCkiiLtghZq3hXuShYr3hXIXCMc8WLczWLerVW2TNfLJECnvABKFCNH+AJIsBarBVDraVc7BUh5MWN4dVe6gWOVhQh5IheePSNz6WO0YiO70CNnWCN2KiN6xhu3phe1EVe45ge3ehe1CWPiPCP4hWQseSO+GWQtbB2uyFLMGcSK+gL2LZ89Lj/dTxGbfZoCBW5CB+QjYbwdzu3jYKXkdkwIBDUCoxAAS5IGgoZX4LHZC0pAAyJkRb4VuVYCHx2dtoFWgNge9ezQixZIDVJXPVRGFgxkaeRkprzGUfmevdlCEhZASuYNzu5XLbgkKgxRungDg7QASDYgepgkYZgcgDQAEApCBtJCEcWhB8ZklTJCCRZCGaJliepe+qgkkoxAC0ZAC/Zj4YwZGFJk9hVeUHXGgi5ddOGbVKnXVnFABVQeAcAOCZBlIVJX/XRAXqWVWcEgHnZlIdQl2k5X5qJa5lWK1zHmBWESIOglfZnEg5AAY52fPLAlVaHkeqQATY3APxGaw7nk9J3/5iDcJETCHtpVwhr2RpuCZIgJ5yGMJdsaZwuiJPM9hmncZxB8ZevZQjvpglF+UBZ5JwglJiEkHp8p12jxkBpOZlo15L5BU0H2QiymQ1jRxd+KXjSGRSlNZ/hiHrylnn2ZQiuyXVlhwDABwAbIGv8pyP/IgE76QDKNwiCBgD+12WWoH3YppRkuXXeFoPJKRbLWQhX5mYjiRnHGYPUqXHW2Z4co52Q8CG8WZmKUpRA+GM3SZ6DMHAkF5WEoABDOAHruULY2Z/nko8aF3z0uQhX1qKC16H4Jo2hhqRECgA6enYBWgiuyW4IQHvtkAAUwHkMyhto2Xi99nMDN4ShpZyGQP+cxpefyHmNd+eRzKl6ggBBVAedxWl80zkgS6oULAqaArmdhTBpyaZ/QlOUf7cOy5eiY7YI5jloUAoAEzoQQuqe34mZ0xeXSVqdTApxbsqjhaBjE1krj7qatzCg0zZxWtEBxIZ+MRemP5gAelagESoIEypxAzeFrbChhCCahvCh3xCig+o9EERteKp6emaXiKmkK7p+femi2/UTGIpuh3qZySaeeoGjxreY1AqlCXBzhcCezmqZ8DVm9dFlOHcafZqdoTkAyTqagIOu5KqYDqCaxeQJaNoLfKaENogYZhcRY8QAJdFnxrcOuslkvZlkPqmDE7gOZ8emBYtnGgmnbOn/sIfwliK6Y4Y6CMcasVD5DecKeJvaGutQZ/cZqC/6Ez6Zls9yqdd6ozlJCFdpXoRggqNKmSUbri6LD5iBgTl7SzopsvjjlCZJsw0oH2JmlSRoqqwTqREBsY8ArFE7p5fQsZjKjgnJj4JqHzt7CtrqCE6bJQT5nlearTH7CCerWgtpraMStgIBtY4gtXFLtZBgtU/2tY2QtuYImF3Sta2At8kztmPrt0oBuKgDrY5AtqwJIQHQUY0IMknAhyWABJIrUjplBAylUwOQuSWlURsFAp4LUUNVUifFUyJguSWVU5rLuRsVug01uhtVAo5Luqi7UarbuawLUa4LTqDLh7AL/1Glq1N227a/SInG2wSHdQJPkLzB2FdQMIxzVYyWtYvKCFfMCFfOeFe1eFiRxYrQC1fV21bX21a+yLzc+71tJb2pSL27WLzN2LzPuLh1ga1uGxBw2whyi790+wjD67VnC7aI20dNQrh3ibV7Ox2Dy7b+a8CXoLcNnMDlamXq8HBDaiEWCJFuJqvPMJUrCLVPObEXSKgXO6dMKQgdSQhWi6Z7ig589rHNhJdbCKhqC5Oh6maBR5gR3LAwy8CR4ILaNWd8KbbVtrRTykIAWX4i3JmGUMJDywhMDKqDwME6u5IzKb/ryqEBQb+70pUECJbPUJqcOZxl6a5nybLA2pZymv+jn8lxY1kIKRyWjGrCSqiqIzuB3Fp4DpxdEEwIX2qDdXKphbbD+tgKQayfvEatiBA0qYnIinvEOYetn8FnneqZ9gk4YHyacCGjTFsLfdplVOazGwCcHEdrnoQVvDmwQSbKC3vBW3ybFZubu5mwv3lnBsifYrx1nzoIcoutAICxP7gTzpnCPbisjNCdQOuf9udpeYy2e7zEr1pB3wl8ECTIjfqnRkuXDBuUh1CqRQxK4QYuN1mfk6yiHLOfmGzN97qDzbBwofZzxzmtGWBpwgGEayZrUgbPHeBtWkwIDkplEHqYE1qhKQfPR1pnEHui+rbLwvrLaorCelJ2pBbH0en/pwCYZDuKOQHMS+UXmX+MXTUKyYBbwUfECO0nxBVtf2fXyPG5qxTNqTJMzrI1dlKajliMlZy8zloRZseZrxJwnJ2sFUvK01q5z+gwpsFWpgxwpuzAdqK6pp6qp79KsQ39q3N6xVvkxuMi0hIteS78woXAzRittSkbmhtbrRGcqG1MzIM8robMCBPHduL61f/paSr9zacQzsw6ziJayaWmqd0s0vB508l8rQzge7o6ygxNpUDdC4edVRH6dWOkABpMqwCtFbiaZIcts10NABDrq2/K0iPco8BMaR0r2SJizCDLkf+ql/Rqr2GNstEqhBNp1u/FkSD9v1Dd1oXwfNhG/9eKfMdTnMNXG6d1LNp6bdwxDYCbjT2AXba/TGbgFmZaGMp35s7e9tPtnGzVzQAZsGPcIxyQvSsCuw5qdmTuGsveM3AL+2U+qw5i5sFFSwhnbLFUrcahZd5J17E+ya9qPQiFNsHF/ZoxzK6wnbg/wdMzaq02Wri4zQ5ipl06RrDhGq9ETNNF6si4OeDHbN9N+NqU3OEZdIFIW8QOvsmQSJDmcL+MkL8rvr+O0L9/i9vJk9G44I8KHOM8zMy50cwqYaTEtY8FLsDCbSv1Kw8q7pFSfQm+jAkwzuA5DsBiHdt9e+NOvtYH/KI8fuErbeUNTOPzCo9Ni+LecOQXm+SQsP/kVevjVQfkM8y3XEvlBczlerzj79jjGF7NWRvkGj3kbTu7j6swkbuHk1u5fIi5fLi5h+67u9syv9tQwZu6tQtRt9u6udtQiw4yjQ5Oskvoezjpulvp4HTpGdO7e5jpLfPotiu/3RGJxtvqXoW8hbW8hQW/d/W8uIi+ccW+gjW+bJW9c7W9t2iMuI5W4ctWvI5W5Tvr53vrurjrxY5Wx35Wvg5X0Bjmg0HmUX2PndDkcY7nDOHlvvXmfL7Acq7j+JXlorXl3t7lUW7gcH4MgE05Yv4M2P7Z9ejijcDt/f3j7djuQi7utW2uMo46glvnWm7XT5634B7cAf95lYfYENf/kvLOzxk82yqnDkksCPAtsdkuokzm1/JNt2h9CMc6lNda4mZ7CE+sSkGr4R5+5VLOnU6Hww0fpUlZ5esusxU+0qptGCZNyYhX1wJ/pDevxIWw8i65fvEd4ocgxUU8s+kcbiLI1gJhm17pxeawbYXQ2WSsrPJt5hOq9fW921wIAHiqyXac2pTM2mwJ3E2s5zWuoq6c4Dkc9rC372sug/XarUHzmBxNqXrv2tX07mJRH3Yf4FS6xm+Pze+q21+9mecshHtfeM4NQtyXdj5adJbm3UtoC7bpaeZ9sLyZ3gBXAaK8zQ/71BD/9diMGFatliI/wRZ4rBV8bk621dnd0uU5/9cE3uZbq5MzX5SL9/opX+64xvtQfJZqlnrarHfIb+HpjvC9ulWvr672SRe+V8GRasuD7/yDHfVjZmhpB6TZbWkMYPu12aAPWquSqhUCfaH5t4LAZtARv60dPwh9On8hb2vPDAgAggAiAYOCCAmHABQNhwOGi4IKA5KClZIJCIIJG4sBmJaiAAECo6MHB6KaogKqp5YCkYOUkwMMkpCwlqGLrACdh6WWChUDAxMUiwemmZvAnoepu5Ky1Iu6i7UAlLiPo9ufvYOJiBWfzaIKE96D086c0YPW17kSghKViQy33PqKACrcq1dvmCQHDShIOCeIn7dbv4wdGzBwEQKGg/9SSELgCEC5RR9QLMowwIE/Sx8+gBsnqJBFgA0HKHg0SxvLS5Y6KAP2bBAogoIMEnwHL9YrgvQGkTQZjiZQADcB6OTUk1Q6UROqAmCWc+cvd0frJa2X7dDSk9hWWvq5seNHn1cXLcwgieihqTwXjQVKEd8/AFk9/g1Y8ekpoQoS0EWIgORMQYERTHDwq4O8Qwwa4KIwYZHGkQPoJpQUUlLgRihVLmpAdwPMQy4PvZX6GmrNQ02/bazggMEECOKeCq1n99BXvWGv7QW8CXWu29SiXuz9W1hcX5OXXffI2zdwacmpLd9V9tDpjrqJ3WQLWvROuKsamKwbnjv17/Ogkx3/mM+jonwDGOOfIAIZtotQDHQwUQeITJTBOsjc80tmE7XjgIIBPpaRJQgcIx9pImkzQYB0kabaXR6WuEhsl1Toj4qX6JfARIXhZMmMA1wWVFSHbQdLcf4cg9Ehrjy1HIQVwDhIedfwiKOOww3CzwCs1eXjk/QZqR8sTE4yYpK5rEJjcBx6OB98kkzpIlhi5ljNlgbuFidQUc5p2GcElQZUSk+xSBaco/A4CnsF+XgKkLsUCdR4XAIqiqCi1LkLV0AhCgujp3RJnnCQrmUoKvVd6qiBHSKjoZ0HforqLnjWo2eeJ9bjZ5Ojhklnp5JI+mOopyiKVK3YAJteoU9ROhSv/6NgGqiwS3IqnKqWWNors6tWu5YIAmSr7bbcduvtt+AKkES435aABLnellACut0aAQK73A7wLrzaDkCvtiDYe68AIGC7r7r7CiDCuvuKMO+98gas7739BlyCv/cCXPDB9Ca878L05htww/8SfO+s1oZ8DQsBlGzyySinrPLKLJfcRMsrn/AEzCqfcALNKUMRAs4oD7AzzyZDAnTJIQg9dAggDF2yzUoHAMLNSoPw89A+N2000Eg3fULSSjMd9dRAV6301TwX3XTWXUM9dNIit+32261e86qrsV4DMnnUQuUsndBmuSiyreStKZfPFtv3MoDHIrjgexOk66GJv/n25P+U2xk3NXPLXTc1dzf6FK5kOn44eEZGrtfinxde6ehsLoo6X40TW6npROYd8mxknVr5NZfvkjnmm+/SeaaM36r6saVr+XnxohteLO35LZ+68Xw/r7xhEHTGiPYUMJiL7ojUJhN54O8OS++lfghSiMYdM0H5fLbPifun+qlAA8dI+b5TkmBYZVqioEBtdmQJCvUFHcT4kpK2EhbfPIYSx3iNr3CjQMkNAgKhoICQYNSl9J1pWGbBn5usIwlKbIIyZhKEsSQhwGjVx4A1AsB4kLTAwQkGfFFhAI50R6hBoJBKH7SKJDA4CA2SSIX1yYAIdSRD2wHAAaEBQAMmIBqtwAL/d+PjUvnMN4rLkcQ9IBqFc0ASqw3k7xBjJMQs+HGZUp2qS9nDRQOYGJUIruUmHWAQBoMoqfP4TTBZ1B9+JjgIP55uEDgaRAfokkf+KSWKo7GVJCSgjC+S0Cwj2oQOHeCACjxjhY8YwAAZmBM9luSQpmkOepa0JQDhUBQVUF/oMJMATnoSge0LxSKl4j1EURIAlqxdnBqAAAcko5hR9J9JxlcqUXLHGPIx4zEYUIxj3MOAgQSmCBnUzAwYcCcUqcAGDMhEglyOI+ELoygsk5oiEnMc7BwEi1r4PUdKaQCbOI6NODTKHkLmO9kUImiYwpLiBJQk7SAkME+ZmybihiXd/7OnR9wySkhBEUbD8c1CtEJMFRoKd0i0RHWgorvlnKWhmsoeBl85xOzcERYdveRDWdhLZF0UlYZBQAcgsNOddoYjJumoTEgCnHJchAHGvEcWJ3CP7NHmEqdCpyAco0gGZWB/A/AeO32zwHqcEyAXUadcAtSOQ8TvqP3xSwXKyqIEjIhK7cimpvLYAM1IciP9vEkWD4immfqjrKR8xKmMURWFbqMbOEULLdgh0Y+E9a43ek9Q0sGAW96SHOgBpWxGiai91uhImECsRP2hAH6w1CJv3Z8wBCVVmdJiHOvwhrSAIVlBKAsWV6VAMZOhDGkewxMyWUg6P1Kg8alpmgUiKf9mFNQACQh3EMlNgFIfIxFrxumcFBWrnExEoImc0RywmUUHnjHHJb0ROlJtbbNEAVJS3GSkAa3TSQuanIB2siIKna8FbXGIuQTLItmF7CEQwkShAGgiz9iALDVLDs7WB74lhY5+/7sI3x5Ddzf5CAWG5N5RKDiIAvUrPsAUUksQWHFzmgAVpVgdoArWkh1QBHGV+h2m3sWqATUHVQXRSKpmMZ6Wk4QlI2lW9jXErpxpZ38rkZnNaK8ls3AxkeWKXsYqWMANfmn/TMnH7RiSdIIVxAY0GRjbPliV+1VsAmTJyvZIsbb7FFEMQ3yIW2ZGRwxO5x9vDIA9JraQaKZwAXP/fJOr0iWNHU5TeT1VwlCs+YOIWsecHRqnDnDvlFIZ0/ikWQEZA6RA0qSmRM6RAWhms5n36OY3oXrkNd2pTEDU7hMxVAH41a0/FxJS/WqCoVoCcoS2uVGKsAwVVxNQ0dbFpYiOiDhyTMQTCzmG98ycQGYLc37WPG4/YrSRFBLbwpeR1C0PHCCPPsrYgV0EDNO8WGu3WRSmJXb6lORPAJCbw1HCEUW0jQtEgfvPXAQyF3fXO1j8znfBg8XwljU9x4HOtdeYbSugZ9vXEeThfSUO60r8K+nBjnrNm931uIgjuw7cfAU/xcENnvBTLPxRzCsIxidrvb+N/E8Nl91QNp5u57FYnCyxu8bjQHXzkxvdfFIwgdKXzvSmL70IV3C61JtehCJM/eomcJfCKAYvjMFLY/viWMQ8Rq+BBcxgW1fYxiBGr4c5jOzwQvvFuM4ur7ML7AxjO7wk9jEnHv3vgH+bCppG+MIb/vCIT7ziF8/4xjv+8ZCPfMlYEPjKW/7ymM+85jfP+c57/vOgD73oR0/60pv+9KhPvepXz/rWu/71sI+97GdP+9rb/va4z73ud8/73vv+98APvvCHT/ziG//4yE++8pfP/OY7//nQj770p0/96lv/+tjPvva3z/3ue//74A+/+I0fCAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Allergogram showing the number of patients with IgE reactivity towards each of the precipitates identified in&nbsp;figure 1. Precipitates are arbitrarily labeled in alphabetical order from left to right. Allergen D is fel D1. The total number of patients in the analysis is 22. The IgE binding score for each allergen is calculated as the sum of the weighted scores for each patient. Arbitrary weights are assigned as follows: 1 = low IgE binding; 2 = intermediate IgE binding; and 3 = high IgE binding.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_42_25263=[""].join("\n");
var outline_f24_42_25263=null;
